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In July of 2013, a pipeline connecting an offshore oil platform to a tanker, operated by PTT 
Global Chemical (PTTGC), a corporation owned by the government of Thailand, leaked and caused 
crude oil to spill into the Sea of Rayong off the coast of Thailand.  The crude oil covered an area 
of approximately 20 square kilometers and washed ashore on the island of Samet in an area called 
“Ao Prao” on 28 July, 2013.  On-land cleanup lasted about a month and was performed by a 
combination of territorial defense volunteers, citizen volunteers, Thai military personnel and 
PTTGC employees.  Cleanup procedures included oil containment and dispersal using absorbent 
pads, and removal and disposal of contaminated soil, sand and rocks.  The goal of this dissertation 
is to determine if Rayong oil spill cleanup workers were exposed to elevated levels of PAHs and 
benzene and if these exposures are associated with recorded acute symptoms. 
We measured the concentration of 1-hydroxypyrene-glucuronide (1-OHPG), a metabolite 
of pyrene, in the 1,343 frozen stored urine samples available from the cleanup workers, and 
retrieved previously measured trans,trans-muconic acid (t,t-MA) data, a benzene metabolite.  This 
allowed us to quantify the internal dose of polycyclic aromatic hydrocarbons (PAHs) and benzene 
in these workers and to examine factors related to their dose.  During the early days of cleanup, 
urinary 1-OHPG of the workers was elevated, comparable to occupational exposures, and declined 
to near background (general population) levels in workers by the end of the cleanup operation.  This 
was consistent with our hypothesis that the exposure levels of PAHs would be the highest in the 
first week of cleanup and decline thereafter.  Detectable levels of t,t-MA also exhibited a decreasing 
trend over the course of the cleanup period.  Job descriptions with the highest levels of urinary 1-
OHPG after adjustment were oil dispersant applicators and contaminated sand/trash handlers. 
Prevalence of several post-shift symptoms, including irritation of throat and nose, increased 
with concentration of urinary 1-OHPG.  Similarly, one group of symptoms determined by factor 
analysis, designated as “irritative symptoms”, including irritation of the eye, throat and/or nose, 
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eye injection (redness) and excessive tearing (epiphora) was associated with increased 
concentration of urinary 1-OHPG.   
 In conclusion, Rayong oil spill cleanup workers exhibited evidence of elevated levels of 
PAH and benzene exposure during the early weeks of cleanup, compared to near background levels 
4 weeks after cleanup began.  These workers also demonstrated an association between prevalence 
of acute irritative symptoms and PAH exposure measured by urinary 1-OHPG.  Long-term health 
monitoring of oil spill cleanup workers should be implemented, particularly among those workers 
suspected of sustaining high exposure to crude oil. 
Thesis Readers 
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 This dissertation consists of five chapters.  The first chapter is an introduction that 
summarizes the Rayong oil spill incident, the subsequent cleanup efforts, and the specific aims of 
this dissertation.  Chapter 2 presents the rational for the dissertation based on literature reviews of 
general oil spill cleanup procedures and research, the Rayong oil spill details, the composition of 
crude oil, potential toxicants (PAHs and benzene) and confounding factors.  Chapters 3 and 4 are 
organized and presented in manuscript format.  The first manuscript (Chapter 3) describes our study 
to quantify internal dose of PAHs and benzene in the Rayong oil spill cleanup workers and to 
examine factors related to their internal dose.  In the second manuscript (Chapter 4), we examined 
prevalence of post-shift acute symptoms among Rayong oil spill cleanup workers, and assessed 
their association with predictive factors, including internal dose biomarkers of PAH and benzene 
exposure, day of cleanup worked, job description, PPE use, and age of workers.  Lastly, Chapter 5 
summarizes our research conclusions according to the specific aims, public health implications, 
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CHAPTER 1: INTRODUCTION 
On 27 July, 2013, the pipeline connecting an offshore oil platform to a tanker, operated by 
PTT Global Chemical (PTTGC), a corporation owned by the government of Thailand, leaked and 
caused crude oil to spill into the sea of Rayong off the coast of Thailand.  The crude oil covered an 
area of approximately 20 square kilometers and washed ashore on the island of Samet in an area 
called “Ao Prao” on 29-31 July, 2013.1, 2  Although PTTGC estimated that the amount of oil spilled 
was about 50 cubic meters or 336 barrels,2 other experts believe the true volume to be as high as 
190 cubic meters or 1,200 barrels.3 
  Clean-up procedures began at Ao Prao on 29 July, 2013 and ended a month later on 30 
August, 2013.1  These procedures included containing, skimming, and dispersing the oil slick, using 
absorbent pads on land, and digging up and disposing of contaminated soil, sand and rocks.  The 
on-land cleanup was performed by a combination of territorial defense volunteers, citizen 
volunteers, military soldiers and PTTGC workers.3   
 Crude oil is a complex mixture of hydrocarbons, some of which may affect human health, 
including volatile organic compounds (VOCs), such as benzene and naphthalene, and polycyclic 
aromatic hydrocarbons (PAHs), such as pyrene and benzo[a]pyrene.4  The International Agency 
for Research on Cancer (IARC) has classified benzene and benzo[a]pyrene as group 1 carcinogens, 
5 known to cause cancer in humans. 
  The Rayong Provincial Public Health Office and Rayong Hospital designed a health 
surveillance plan for the workers, collecting urine samples post-shift to assess urinary tran,tran-
muconic acid (t,t-MA), a metabolite of benzene.  However, given the lack of smoking status6 data 
and confounding effects of smoking on urinary t,t-MA concentration,7 we believe these exposure 
estimates should be re-examined and expanded to include estimates of PAH exposure and a tobacco 
biomarker (cotinine).8   
  In addition, acute symptoms including respiratory symptoms and irritation symptoms were 
observed and recorded in health survey questionnaires administered after worker’s shifts – even in 
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workers with urinary t,t-MA levels below 500 ug/gCr (OSHA Standard).9  About 1,343 left-over 
urine samples from the Rayong Hospital’s analysis were stored at -30o Celsius as part of the original 
surveillance plan, however, government funding was suspended and there was no plan for further 
use of these samples.  Subsequently, the urine samples, packed in dry-ice were shipped to Dr. 
Strickland’s lab in Baltimore for laboratory analysis, including measuring the PAH metabolite, 1-
hydroxypyrene-glucuronide (1-OHPG), as well as creatinine and cotinine, to expand our 
understanding of the exposures sustained by these workers and lay the groundwork for further 





 The goal of this dissertation is to determine if Rayong oil spill cleanup workers were 
exposed to elevated levels of PAHs and benzene and if these exposures are associated with recorded 
acute symptoms. 
 The specific aims of this study are the following: 
Aim 1: To determine the internal dose of PAHs and benzene among 1,343 Rayong oil spill cleanup 
workers by measuring the PAH biomarker 1-OHPG in previously collected urine samples and re-
examining the urinary t,t-MA concentrations previously measured. 
Aim 2: To compare the internal dose of workers who worked on different days of cleanup: early 
week 1 (day 2-4), late week 1 (day 5-7), week 2, week 3 and week 4, adjusting for smoking status 
(cotinine) and to examine factors related to their dose, including personal protective equipment 
(PPE) use and job descriptions. 
Aim 3: To examine the association between levels of internal dose biomarkers measured in the 
workers and acute symptoms previously recorded. 
 These aims were achieved by measuring an internal dose biomarker of PAHs (1-OHPG) 
and a biomarker of tobacco smoking (cotinine) in the 1,343 frozen urine samples, combined with 
information from the questionnaires and t,t-MA measurements previously recorded.  The 
questionnaire contained data on demographic factors, cleanup jobs, days of cleanup worked, PPE 
use, smoking status (partial data) and symptoms.  
The main hypothesis of our study is that workers who worked during the early days of 
cleanup will have higher levels of exposure and higher prevalence of acute symptoms than those 





CHAPTER 2: BACKGROUND 
A. General Oil Spill Background and Research 
Oil spills involve the release or discharge of a liquid petroleum hydrocarbon into the 
environment, either on land or offshore.1  The size and frequency of oil spills has increased with 
the global development of crude oil production. Oil spills are caused by several common factors: 
human error, instrument error, or natural disaster. 
Oil spills can be caused by human mistakes or carelessness.  An example was the spill 
incident of the Atlantic Empress when the oil tanker collided with Aegean Captain, another 
supertanker off the coast of Liberia.2  In Alaska, the Exxon Valdez oil spill was another example, 
where the ship collided with a reef while the captain, reported to have been drinking heavily the 
night of the incident, was not at the controls.3  
Oil spills can be caused by instrument or equipment failures.  Malfunction of instruments 
related to an oil platform including pipelines, mechanical valves and a blowout preventer were the 
cause of the Deepwater Horizon (BP) oil spill.  An explosion on the oil platform followed by the 
failure of the main blowout preventer was responsible for this massive spill.4  The Rayong oil spill, 
the focus of my dissertation, was an example of pipeline leakage.1 
Oil spills can also be related to natural disasters.  Such was the case in the Prestige tanker 
oil spill.  One of the fuel tanks of the Prestige tanker exploded due to a storm and the tanker sank 




1. Size or Tiers of Oil Spills 
“Tier levels” are used to describe the size and scope of a potential oil spill response. The 
tiered approach to oil spill planning and preparedness is used by U.S. and International 
governmental and non-governmental organizations in developing oil spill response strategies, 
response team structures, and training and exercise programs.  Note that tier levels are typically not 
associated with the volume of oil spilled.  It is the overall impact of the spill, not the quantity alone, 
that dictates the types and amounts of resources required and duration of cleanup operations.6-8  To 
illustrate, 20 cubic meters of crude oil spilled in a small canal might be considered more severe 
than the same amount spilled in the Pacific Ocean.  Thus, the size of the contaminated marine area 
or the concentration of the spilled crude oil must also be considered.  It is recommended that 
organizations adopt a 3-tier oil spill response planning system, similar to the example below, in 
order to scale oil spill response training and exercise programs in an efficient manner.6-8    
Tier 1: Minor spills, including incipient spills that are quickly controlled, contained and 
cleaned up using local (onsite or immediately available) equipment and personnel resources. A Tier 
1 spill would typically be resolved within a few hours or days.  The approximate spilled volume is 
usually up to about 20 cubic meters.  
Tier 2: Moderate spills requiring activation of significant regional oil spill response 
resources. A Tier 2 spill response may continue for several days or weeks. The approximate spilled 
volume is roughly between 20 to 1,000 cubic meters. 
Tier 3: Major spills requiring activation of large quantities and multiple types of response 
resources including those from out of the region, and possibly international sources.  A Tier 3 spill 
response may continue for many weeks or months.  The approximate spilled volume is usually 





There have been many large and small oil spills since the expansion of crude oil production 
in the mid-1800’s.  The amount of oil spilled in a large oil spill incident may be up to 500,000 to 
1,000,000 cubic meters. (Table 2.1)  In global rankings based on oil volume, the Rayong oil spill 
is ranked 158th.8  
Table 2.1: List of 10 Largest Oil Spills by Volume (not related to war) and the Rayong Oil 
Spill   
  
Rank Spill/vessel Location Date Amount Spilled 
(Cubic meters) 
Refs 
1 Lakeview Gusher United States 14 March 1910 – 
10 September 1911 
1,426,800 9 
2 Deepwater Horizon United States 20 April 2010 –  





3 Ixtoc I  Mexico 3 June 1979 – 
23 March 1980 
529,950 11 




19 Jul 1979 332,920 2, 12 
5 Fergana Valley Ozbekistan 2 March 1992 320,000 13 
6 ABT Summer  Angola 28 May 1991 300,000 2, 12 
7 Nowruz Field 
Platform 
Iran 4 February 1983 300,000 2, 12 
8 Castillo de Bellver South Africa 6 August 1983 292,000 12 
9 Amoco Cadiz France 16 March 1978 263,000 12 
10 MT Haven Italy 11 April 1991 167,000 2, 12 





2. Oil Spill Effects 
 A crude oil spill can directly affect the environment and human health, exposing 
individuals to toxicants from crude oil and oil dispersants used for oil spill cleanup.8, 14  Oil spills 
can also indirectly affect the socio-economic fabric of the contaminated area.1, 14-16  For example, a 
spill might result in temporary or permanent damage to fishing or marine recreation industries, 
causing unemployment and regional economic losses.15, 17  Examples of impacts of oil spills on the 
environment and regional and national economy are described below. 
 Environmental Impacts 
 Oil spills can affect a variety of marine organisms, including plants, coral reefs, plankton, 
fish, turtles and birds.18, 19  The toxicokinetic and toxicodynamic processes in marine species are 
varied, and thus result in differences in oil impacts on different species.  For example, many coral 
communities near the Deepwater Horizon oil spill showed signs of stress, including tissue loss, 
sclerite enlargement, bleached and excess mucous production, acutely20 and 2 years21 after the oil 
spill. Whereas, many types of phytoplankton experienced an increase in mortality and growth 
inhibition after exposure to crude oil contaminated water in laboratory experiments.4  Mammals 
are also affected as reported in a study following the Deepwater Horizon oil spill where about 1,000 
cetaceans (marine mammals) including dolphins were stranded or dead immediately after the 
incident.22  
A study from the Exxon Valdez oil spill showed an increase in mortality of sea otters 10 
years after the incident.23  Increased PAH concentrations associated with unusual mortality events 
(UME) were found in fish and their embryos after the Heibei Spirit (Korea),24 Prestige,25 Exxon 
Valdez,26 and Deepwater Horizon oil spills.22  Oil-related lethality of up to 100 sea turtles was 
reported after the Deepwater Horizon oil spill.27  In waterfowl, the cause of death can often be the 
loss of thermal insulation due to oil-coated feathers.28, 29  After the Deepwater Horizon oil spill, 
more than 4,000 seabirds were contaminated with oil and about 2,000 of those were found dead.27   
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Laboratory studies suggested that a reason for UME in marine animals might be the genotoxic and 
immunotoxic effects from PAHs found in crude oil.24, 25, 30, 31   
 Economic Impacts 
 The major direct economic cost of an oil spill is usually in the form of damage to natural 
resources and local industries – often seafood or tourism – and subsequent compensation costs by 
the responsible oil company.  After the Deepwater Horizon oil spill, the BP Exploration & 
Production company was charged an unprecedented $5.5 billion USD Clean Water Act penalty and 
up to $8.8 billion USD in natural resource damages.32  Meanwhile, the estimated short-term 
economic impact of the Deepwater Horizon oil spill on the local seafood industry was $952 million 
USD lost due to decreasing sales, $21 million USD lost due to decreasing income, and 9,315 jobs 
lost due to the temporary stop of seafood production.33  In addition, the indirect loss from 
recreational fishing was about $585 million USD.17  In the Prestige oil spill off the coast of Spain, 
the Galicia government paid a total of €146 million Euros for fishing activity compensation and oil 
spill cleanup.15  The fishing income lost from the Prestige oil spill was estimated to be around €81 




3. Human Health Impacts 
This dissertation focuses on human exposure and health consequences from an oil spill off 
the coast of Thailand.  Therefore, the human health impacts will be discussed in more detail than 
the environmental and economic impacts.  Several oil spills specifically related to human health 
effects will be discussed referring to the incidents listed in Table 2.2 below: 
 
Table 2.2: Oil Spill Incidents with Research Related to Human Health (by amount of spill) 
(modified from Aguilera et al, 2010 and Laffon et al, 2016)34, 35 
 
Incident Date Country Amount spilled 
(Cubic meters) 
Deepwater Horizon 20 April 2010 USA 847,000-1,035,000 
MV Braer 5 January 1993 UK 100,000 
Sea Empress 15 February 1996 UK 85,000 
Prestige 19 November 2002 Spain 74,000 
Exxon Valdez 24 March 1989 USA 44,000 
Tasman Spirit 26 July 2003 Pakistan 44,000 
Erika 12 December 1999 France 24,000 
Hebei Spirit 7 December 2007 Korea 13,000 
Nakhodka 2 January 1997 Japan 7,000 
  
There have been about 11,000 research reports in the oil spill literature since 1967.36  The 
number of oil spill-related health impact studies increased steadily from 1974 to 2014 at a rate of 
about 5% per year.36  One-third of these studies focused primarily on biological endpoints, while 
only 1% of studies was related to human health.36  However, recently due to the Deepwater Horizon 





Figure 2.1: Trend in Number of Oil Spill Studies related to Human Health (Adapted from 
Murphy D. et al. 2016)36 
 
 
 Even with the increasing number of human health studies, information on long-term health 
effects is still lacking.36  One of the few studies from the Prestige oil spill investigated long-term 
health outcomes such as chromosomal damage37, 38 and persistent respiratory symptoms39 at 4 to 7 
years after the oil spill. 
 Acute Symptoms  
 Many studies from oil spill incidents have used structured questionnaire surveys to 
examine acute symptoms in cleanup workers and residents exposed to oil spills.40, 41  The prevalence 
of symptoms related to, or increased in, oil-exposed subjects by the order of decreasing frequency 
are summarized as follows: 40, 41 
•Respiratory symptoms, including throat irritation, sore throat, other throat symptoms, cough, 
shortness of breath and runny nose 
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•Skin symptoms, including irritation, itching, and rash and skin lesions 
•Nausea 
•Dizziness 
•Tiredness or fatigue 
•Muscle pain and injuries, including back pain 
The prevalence of these acute symptoms is sometimes associated with days of cleanup 
work and duration of work.40, 41  Females and children may be susceptible populations with a 
tendency to have higher prevalence of symptoms.40  A study from the Heibei Spirit oil spill found 
that urinary VOC and PAH metabolites were associated with  some of these symptoms.41  
Short and Long-Term Respiratory Symptoms 
Spirometry is the primary method used for measuring pulmonary function and respiratory 
outcomes in clinical and research settings.42  The parameters of spirometry used for measuring 
pulmonary function are peak expiratory flow (PEF), forced expiratory volume in the first second 
(FEV1), forced vital capacity (FVC) and forced expiratory flow (FEF) 25-75%.42, 43  The FEF25-75% is 
the forced expiratory flow during the middle half of the FVC.42 The ratio FEV1/FVC% is the ratio 
of the forced expiratory volume in one second to the forced vital capacity, recorded as a 
percentage.42  
 Two studies from the Braer oil spill in 1993 did follow-up respiratory health exams, 
measuring PEF at 3-56 days and 6 months after the oil spill in children44 and residents43 residing 
near the shipwreck.  PEF in exposed populations from the two studies were within the normal 
range.43, 44  Meo et al. studied lung function in 31 exposed subjects a year after the Tasman Spirit 
oil spill comparing them with age, height and weight matched controls.45  The study found a decline 
in FEV1, FVC and FEF25-75% in the exposed subjects, compared to the controls.45  A study 
conducted 1.5 years after the Hebei Spirit oil spill (Jung et al) reported significantly lower FEV1 
and higher prevalence of asthma attacks in children who lived near the oil spill than among children 
who lived farther away from the oil spill site.46  Two studies from the Prestige oil spill (Zock J.P. 
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et al, 2012, 2014) examined the persistent respiratory symptoms and pulmonary function of clean-
up workers 5 to 6 years after the oil spill.39, 47  Both studies showed no significant differences in 
respiratory symptoms and pulmonary function between the clean-up workers and controls. 
 Psychological and Mental Health 
 Many studies from various oil spill incidents have explored the psychological/mental 
impacts of oil spills.40, 41  Common mental conditions examined in studies include depression, 
anxiety disorders, event-related psychological stress, and post-traumatic stress disorder (PTSD).40, 
41  Depression was generally assessed by the Center for Epidemiologic Studies Depression (CES-
D) score48 and the patient health questionnaire (PHQ)-9.49  Anxiety disorders were examined by 
State-Trait Anxiety Inventory (STAI-X-1) or generalized anxiety disorder (GAD)-9.41  PTSD was 
usually evaluated using the Posttraumatic Diagnostic Scale (PDS). General mental health was 
evaluated with Symptom Checklists (SCL-36 and SCL-90-R), the Short Form-36 (SF-36) and/or 
the Psychological Well-Being Index (PWI).40, 41  Generally, studies from oil spill incidents found 
that the prevalence and symptom score for depression, anxiety disorders, psychological stress and 
PTSD were higher in the oil-exposed population than in unexposed controls.40, 41  In addition, 
adequate social and economic support helped the exposed population and communities to better 
cope with stress from oil spills.41  
4. Biomarkers of Crude Oil Exposure and Effect in Blood and Urine 
 Metabolites of PAHs, VOCs and heavy metals have been measured in several studies from 
the Hebei Spirit oil spill. 40, 41  Few studies from other oil spill incidents measured these metabolites. 
Ha et al. reported that in cleanup volunteers at the Hebei Spirit oil spill, the levels of t,t-muconic 
acid, (a metabolite of benzene), mandelic acid (a metabolite of VOCs), and 1-hydroxypyrene (a 
metabolite of PAHs)  were higher in the urine collected after the cleanup than in the urine collected 
before the cleanup.50  Lee et al. conducted a cross-sectional study to compare the levels of VOC 
and PAH metabolites in urine from residents and volunteers who wore or who did not wear personal 
protective equipment (PPE).  The study found that the concentration of VOC and PAH metabolites 
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in urine was not different between the residents who wore or did not wear PPEs.51  However, the 
study was limited due to the fact that it was conducted in the later weeks of oil spill cleanup when 
the levels of PAHs and VOCs were expected to be low.  Similarly, other studies from the Hebei oil 
spill examined internal dose biomarkers of PAHs and VOCs at least 2 weeks after the cleanup.41  
The half-life of VOCs and volatile PAHs are relatively short, ranging from 6 to 24 hours,52 
Therefore, the low levels of biomarkers in those studies were as expected.  From the Deepwater 
Horizon oil spill, D’Andrea and Reddy reported that 80% of 117 cleanup workers had detectable 
levels of urinary phenol, a metabolite of benzene which is normally found only in workers exposed 
to benzene at more than 1 ppm.53  
A number of biomarkers of biological effect have been examined in various studies related 
to oil spills, including complete blood cell counts (CBC), hemoglobin concentration, hematocrit, 
liver function tests, and renal function tests.34, 35, 54  The urinary biomarkers of oxidative stress that 
were assessed in a few studies were malondialdehyde (MDA) and 8-hydroxy-2'-deoxyguanosine 
(8-OHdG).  From the Tasman Spirit oil spill, Khurshid et al. reported that lymphocyte and 
eosinophil counts in people living near the oil-contaminated beaches were slightly increased, 
compared to the standard value.55  A study of Noh et al. from the Hebei Spirit oil spill reported that 
levels of MDA and 8-OHdG were positively associated with the levels of 1-OHP.56  D’Andrea and 
Reddy reported in their two studies from the Deepwater Horizon oil spill that platelet counts were 
decreased, while hemoglobin and hematocrit levels were increased, in the oil spill cleanup 
workers.53, 57  In addition, the liver enzymes AST and ALT and creatinine were above the upper 
limit of normal in 15%, 31% and 23% of the workers, respectively.53, 57  
Several biomarkers of genotoxicity have been assessed in oil spill volunteers and workers, 
including the comet assay, the micronucleus (MN) test, and sister chromatid exchanges (SCE).34, 35 
In workers from the Braer oil spill, there was no evidence of DNA damage reported in the only 
paper available, however, the sample size was small (n=26).58  In the Prestige oil spill, an early 
study from years 2006-2008 showed evidence of higher levels of DNA damage (by the comet assay 
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and the MN test) and altered frequencies of DNA repair genetic polymorphisms in volunteers and 
hired workers compared to controls.34, 59, 60  In addition, the genotoxicity results were influenced by 
sex, age and cigarette smoke.40  A follow-up study in year 2010 from the Prestige oil spill by 
Rodriguez-Trigo et al, found structural chromosomal alterations in the circulating lymphocyte of 
local fishermen.61  However, two further studies at 6 and 7 years after the spill (in year 2014 and 
2015) did not find any chromosomal aberrations in these fishermen.37, 38  Thus, these findings might 
suggest that DNA damage in bone marrow cells due to crude oil was transient and reversible. 
Conversely, these findings may indicate that the initial findings were not correct.  
Biomarkers of endocrine effects, including cortisol and prolactin, were used as evidence of 
endocrine disruption in various studies of the Prestige oil spill. No studies from other oil spill 
incidents examined endocrine effects.34, 35  The Prestige results indicated that serum cortisol and 
prolactin levels decreased in cleanup workers compared to unexposed controls.43,44,62  
The genotoxicity studies mentioned above were mainly post-spill cross-sectional studies 
without follow up or baseline data. In addition, no quantitative exposure assessment was performed 
for the cases and control group. Therefore, it is difficult to conclude that the observed genotoxic 
effects were due to exposure to toxicants from the oil spill cleanup.   
5. General Cleanup Procedures 
Several methods are available and can be used in combination to contain, restrict and 
eliminate crude oil that has contaminated environmental media, including soil, rock and water.1, 7, 
63, 64  Containment and dispersal are the primary methods used immediately after most oil spill 
incidents. Containment involves the use of booms wrapped with hydrophobic material, including 
foam and plastic. So-called “hard booms” are used for the sole purpose of oil containment (Figure 
2.2). Whereas, sorbent booms are made of material which can absorb oils and float on water such 
as polypropylene. Fire booms, made from fire resistant material, are used to contain crude oil before 
burning.   
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Oil dispersants are emulsifiers, such as butoxyethanol or kerosene, that can link 
hydrocarbon (uncharged) bonds to the covalent (charged) bonds of water.8  Examples of 
commercial oil dispersants are Superdispersant-2564 and COREXIT E-series63 composed mainly of 
2-butoxyethanol (10-30%) and dioctyl sulphosuccinate (10% as a surfactant).8, 63  During oil spill 
cleanup, the dispersants are distributed by aerial or water-level spraying.  Important factors to 
consider before spraying are distance from coral reefs, seawater wave power, and depth of the 
water.7 The amount of dispersant used must be properly estimated and monitored since excess 
exposure, such as occurred in the Deepwater Horizon oil spill cleanup, might induce stress and 
UME in fishes,65, 66 corals67 and their larvae.67  COREXIT 9500 and 9527 were used in the 
Deepwater Horizon oil spill,32 whereas, Superdispersant-25 and Slickgone NS were used in the 
Rayong oil spill.1, 64 
 
Figure 2.2: Containment Boom43 
 
 
Removal or elimination methods involve several procedures, including skimming, 
controlled burning, vacuuming, shoveling, high-pressure hot water spraying, absorbing and 
bioremediation, to eliminate or accelerate the degradation of crude oil and its components. 
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` Oil skimmers are devices that are attached to tow boats and used to separate oil that floats 
on the surface of water from water. Skimmers can be divided into 2 major types, pumping and 
adsorbing skimmers.  Pumping skimmers are used on very thick oil films (Figure 2.3) and vacuum 
oil off the surface of the water, whereas, adsorbing skimmers are used on thinner oil films, and are 
made of adsorbing hydrophoic materials such as Teflon (Figure 2.4).   
Figure 2.3: Pumping Skimmer43 
 




Controlled burning, or in situ burning, was the method used in the Deepwater Horizon oil 
spill.  This involves burning the contained oil at the site of the spill.68  However, this method has 
the potential for widespread air pollution in the form of particulate matter or VOCs.32  In addition, 
the combustion byproducts, carbon dioxide and carbon monoxide, can contribute to climate 
change.8  Therefore, the appropriateness of the method for widespread use is still questionable. 
Manual removal, vacuuming and on-site treatments are approaches that require the use of 
vacuum trucks or other vacuum equipment, and hand tools to remove crude oil-contaminated water 
or soil (Figure 2.5).  Contaminated water can be treated initially with portable on-site wastewater 
treatment systems, and subsequently transferred to standard wastewater treatment plants for further 
treatment.8  Absorbing spilled oil requires the use of absorbing materials that can absorb oil and 
separate it from water.  A common example is the use of absorbent pads made from polypropylene 
to absorb crude oil on beaches. 
 




High-pressure hot water treatment of oil-contaminated beaches and rock is used to distill 
the oil and drain it into an area with installed booms.  However, this method is not ideal because it 
reintroduces toxicants from crude oil into the ambient air and water. 
Bioremediation is a method that adds natural nutrition or substances that can accelerate the 
oxidative reactions or the decay processes of crude oil components.  Common examples of 
bioremediation agents are hydrocarbon-degrading bacteria, micronutrients, and biodiesels.69  The 
usefulness of these bioaugmentation and biostimulation substances is somewhat controversial. In 
some studies or situations, these substances have not proved to be helpful for the decay and 
degradation of crude oil, especially in dealing with thick-layered crude oil.70, 71  
 
B. Rayong Oil Spill Background   
1. Causes and Oil Spread 
On 27 July 2013, the pipeline connecting an offshore oil platform to a tanker, operated by 
PTT Global Chemical (PTTGC), a corporation owned by the government of Thailand, leaked and 
caused crude oil to spill into the sea of Rayong off the coast of Thailand. The leakage was found at 
a single point mooring that discharged the crude oil from the vessel to the refinery.64  The crude oil 
covered an area of approximately 20 square kilometers (Figure 2.6) and washed ashore on the island 
of Samet in an area called “Ao Prao” on 28 July 2013.1  Although PTTGC estimated that the amount 
of oil spilled was about 50 cubic meters or 336 barrels64, other experts believe the true volume to 
be as high as 190 cubic meters or 1,200 barrels.1  The on-water containment procedures started on 
27 July 2013, the same day as the oil spill.  However, the containment efforts failed and the oil 
slick washed ashore on the morning of 29 July 2013 (Figure 2.6) when the on-land cleanup began1 
and continued until 26 August 2013.1  
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Figure 2.6: Satellite Photograph of Oil Spill Off the Coast of Rayong Province, Thailand, 
After Contaminating Beaches at Ao Prao Bay (29 July, 2013) 
 
 
2. Cleanup Procedures 
To mitigate the situation, the pipeline valves were closed as soon as the leakage was 
detected.64  Then oil spill cleanup procedures were followed which included on-water and on-land 
cleanup.  The on-water cleanup initiated by the PTTGC oil company and the Thai National 
Emergency Response Team used containing booms, skimmers and oil dispersants.64 The oil 
dispersants used in the cleanup were 6,930 liters of Superdispersant-25, that contains the potential 
toxicants 2-butoxyethanol and dioctyl sulphosuccinate, and 30,612 liters of Slickgone-NS, that 
contains the potential toxicants kerosene and sodium dioctyl sulphosuccinate.72  The cleanup 
schedule was as follows:64 
27th July 2013: skimmers were used to collect oil from the sea surface.  Oil dispersants were 
sprayed by ships and aircraft.  
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28th July 2013: floating booms were placed to contain the spill.  Ships from the PTTGC 
company, the Royal Thai Navy, the Marine Department and International Regulations for 
Preventing Collisions at Sea (IRPC) and aircraft from Oil Spill Response Limited (an 
international industry-funded cooperative that deals with oil spills) from Singapore coordinated 
to contain and clean the oil slick.  However, the containment was not completely successful 
and the crude oil washed ashore at the Prao bay area on Samet Island. 
29th July 2013: the on-land cleanup was implemented by the Thai Navy and Thai government.  
Procedures included shoveling contaminated rocks and soil, vacuuming oil, high-pressure 
water cleaning and using absorbent pads to collect and remove crude oil.  The workers who 
cleaned the contaminated area included company employees, soldiers from the Royal Thai 
Navy, and citizen volunteers.1, 73  
29th July - 2nd August 2013: (Day 1 to Day 5 of on-land cleanup) Intensive cleanup by 
shoveling, vacuuming, high-pressure water and absorbent pad use. 
 
Figure 2.7: On-Land Cleanup of Rayong Oil Spill, 30 July 2013 (From Thai Naval Medicine) 
     
3rd – 5th August 2013: (Day 6 to Day 8 of on-land cleanup) The oil debris collected was moved 
by cranes and bulldozers to Higgins boats (landing craft) and the frigate HTMS Angthong 791, 
which transferred the oil contaminated debris from Samet island to PPTGC refineries on the 




Figure 2.8: Transferring of Oil Contaminated Debris by Landing Craft and HTMS Angthong 
(From Thai Naval Medicine) 
 
   
6th – 26th August 2013: (Day 9 to Day 29 of on-land cleanup) continued collection of 
contaminated debris. 
27th August 2013: The on-land cleanup ended.  Subsequent environmental monitoring and 
sampling of water and air were performed by the Thai Pollution Control Department of the 
Thai government.  Seafood sampling was performed by the Thai Medical Science Department 
of the Thai government.  However, detailed data was not reported to the public.1 
3. Previous Health Follow-up and Surveillance Plan 
The Rayong Provincial Public Health Office, Rayong Hospital, the Thai Bureau of 
Occupational and Environmental Diseases, and the Thai Naval Medical Department designed a 
health surveillance plan for the oil-spill cleanup workers.  They collected urine samples post-shift 
to measure urinary tran,tran-muconic acid (t,t-MA), an internal dose biomarker of benzene, and 
administered a questionnaire survey post-shift asking about demographic factors, cleanup jobs, 
days worked, hours worked, personal protective equipment (PPE) use, underlying diseases, 
smoking status and acute symptoms.  However, the health surveillance protocols were approved a 
day after the on-land cleanup began.  The earliest day with available urine and questionnaire data 
was 30 July 2013 – the day after cleanup began.  Blood sampling, chest radiography, and more 
detailed questionnaires started on 5 August 2013 -- 7 days after the cleanup began.  Detailed 
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information on the workers and questionnaires will be discussed in chapter 3.  The timeline of the 
spill, the cleanup and the health surveillance plan is summarized in the calendar (Figure 2.9): 
 
Figure 2.9: Rayong Oil Spill Cleanup Sequence of Events (27 July 2013 – 26 August 2013)  
 
Note: On-water containment included oil dispersants, foam injection and containment booms. 
Note: Contaminated sand and water were transferred to a refinery on the mainland for further treatment. 
 
Some of the cleanup workers were asked to voluntarily provide a urine sample immediately 
post-shift.  The samples were tested for urinary t,t-MA in Thai government laboratories.  In 
addition, a personal medical history and screening physical examination by organ system for every 
worker was performed by Thai government physicians.  Moreover, workers were asked to 
voluntarily provide their blood for further laboratory tests, including complete blood counts (CBC), 
liver enzymes (AST and ALT), blood urea nitrogen (BUN) and creatinine.  Furthermore, a chest x-
ray was performed in workers who agreed to it. 
 For long-term follow up, the workers who worked in the first week of cleanup (29th July- 
5th August) were advised to have their blood tested for CBC every 3 months in the first year after 
the oil spill and once every year after that.  Their liver enzymes, BUN, creatinine and chest 
radiography were to be performed every year for at least 5 years after the Rayong oil spill.  The 
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rest of the workers were advised to have their blood tested for CBC, liver enzymes, BUN, and 
creatinine measured and chest radiography at the 2nd and 5th years after the oil spill. 
  Data from this health surveillance program was available for our research, including 
questionnaires, urinary t,t-MA and (partial) creatinine measurements.  There were a total of 2,118 
records from a short post-shift questionnaire (including demographic factors, days of cleanup 
worked, job descriptions and acute symptoms) collected at the same time as the urine sample 
collection.  Of the 2,118 records, only 1,343 urine samples were available for further laboratory 
analysis as shown in Figure 2.10.  There was another subset of workers containing 2,386 records 
which included blood samples and a long questionnaire (including smoking status) at the end of 
cleanup in September, 2013.  This subset did not include urine samples except for a small number 
(n=400) of workers.  
Figure 2.10: Venn Diagram Summarizing Worker Population with Urine Samples and Blood 
Samples 
 
 The demographic factors of the 2,118 records are shown in Table 2.3.  Of the 2,118 
worker records, 88% of them were male and the median age was 28 years old.  Most of them 
were military personnel or PTTGC employees, and worked during day 2 to 4 of cleanup.  The 
distribution of these 2,118 worker records by age, sex, background and days of cleanup were 
similar to the distributions among the 1,343 urine samples, as described in Chapter 3.  
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Table 2.3: Demographic Factors of Cleanup Workers from Short Questionnaire 
Demographic Factors Descriptions Number of Workers Percent 
Total    2118 100.0 
Age Median (1st-3rd Quartiles) 28.0 (22.0-40.0) 
 Unknown Age 44 2.1 
Sex Male 1869 88.2 
  Female 202 9.5 
  Missing 47 2.2 
Background Military Personnel 968 45.7 
  PTTGC Company Employees 782 36.9 
  Citizen Volunteers 359 16.9 
  Unknown 9 0.4 
Days of Cleanup Day 2-4 1159 54.7 
  Day 5-7 446 21.0 
  Day 8-14 300 14.2 
  Day 15-21 117 5.5 
  Day 21-28 85 4.0 
 Missing 11 0.5 
 
4. Previous Studies from the Rayong Oil Spill 
Only two studies have been published so far regarding the Rayong oil spill cleanup 
workers, using data from the questionnaires and the health examinations performed as part of the 
surveillance program.  A peer-reviewed study by Sithisarankul et al (2014), published in English, 
is a preliminary report of workers characteristics, urinary t,t-MA levels, and their self-reported 
acute symptoms, using a dataset of 2,118 workers who voluntarily provided their urine samples.74  
Almost all of them (90.2%) were male with occupation reported as a military professional 
(45.7%).74  The mean age of the workers was 31.9 years and 82.2% of the workers worked on day 
1 to day 5 of the cleanup (29 July to 2 August).74  The urinary t,t-MA levels were reported in 
categories using the cut-off at 500 ug/gCr of urinary t,t-MA and the limit of detection was unclear.  
Only 1 worker was reported to have a t,t-MA level more than 500 ug/gCr.  Detailed values of 
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individual worker’s t,t-MA concentration were not reported in the study.  The acute symptoms were 
grouped and reported by organ system.  The organ system with the most frequently reported 
symptoms was the pulmonary system (38.2%).  The organ system with the least frequently reported 
symptoms was the gastrointestinal system (6.0%).  Figure 2.11 summarizes the acute symptoms by 
organ systems in the order of numbers of cases from Sithisarankul’s study.     
Figure 2.11: Percentage of Workers with Reported Symptoms by Organ Systems. (Adjusted 




Being a preliminary report, the study of Sithisarakul et al is somewhat limited, showing 
only summary data and descriptive statistics.  However, the study reports an interestingly high 
prevalence of pulmonary symptoms which should be further explored.  Further study designs with 
inferential statistics are needed to assess associations between the acute symptoms and estimated 
exposure days and PPE use.  
A second study of Rayong oil-spill workers conducted by Rheanpumikankit et al, was 
published in a Thai regional medical university journal.  The study examined an expanded group 
of workers from those studied by Sithisarakul et al that included 2,409 workers who voluntarily 
consented to have their blood tested.  The study classified cleanup workers into 3 separate groups 
by days of cleanup work, hours worked, and job descriptions.  The high exposure group included 
















































participated for at least 6 hours/day for at least one day during Days 1-5, and the oil transporters 
who worked during Days 6-8.  The medium exposure group were workers whose job descriptions 
included sand removal, journalist, or supervisors who participated for at least 6 hours/day for at 
least one day during Days 1-5.  Whereas, the low exposure group included workers who 
participated for less than 6 hours during Days 1-5 and the workers who worked during Days 6-29 
regardless of duration. 
The focus of this study was the initial and follow-up results of CBC, creatinine and liver 
enzymes.  The acute symptoms were also vaguely reported as the number of cases and 
percentages.75  However, some of the results seem doubtful since irritating nose symptoms were 
reported as 100% prevalent in all 2409 workers.  The laboratory results were compared among the 
three pre-defined exposure groups mentioned above.  The study reported that, immediately after 
the Rayong oil spill, the proportion of workers with serum AST and ALT levels more than 35 
IU/liters was higher in the high exposure group than in the medium and low exposure groups.  The 
proportion of workers with anemia and serum creatinine more than 1.5 mg/dL was not different 
among the 3 groups.  Only the high exposure group was retested at one year of followup for CBC, 
serum creatinine, AST and ALT.  However, there was no change in proportion of workers with 
AST and ALT levels more than 35 IU/L as compared to the baseline post oil spill results.  This 
suggests that the observed larger proportion of workers with high AST and ALT in the high 
exposure group at baseline could be due to unrelated factors rather than exposure to toxicants from 
the Rayong oil spill.  Other potential factors that can cause an increase in AST and ALT levels are 
alcohol consumption and liver diseases (e.g., non-alcoholic steatolic hepatitis (NASH)), caused by 
obesity and hyperlipidemia.  Furthermore, the fact that the medium and low exposure groups were 
not followed up at one year after the oil spill, means that there was no control to compare with the 
high exposure group. 
The paper by Rheanpumikankit et al. had a number of other limitations. Firstly, the 
classification of exposure groups was not clear or practical.  The study differentiates high and 
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medium groups only by job descriptions.  Misclassification might be an issue because participants 
might perform several jobs in the same day.  Another issue is the classification by the working 
hours of the workers.  As mentioned above, to satisfy the criteria for high and medium exposure 
the cleanup workers had to work at least 6 hours.  About 20% of workers did not provide 
information on the duration of cleanup jobs, making it hard to classify by the proposed exposure 
group criteria.  Secondly, the blood samples were not drawn on the same day as cleanup work. 
Some of the samples were taken up to 30 days after the day worked.  This point was not mentioned 
and accounted for in Rheanpumikankit’s paper.  Thirdly, anemia, creatinine, AST and ALT were 
used as categorical variables, thus reducing the statistical power of these measures as compared to 
using continuous variables.  In addition, the classification of anemia, high creatinine, high AST and 
high ALT were not clearly described and did not use standard classifications.  Furthermore, WBC 
and platelets are more sensitive to the exposure to benzene than is hemoglobin.76  Therefore, the 
study should examine the number of WBC and platelets, in addition to hemoglobin concentration. 
The proposed health surveillance plan from the Rayong provincial hospital, the Thai Naval 
Medical department and the Rayong local health office could be improved.  For long-term follow 
up, all workers should be advised and given the same blood exams every year.  Currently, there is 
no evidence that the workers who worked in the first week of cleanup are more likely to have 
abnormal CBC and liver enzyme levels than the workers who worked during the subsequent weeks.  
In terms of risk assessment, all workers should be considered exposed to toxicant levels sufficient 
to cause adverse health effects until there are enough data to disprove potential adverse health 





C. Crude Oil Composition, Potential Toxicants and Confounding Factors 
Crude oil is composed of 84-87% carbon, 11-14% hydrogen, 0.06-2% sulfur, 0.1-2% 
nitrogen, 0.1-2% oxygen and trace amounts of metals.77  It is a complex mixture of hydrocarbons, 
some of which may affect human health, including VOCs such as benzene, and PAHs such as 
pyrene and benzo[a]pyrene.78  The composition of crude oil is summarized in Table 2.4. 












1 Paraffin (C6 - C12) 0.15 86-170 710 4.755 
2 Paraffin (C13 - C25) 0.15 184-352 770 0.007 
3 Cycloparaffin (C6 - C12) 0.2 84-164 810 28 
4 Cycloparaffin (C13 -C23) 0.2 156-318 900 0.5 
5 
Aromatic mono and 
dicyclic (C6 - C11) 
0.042 78-143 940 890 
6 
Aromatic polycyclic 
(C12 - C18) 
0.03 128-234 1000 6.25 
7 
Naphtheno - aromatic 
(C9 - C25) 




0.15 300-900 1010 0 
9 Benzene 0.001 78.11 878.6 800 
10 Toluene 0.003 92.14 867 526 
11 Ethylbenzene 0.001 106.17 867 206 
12 Ortho-,meta-,para-Xylene 0.003 106.17 870 0 
 
Of these components, we selected two toxicants, benzene and aromatic polycyclics, that 
can affect human health and have internal dose biomarkers measurable in urine.  In addition, the 
International Agency for Research on Cancer (IARC) has classified benzene and benzo[a]pyrene 
(a PAH) as group 1 carcinogens79, known to cause cancer in humans.  A few studies from previous 
oil spills have measured internal biomarkers in urine of PAHs and benzene.  Two of the studies 
from the Hebei oil spill (Ha et al. and Lee et al.) measured the levels of t,t-MA and 1-hydroxypyrene 
in the urine of cleanup volunteers.50, 51  A study from the Deepwater Horizon oil spill by D’Andrea 
and Reddy measured urinary phenol, a metabolite of benzene.53  Since my dissertation focuses on 
PAHs and benzene, the two toxicants will be discussed in detail. 
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1. Polycyclic Aromatic Hydrocarbon (PAH) 
Polycyclic aromatic hydrocarbons, or PAHs, are a group of over 100 different organic 
compounds, consisting of two or more fused benzene rings, arranged in various forms.80, 81  In 
general, the sources of PAHs are incomplete combustions of organic materials, formed by various 
processes, including power production, coke production, iron/steel foundries, forest fires, internal 
combustion engines, cooking processes, food production (smoked products) and tobacco smoke. 82, 
83  Physical and chemical properties of PAHs vary based on the numbers and arrangement of 
aromatic rings, molecular weights and functional groups attached to the benzene rings.84  IARC has 
classified several PAHs as known (group 1), probable (group 2A), possible (group 2B), or unknown 
(group 3) human carcinogens as indicated in Figure 2.12.80  Although animal studies are conducted 
to test the carcinogenicity of individual PAHs85, humans are exposed to mixtures of PAHs rather 
than individual PAHs.  Thus, epidemiological studies are conducted to link cancer outcomes to 
PAH mixture scenarios such as lung cancer mortality to coke oven emission86, 87 or cigarette 
smoke.88  General populations are exposed to PAHs via cigarette smoke, indoor air pollution from 




Figure 2.12: Structures and Nomenclature of 16 PAHs and Their IARC Classifications 
(Adapted from Dipple 1985)90  
 
 
Labeled in red are the IARC classifications of the PAHs.  
Group 1: Known to cause cancer in humans 
Group 2A: Probably carcinogenic to humans 
Group 2B: Possibly carcinogenic to humans 
Group 3: Not classifiable as to its carcinogenicity to humans 
 
 Absorption, Distribution, Metabolism and Excretion of PAHs in Humans 
PAHs can be absorbed into the human body by inhalation, ingestion or dermal absorption.80 
The rate of absorption after inhalation depends on the properties and sizes of the particle carriers.   
Pure PAHs are cleared by 50% from the lung within 5 hours, while PAHs attached to small carbon 
particles take around 36 hours to be cleared by 50% from the lung in mice.91  PAHs adsorbed to 
water-soluble particles are easily dissolved and absorbed by mucoepithelial cells.92  More than 95% 
of pure PAHs are cleared within 24 hours after inhalation.92  PAHs are absorbed at alveoli, enter 
the blood circulation, and then are metabolized by cytochrome P-450 enzymes in the liver.  A study 
by Withey et al showed that the distribution of benzo[a]pyrene is highest in lung and fat at 0 and 6 
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hours, respectively after the inhalation.93  Immediately after inhalation, the levels of benzo[a]pyrene 
and total PAH metabolites in organs were as follows: lung>blood>liver>kidney>fat>fetus. While 
at 6 hours, the order was fat>lung>kidney>liver>blood>fetus. 
A common exposure pathway in humans is ingestion of food containing PAHs.  A large 
proportion (38-58%) of PAHs in ingested food is absorbed.80, 94  Benzo[a]pyrene, pyrene, chrysene 
and anthracene are easily absorbed by the gastrointestinal tract (50-80%), while phenanthrene is 
poorly absorbed (4-7%).80, 94  PAH absorption in the intestines is enhanced by bile acid produced 
by the gall bladder.95  Dermal absorption is another common absorption pathway for PAHs.  Dermal 
absorption of benzo[a]pyrene and pyrene from coal tar treatment is about 25% and 20% on human 
skin, respectively.96  PAH absorption also varies by anatomical site in the order: shoulder> 
forehead, forearm, groin > ankle, hand (palmar site).97  Few studies have examined the detailed 
distribution of PAHs by ingestion and dermal absorption. However, a study in rats found that 3 
hours after ingestion, the levels of benzo[a]pyrene and its metabolites were highest in lung, kidney 
and liver.98 For the dermal route, a study in rats found that the level of pyrene and metabolites was 
highest in liver, kidneys and fat.99  The metabolism of PAHs occurs in several organs, including 
the liver, lung and kidneys.80    
Metabolites of PAHs in serum and urine have been used extensively in various studies as 
internal dose biomarkers to quantify PAH intake by participants.  Hydroxylated metabolites and 
DNA and protein adducts have been used in both occupational and non-occupational studies to 
quantify the internal dose of PAHs.100-102  However, the use of DNA and protein adducts of PAHs 
is somewhat limited due to cost, detection limits, and stability issues, especially in frozen stored 
urine.100  Therefore, hydroxylated metabolites are candidate options for our current study involving 
the analysis of 1,343 human urine samples.  In particular, the metabolites of pyrene, 1-
hydroxypyrene (1-OHP) and 1-hydroxypyrene-glucuronide (1-OHPG) (Figure 2.13) are widely 
used as surrogate internal dose biomarkers in many studies including the large US cross-sectional 
study, NHANES, and several other studies.100, 101, 103, 104  In addition, in prior investigations, Dr. 
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Strickland’s laboratory has used biomarkers of PAH exposure in a variety of occupationally or 
environmentally exposed populations.101, 103  Urinary 1-OHPG, the major human metabolite of 
pyrene, or its deconjugated form 1-OHP, have been shown to be elevated in smokers, patients 
receiving coal tar treatment, asphalt road pavers, and coke oven and blast furnace workers, and 
subjects ingesting broiled meat.100, 103, 105  
 
Figure 2.13: Metabolism of Pyrene and Formation of 1-OHPG 
 
 
Dr. Strickland’s study of steel plant workers in Korea showed exposure-related increases 
in the concentration of 1-OHPG in post-shift urine samples.103  In the current dissertation, the 
selected internal dose biomarker of PAHs will be 1-OHPG.  Since the half-life of  urinary 1-OHPG 
is about 6-35 hrs,106 the levels of 1-OHPG will reflect the PAHs that cleanup workers were exposed 
to on the day of urine collection or the cumulative dose from the day before.  Levels of 1-OHPG 




Table 2.5: Levels of PAH Exposure by Urinary 1-OHPG Concentration (pmol/ml) Among 





Steel Plant Jobs 
1-OHPG Concentration (pmol/ml) 
Mean(sd) 
Smokers Non-Smokers 
High Blast furnace, coke oven 4.91 (1.02) 2.84 (0.90) 
Medium Casting, steel/iron production 0.94 (0.42) 0.70 (0.28) 
Low Office, construction, transport  0.55 (0.07) 0.26 (0.06) 
 
Laboratory Analysis of 1-OHPG 
In this dissertation, urinary 1-OHPG was measured using immunoaffinity chromatography 
and synchronous fluorescence spectroscopy (SFS), modified from protocols of Strickland et al, 
1994.101  Urine samples (2 ml) were treated with 0.1 N HC1 (at 90°C) for 60 minutes to hydrolyze 
acid-labile metabolites.  The hydrolyzed samples were neutralized and loaded onto Sep-Pak C18 
cartridges (Waters), washed with 4 ml of 30% methanol (in water), and the relatively non-polar 
metabolites were eluted with 4 ml of 80% methanol (in water).  The total eluate volume was reduced 
(0.5 ml) using vacuum evaporation. Immunoaffinity columns were prepared using poly-prep 
columns (0.8x4 cm) filled with CNBr-activated Sepharose4B (0.8 ml) coupled with monoclonal 
antibody 8E11, which recognizes PAH metabolites.  Then 1.5 ml of 15mM phosphate buffered 
saline (PBS) was added to the 0.5 ml eluate samples and incubated at 37oC for 30 minutes.  The 
incubated samples were diluted with an additional 2 ml of PBS and loaded on the immunoaffinity 
columns.  After washing the columns with 35% methanol (in PBS), the bound material was eluted 
with 4 ml of 55% methanol (in PBS) and collected for SFS analysis.  Using SFS with a wavelength 
difference of 34 nm, samples containing 1-OHPG possess a characteristic fluorescence excitation 
maximum at 347 nm with emission at 381 nm (Figure 2.14).  Fluorescence intensity was used to 
quantify 1-OHPG; the limit of detection was 0.03 pmol/ml urine.  The detailed protocol can be 




Figure 2.14:  Synchronous Fluorescence Spectroscopy (SFS) of Immunopurified Urine 









Health Effects of PAHs 
In occupational settings, chronic high levels of PAHs can cause bloody vomit, breathing 
problems, chest pains, chest and throat irritation, and abnormalities in chest X-rays.107  In the 
general population, people exposed to PAHs from traffic can develop increased respiratory 
symptoms such as cough, wheezing, irritating throat, exacerbation of asthma, allergic rhinitis and 
impaired lung function.104, 108-111 In addition, two studies in oil spill cleanup workers, reported that 
urinary metabolites of VOCs or PAHs were also related to increased prevalence of respiratory 
symptoms.46, 112 
PAHs are suspected to play a role in smoking-induced atherosclerosis and other 
cardiovascular effects.113-116  One hypothesis is that the PAHs can down-regulate the liver X 
receptor (LXR) alpha gene that controls cholesterol distribution in humans. This may stimulate 
cholesterol deposition in the endothelial cells of blood vessels.114  In addition, studies using 
NHANES data found that urinary metabolites of PAHs were related to self-reported cardiovascular 
diseases and biomarkers of inflammation related to cardiovascular diseases.117-119  The carcinogenic 
effects of PAHs are well documented. Studies in humans and animals demonstrate the genotoxicity 
of PAHs by epoxide formation.89, 120-123  The most common cancer related to PAHs is lung 
cancer,124-126 while other cancers associated with PAHs are stomach, esophageal and skin cancer.80 
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 Factors Associated with PAH Exposure in Oil Spill Cleanup Workers 
 PAHs are a component of crude oil, and factors related to PAH exposure among oil spill 
cleanup jobs are expected to be: day of cleanup work, duration of cleanup work and job 
descriptions. PAHs in crude oil can last for up to weeks or months, depending on the specific PAH.  
If cleanup procedures are effective, then the amount of crude oil (and with the amount of PAHs) at 
the spill site should decrease as the cleanup progresses.  Workers who participate in the first week 
of cleanup should be exposed to higher levels of PAHs than the workers who work in subsequent 
weeks.  Regarding specific job descriptions, workers whose jobs involve direct contact with crude 
oil, including oil dispersant spraying, and shoveling and removal of oil contaminated rock and sand, 
should have higher levels of PAH exposure than support workers whose jobs do not involve direct 
contact with oil, such as supervisors, journalists, photographers and health care workers.  Similarly, 
longer duration of work in direct contact with oil should be associated with higher levels of PAH 
exposure.  
Apart from PAHs in crude oil, cleanup workers may be exposed to PAHs from smoking or 
diet.  Cigarette smoke contains various PAHs including benzo[a]pyrene and pyrene in both 
mainstream and sidestream fractions.127  The concentration of benzo[a]pyrene in mainstream smoke 
is reported to be 118-374 ng/cigarette, with the concentration in sidestream smoke  estimated to be 
2.5 to 10 times higher.127  Thus both current smokers and non-smokers exposed to secondhand 
smoke are exposed to PAHs.104  In current smokers, the levels of 1-OHPG measured in urine are 2-
3 fold higher than in the urine of non-smokers.103 
 Diet is another major source of PAH exposure in humans.  Foods cooked directly over an 
open flame or broiled at high temperature causing the pyrolysis of fats, carbohydrates, or proteins, 
can produce high levels of PAHs.128  Broiled meat and other smoked foods can contain up to 184 
ng BaP/g, and its consumption can increase levels of PAH metabolites in urine.111,129, 130  Thus, 





Benzene or benzol is a colorless liquid with sweet odor, highly flammable, water-soluble 
and volatile.76  Common sources of benzene exposure in the general population are cigarette 
smoke131-133, evaporation from gasoline service stations134, 135, crude oil, and burning of gasoline, 
coal and oil.136, 137  Benzene in air breaks down and reacts with other chemicals within a few days,138 
however, when dissolved in water or soil, benzene breaks down slowly over the course of a few 
weeks.139  Therefore, during an oil spill cleanup, workers might be exposed initially to benzene by 
inhalation in the first few days, but exposed to benzene by dermal absorption in subsequent days 
and weeks. 
Absorption, Distribution, Metabolism and Excretion of Benzene 
Benzene can be absorbed into the human body by inhalation, ingestion and dermal 
absorption.  Inhalation is the major route of human exposure to benzene. Immediately after 
inhalation (5 minutes), 70-80% of benzene is absorbed to the systemic circulation.140,141  Lindstrom 
et al. reported that showering with benzene contaminated water resulted in 40% absorption of 
benzene by inhalation and 60% by dermal absorption.142 
Information on oral absorption of benzene in humans is usually associated with accidental 
or intentional poisoning.143  After ingestion, benzene is rapidly absorbed by the gastrointestinal 
tract.143  Data from animal studies indicates that after ingestion, the absorption is 90-97% of the 
ingested dose.144, 145  Conversely, benzene is absorbed through the skin to the systemic circulation 
by passive diffusion.  Thus, the proportion absorbed by skin is small, about 0.2-1.1% of the total 
amount in contact with the skin, as reported in various human studies.146-148 
Since benzene is lipophilic, its distribution to fatty tissues is expected.  After inhalation, 
ingestion or dermal absorption, benzene is distributed throughout the body by blood.  Autopsies of 
dead workers who inhaled high levels of benzene showed that organ levels of benzene ordered by 
concentration were: 3.9 mg% in brain, 2.2 mg% in abdominal fat, 2.0 mg% in blood, 1.9 mg% 
kidney, 1.6 mg% in liver and 1 mg% in stomach.76  Benzene is rapidly metabolized to catechol149 
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and hydroquinone, a genotoxic metabolite.150  In rodent studies, six hours after inhalation, benzene 
was found in blood, bone marrow, fat, kidney, lung, liver, brain and spleen.  However, its 
metabolites, phenol, catechol and hydroquinone were found mainly in bone marrow at levels higher 
than in blood.150, 151 
Metabolism 
 The first step of benzene metabolism takes place in the liver, where benzene is 
biotransformed by the phase I enzyme cytochrome P-450 (CYP) 2E1 via oxidative reaction forming 
benzene oxide.152  There are various oxidative reactions and pathways that benzene oxide can 
undergo (Figure 2.15).  The predominant pathway is to form phenol by non-enzymatic 
rearrangement.153 Phenol is then oxidized by CYP2E1 to catechol or hydroquinone, which are 
further oxidized by myeloperoxidase to the reactive metabolites 1,2- and 1,4-benzoquinone, 
respectively.154  Alternatively, benzene oxide may be converted to benzene dihydrodiol and 
catechol by epoxide hydrolase and dihydrodiol dehydrogenase, respectively.154  All metabolites, 
including phenol, catechol, hydroquinone, and 1,2,4-benzenetriol can undergo conjugation with 
glucuronic acid or sulfonyl groups.154  Alternatively, benzene oxide can react directly with 
glutathione to form S-phenylmercapturic acid (S-PMA) or undergo iron-catalyzed ring-opening to 
form trans,trans-muconic acid (t,t-MA).144, 154  The metabolic pathways of benzene are summarized 





Figure 2.15: Metabolic Pathways for Benzene (Adapted from Nebert et al. 2002)76, 154 
 
ADH = Alcohol Dehydrogenase; ALDH = Aldehyde Dehydrogenase,  
CYP2E1 = Cytochrome P-450 2E1, DHDD= Dihydrodiol Dehydrogenase; EH= Epoxide Hydrolase; GSH = 
Glutathione; MPO = Myeloperoxidase;  
NQ01= NAD(P)H Quinone Oxidoreductase 
 
The major elimination pathway of benzene is via exhalation.  The exhalation of benzene 
has three phases, starting with a rapid phase (half-life =42 min) followed by a slower phase  (half-
life = 8 hours).155  A smaller proportion of absorbed benzene is excreted in urine (0.2%) as phenol 
and conjugates formed with glucuronides and sulfates.76,148   
 Urinary Biomarkers of Benzene 
Urinary metabolites of benzene are important internal dose biomarkers.  Three urinary 
metabolites of benzene that have been extensively used as biomarkers in occupational settings are 
urinary phenol, t,t-MA and S-PMA.156-158  Each of these metabolite has its own utility, strengths 
and drawbacks.  Urinary phenol correlates well with benzene at high concentrations -- levels as 
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high as 620 ppm,159 however it is insensitive at levels of benzene less than 1 ppm.158  Phenol is also 
not specific to benzene because intake of certain drugs or medicines such as phenyl salicylate can 
raise levels of phenol.160  t,t-MA and S-PMA are more sensitive than phenol, especially at benzene 
levels less than 1 ppm.52, 161  The half-life of t,t-MA (5 hours) is somewhat shorter than that of S-
PMA (8-9 hours).52, 161  More importantly, t,t-MA can be confounded by sorbic acid which is found 
in processed foods including ham, wine and citrus fruit juices.162  Overall, S-PMA is more specific 
to benzene than t,t-MA.   
Two methods are commonly used to measure t,t-MA: high-performance liquid 
chromatography (HPLC) and gas chromatography (GC).  The limit of detection for both methods 
is usually about 10 ng/ml.158  The HPLC method was used by the Rayong hospital to measure 
urinary t,t-MA in the Rayong oil spill cleanup workers,163 however, the limit of detection of these 
measurements is not specified.  
Health Effects of Benzene 
Acute toxicity has been reported in individuals exposed to high levels of benzene.  In 
extreme cases, individuals exposed to benzene at levels as high as of 20,000 ppm experienced rapid 
death by asphyxiation, central nervous system depression and cardiac collapse.164  Autopsy of dead 
workers accidentally exposed to high levels of benzene revealed acute granular tracheitis, 
laryngitis, bronchitis, and massive hemorrhage in lung.149  Less extreme chronic exposure to 
benzene has been studied in occupational settings.  Nasal irritation, dyspnea, and sore throat were 
reported in workers exposed to benzene concentrations of more than 60 ppm for more than 1 
year.165, 166  
Acute hematologic effects have been reported in workers exposed to benzene at levels more 
than 60 ppm.  Leukopenia, anemia and thrombocytopenia were observed in these workers more 
than 2 days after exposure.167  At levels of benzene below 1 ppm, hematologic effects have also 
been observed.  Lan et al reported that most types of white blood cells decreased in workers exposed 
to <1 ppm benzene, except for monocytes, CD8+-T cells, and platelets.168  Hemoglobin decreased 
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only among the highest exposure group (>10 ppm) after adjusting for age, gender, cigarette 
smoking, alcohol consumption, recent infection, and body mass index.168  Over longer time periods, 
sub-chronic to chronic exposure to benzene can result in pancytopenia, aplastic anemia and 
eventually leukemia -- especially acute myelogenous leukemia (AML).76, 169-175   
Factor Associated with Benzene Exposure in Oil Spill Cleanup Workers 
The main source of benzene in an oil spill is directly from the crude oil.  Therefore, factors 
associated with potential benzene exposure are day of work, duration of work, and job description. 
Benzene is volatile and can break down in air within a few days, and in water within a few weeks.   
Consequently, benzene levels would be expected to decrease fairly rapidly within the first few days 
of cleanup.  Benzene metabolite levels in workers should be high in the first few days of cleanup, 
then rapidly decline in subsequent weeks.  Regarding job descriptions, workers with direct contact 
with crude oil are expected to have higher levels of benzene exposure than those with jobs that do 
not involve direct contact with oil, such as supervisors, reporters, photographers, and health care 
workers.  Similarly, longer duration of cleanup work should be associated with higher levels of 
benzene exposure. 
Another factor that will confound benzene biomarker measurements is cigarette smoke.  
The average heavy smoker (32 cigarettes per day) takes in about 1.8 mg of benzene per day.80  This 
is estimated to raise the mean urinary concentration of urinary t,t-MA in smokers 3- to 5-fold 
compared to the mean concentration in nonsmokers.176  This implies that cigarette smoking may 
affect the urinary level of benzene metabolites to a greater degree than PAH metabolites. 
Finally, sorbic acid in processed meat, wine, and citrus fruit juice can interfere with and 
bias the results of urinary t,t-MA measurements, leading to misclassification or overestimation of 
benzene exposure.162  
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CHAPTER 3: EXPOSURE ASSESSMENT OF RAYONG OIL SPILL CLEANUP 
WORKERS 
ABSTRACT 
Background: In July of 2013, a pipeline connecting an offshore oil platform to a tanker caused 
crude oil to spill into the Sea of Rayong off the coast of Thailand.  The estimated amount of oil 
spilled was between 50 and 190 cubic meters or 336-1,200 barrels.  The resulting oil slick washed 
ashore one day later on the island of Samet. On-land cleanup lasted about a month and was 
performed by a combination of territorial defense volunteers, citizen volunteers, Thai military 
personnel and company employees.  We conducted a study to quantify internal dose of polycyclic 
aromatic hydrocarbons (PAHs) and benzene in these workers and to examine factors related to their 
dose. 
Methods: Frozen stored urine samples (n=1343) collected from the workers throughout the one 
month cleanup were used to measure the concentration of 1-hydroxypyrene-glucuronide (1-
OHPG), cotinine and creatinine.  Data from questionnaires and urinary trans,trans-muconic acid 
(t,t-MA) measured as part of a cleanup worker health surveillance plan, were linked with the 
laboratory data. 
Results: The internal dose of PAHs as measured by urinary 1-OHPG was highest in individuals 
who worked during the first 3 days of cleanup work (median: 0.97 pmol/ml) and was 66.7% lower 
(median: 0.32 pmol/ml) among individuals who worked in the final week of the study (days 21-
28).  This was consistent with our hypothesis that the exposure levels of PAHs would be the highest 
in the first week of cleanup and decline thereafter.  After adjusting for cotinine and creatinine by 
regression analysis, the decline in urinary 1-OHPG concentration with days of cleanup remained 
significant (P-trend <0.001).  Job descriptions with the highest level of urinary 1-OHPG after 
adjustment were oil dispersant applicators and contaminated sand/trash handlers.  A decreasing 




Conclusion: Rayong oil spill cleanup workers exhibited evidence of elevated levels of PAH and 
benzene exposure during the early weeks of cleanup, compared to near background levels 4 weeks 







 The frequency and size of off-shore oil spills has increased dramatically in the last 50 
years.1  More than 11,000 oil spill-related publications have been published since 1968.1  Spilled 
crude oil can affect the environment, local economics and the health of local communities.2, 3  A 
recent medium tier oil spill in the Sea of Rayong resulted in a month-long cleanup effort by a 
combination of local volunteers, military personnel, and oil company employees.  We conducted a 
study to quantify internal dose of polycyclic aromatic hydrocarbons (PAHs) and benzene in these 
workers and to examine factors related to their dose. 
On 27 July, 2013, a pipeline connecting an offshore oil platform to a tanker, operated by 
PTT Global Chemical (PTTGC), a corporation owned by the government of Thailand, leaked and 
caused crude oil to spill into the Sea of Rayong off the coast of Thailand.4  The crude oil covered 
an area of approximately 20 square kilometers and washed ashore on the island of Samet in an area 
called “Ao Prao” on 28 July, 2013.5  The estimated amount of oil spilled was between 50 and 190 
cubic meters or 336-1,200 barrels.4  On-land cleanup lasted about a month and was performed by 
a combination of territorial defense volunteers, citizen volunteers, Thai military personnel and 
PTTGC employees.  Cleanup procedures included oil containment, skimming, and dispersal, using 
absorbent pads, high-pressure water spraying and removal and disposal of contaminated soil, sand 
and rocks.5   
 Crude oil is a complex mixture of hydrocarbons, some of which may affect human health, 
including volatile organic compounds (VOCs), such as benzene, and polycyclic aromatic 
hydrocarbons (PAHs), such as pyrene and benzo[a]pyrene.6  Chronic exposure to benzene has been 
associated with acute myelogenous leukemia and acute non-lymphocytic leukemia.7  Some PAHs, 
including benzo[a]pyrene, have been associated with lung and liver cancers (adenocarcinoma).8  
Several studies from previous oil spill incidents, including the Hebei Spirit and Deepwater Horizon 
oil spills, found elevated levels of metabolites of PAHs and VOCs in the urine of cleanup workers.9-
11  Ha et al. (2012) found that a subgroup of the Hebei Spirit oil spill workers had elevated levels 
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of trans,trans-muconic acid (t,t-MA), a metabolite of benzene; mandelic acid, a metabolite of 
VOCs; and 1-hydroxypyrene, a metabolite of PAHs, compared to levels before their participation 
in the cleanup effort (N=105).9  From the same incident, Cheong et al. (2012) found that levels of 
urinary 1-hydroxypyrene in cleanup workers in the second and third weeks of cleanup (N=124) 
were higher than levels in workers in the fifth and sixth weeks of cleanup (N=30).10 
   During and after the Rayong oil spill cleanup, the Rayong Provincial Public Health Office 
and Rayong Hospital designed a health surveillance plan for the workers, collecting urine samples 
post-shift to assess urinary ttMA. These samples were analyzed in several government laboratories 
in Thailand, however, the results were only partially reported as categories (>or<500 ug/gCr),12 
rather than as continuous values.  In the current study, we have re-examined these ttMA 
measurements as continuous data (including values below 500 ug/gCr) and expanded the laboratory 
analysis to include an internal dose biomarker of PAHs, 1-hydroxypyrene-glucuronide (1-OHPG).  
These results should expand our understanding of the exposures sustained by these workers and lay 
the groundwork for further assessment of potential acute and chronic health effects. 
MATERIALS AND METHODS 
 The urine samples were first collected as part of the health surveillance for oil spill cleanup 
workers. The consent for use of urine samples for scientific study was obtained by the Rayong 
Hospital and the Thai Naval Medical Department.  Approval for the analysis of de-identified urine 
samples and data in our study was approved by the institutional review board of the Johns Hopkins 
Bloomberg School of Public Health, and the ethical committees of the Prince of Songkla 
University, Rayong Hospital, and the Thai Naval Medical Department. 
Study Populations and Urine Samples 
 Our study used the available data and frozen urine samples previously collected by Rayong 
hospital.  The urine samples were transported to our laboratory in Baltimore, MD, USA, on dry ice. 
The total number of oil spill cleanup workers with available questionnaire and urinary t,t-MA data 
was 2,118.  Of the 1,486 urine samples available to our research team, 1,343 samples had sufficient 
45 
 
volume (> 2 mls), for measuring urinary 1-OHPG and cotinine. Creatinine was previously 
measured in 1,282 of those samples by Rayong Hospital, and we measured creatinine in the 
remaining 61 urine samples in our laboratory.  Figure 3.1 below summarizes our selection process 
for urine sample analyses. 
Figure 3.1: Flow Chart Summarizing Urine Sample Selection and Analyses  
 
 The urinary creatinine measurements previously performed by Rayong Hospital used an 
enzymatic assay (OSR 61204) using creatinase enzyme on a Beckman Coulter AU analyzer 
(Beckman Coulter, Inc., Brea, CA), while our laboratory used Jaffe’s kinetic reaction (Cayman 
Chemical Company, Ann Arbor, MI) to measure the remaining 61 urine samples plus the 60 repeat 
measurements of urines already assayed by Rayong Hospital.  Because the two methods gave 
slightly different results on assays of the same 60 samples, we adjusted the results of the 61 samples 




Characteristics, Job Descriptions and Personal Protective Equipment (PPE) Uses of the 
Rayong Oil Spill Cleanup Workers. 
The date that the on-land cleanup began (29 July 2013) was counted as Day 1 of cleanup 
in our study.  The health surveillance protocol, including questionnaire and urine sample collection, 
began the next day (Day 2).  A calendar depicting the cleanup sequence and our study time periods 
is shown below (Figure 3.2). 
Figure 3.2: Rayong Oil Spill Cleanup Study (27 July 2013 – 26 August 2013) 
 
 
Of the 1,343 urine samples, 80 were collected from workers on their second day of work, 
and 1 was collected from a worker on his 3rd day of work (Table 3.1).  For these workers, at least 4 
days had elapsed between different work days.  Generalized estimating equations (GEE) were used 










Demographic factors and their distribution are shown in Table 3.2. Of 1,343 usable urine 
samples, 93.2% of them were provided by male workers.  The median age was 27 years old 
(Interquartile Range (IQR) = 18.0) and the majority (55.3%) of the urine samples were provided 
by workers whose background occupation was military personnel.  Forty percent of the urine 
samples were provided on Day 2 to Day 4 of the oil spill cleanup, and 24.4% of the samples were 
provided on Day 5 to Day 7 of cleanup.  Working hours per day was not available in the 
questionnaires. 
Table 3.2: Demographic Factors of Cleanup Workers  
Demographic Factors Descriptions Number of Workers Percent 
Total    1,343 100.0 
Age Median (1st-3rd Quartiles) 27.0 (22.0-40.0) 
 Unknown Age 9 0.7 
Sex Male 1,252 93.2 
  Female 90 6.7 
  Missing 1 0.1 
Background Military Personnel 743 55.3 
  PTTGC Company Employees 408 30.4 
  Citizen Volunteers 183 13.6 
  Unknown 9 0.7 
Days of Cleanup Day 2-4 537 40.0 
  Day 5-7 328 24.4 
  Day 8-14 282 21.0 
  Day 15-21 115 8.6 














1st sample collected 537 326 240 78 81 1262 
2nd sample collected 0 2 42 36 0 80 
3rd sample collected 0 0 0 1 0 1 
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The urine samples were provided by workers who performed various oil spill cleanup jobs. 
Of 1,343 usable urines, 57.9% were provided by workers whose cleanup job was to manually 
remove oil-contaminated sand, rocks, and trash (Table 3.3), and 23.5% were from workers whose 
job description was to vacuum or manually remove the oil slick from water.   
Table 3.3: Job Descriptions of Cleanup Workers  
Job Descriptions Number of Workers Percent 
Total 1,343 100.0 
Contaminated Sand/Trash Removal 778 57.9 
Oil Vacuum/Oil Slick Removal 315 23.5 
Support Personnel* 61 4.5 
Supervisor/Health Care Professional 38 2.8 
Transport Driver/Ship Pilot 23 1.7 
Oil Dispersant Applicator 17 1.3 
Environmental Sampling Personnel 9 0.7 
Others 44 3.3 
Missing 58 4.3 
* Coordinators, PTTGC Corporate Representatives, Visitors, Photographers, and Journalists were grouped as the 
support personnel. 
 
 Workers who provided urine samples were also asked about their personal protective 
equipment (PPE) use.  They were asked if they wore any PPE, an N95 mask, an R95 mask, any 
mask with filter, coveralls, gloves or boots.  The mask questions were grouped as “any mask use” 
if the workers answered “yes” to at least one of the questions, regarding the use of N95, R95 or 
mask with filter. Most of the workers (84%) self-reported using at least one piece of PPE (either 
mask, coveralls, gloves or boots) during their shifts (Table 3.4).  However, only 16.8% of the 
workers wore the complete set of PPE, and 31.7% reported that they “often” wore at least one piece 




Table 3.4: Personal Protective Equipment Use of Workers  
Personal Protective Equipment (PPE) Use Number of Workers Percent 
Total 1,343 100.0 
Any PPE Use 1132 84.3 
Mask* 603 44.9 
Coveralls 523 38.9 
Gloves 770 57.3 
Boots 589 43.9 
Missing Data 49 3.6 
Complete Set of PPE (Wearing 4 of The Above) 226 16.8 
Frequency of PPE Use   
- Never 46 3.4 
- Sometimes 737 54.9 
- Often 426 31.7 
Missing Data 134 9.9 
*Either one of N95, R95 or mask with filter 
 
Laboratory Methods 
Urinary 1-Hydroxypyrene-Glucuronide (1-OHPG) Analysis 
 To quantify the PAH exposure in cleanup workers, 1-OHPG, a metabolite of pyrene 
measurable in urine, was used as the surrogate biomarker for the whole group of PAHs. Urinary 1-
OHPG were measured using immunoaffinity chromatography and synchronous fluorescence 
spectroscopy (SFS), modified from protocols of Strickland et al.13  Two mls of urine was hot acid-
hydrolyzed with 0.1 NHCl at 90oC for 1 h.  Then, the hydrolyzed samples were loaded onto Sep-
Pak C18 cartridges (Waters, Milford, MA, USA) and washed with 4 ml of 30% methanol (in water). 
The metabolites were then eluted with 4 ml of 80% methanol (in water).  The total volume was 
reduced to 0.5 ml under vacuum centrifugation and phosphate buffered saline (PBS) (pH 7.4) was 
added to a final volume of 4 ml at 37o Celsius.  The samples were then loaded on the immunoaffinity 
columns, prepared with CNBr-activated Sepharose4B (0.8 ml) coupled with monoclonal antibody 
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8E11, which recognizes PAHs metabolites.  The urinary 1-OHPG fractions were eluted with 55% 
methanol (in PBS; 4 ml) and collected for synchronous fluorescence spectroscopy analysis (Perkin 
Elmer LS50B Luminescence spectrometer, Norwalk, CT, USA) using a wavelength difference of 
34 nm.  Samples containing 1-OHPG possess a characteristic fluorescence excitation maximum at 
347 nm with emission at 381 nm. The limit of detection (LOD) was 0.04 pmol/ml.  The recovery 
of the assay was 82% and the coefficient of variation was 5.6%.     
 
Urinary Creatinine Analysis 
 As mentioned above, 61 urine samples did not have available urinary creatinine data from 
Rayong Hospital. Therefore, we randomly selected 60 urine samples with available urinary 
creatinine measurements from Rayong Hosptial as a validation set to compare and quantify the 
differences in the urinary creatinine levels measured by our laboratory and Rayong Hospital’s 
laboratory.  Our laboratory used an assay based on Jaffe’s kinetic reaction (Cayman Chemical 
Company, Ann Arbor, MI) in which a yellow/orange color appears from the reaction between 
creatinine and alkaline picrate.  The color is then extinguished by adding a mixture of sulfuric and 
acetic acid solution, and the difference in color intensity measured at 490-500 nm before and after 
acidification is proportional to the creatinine concentration.  The coefficient of variation was 5% 
and the limit of detection was 0.1 mg/dl.  Rayong Hospital uses the enzymatic assay (OSR 61204), 
using creatinase enzyme on a Beckman Coulter AU analyzer (Beckman Coulter, Inc., Brea, CA). 
 The differences between creatinine from our laboratory and Rayong hospital’s laboratory 
were assessed using linear regression analysis.  The coefficient and intercept from the linear 
regression model were used to calculate and to convert the creatinine concentrations (mg/dl) 





Figure 3.3: Scatter Plot Illustrating Differences in Urinary Creatinine Levels between 
Strickland’s (X-axis) and Rayong’s (Y-axis) Laboratory 
 
  From linear regression, the derived equation was  
Y (Rayong’s Creatinine) = 0.724*X (Strickland’s Creatinine) + 14.8;  (r2=0.94) 
We converted Strickland’s (our) creatinine to Rayong equivalent concentration before further 
statistical analysis. 
 
Urinary Cotinine Analysis 
 Many people are exposed to nicotine from tobacco products either directly or indirectly.14  
Since tobacco smoke is a source of PAHs independent of oil exposure, we measured urinary 
cotinine, a metabolite of nicotine, to estimate tobacco smoke exposure.15  In epidemiological 
research, cotinine in blood, saliva and urine have been used extensively as a valid and specific 
biomarker for smoking.16  The half-life of cotinine in urine is about 16-19 hours16, 17 and therefore, 
reflects recent smoke exposure within the previous day or two.  This corresponds roughly to the 
half-life of urinary t,t-MA and 1-OHPG, the exposure biomarkers used in our study.  We used a 
Y = 0.724X + 14.8   
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solid phase competitive ELISA (Calbiotech, El Cajon, CA) assay to measure urinary cotinine.  The 
coefficient of variation was 8% and the limit of detection was 2 ng/ml.  Generally, a cut-off of 50 
ng/ml is recommended to differentiate between non-smokers and passive or active smokers.18, 19 
 
Urinary t,t-MA Data 
 Urinary t,t-MA data from Rayong Hospital was retrieved and linked to the questionnaire 
data. Urinary t,t-MA, from Rayong Hospital was measured using high performance liquid 
chromatography with fluorescent detection.20  The limit of quantitation (LOQ) was estimated to be 
0.01 mg/dl or 0.10 µg/ml. 
 
Statistical Methods 
 All available questionnaire data was linked to the 1-OHPG, t,t-MA, and cotinine 
measurements.  Non-detectable measurements of urinary 1-OHPG and cotinine were replaced with 
the value of the LOD/21/2, assuming log normal distributions. For descriptive analysis, continuous 
variables, including urinary 1-OHPG, urinary cotinine, and age were presented as median (1st-3rd 
quartile) values due to non-normal distributions.  Categorical variables, such as number of workers 
by days of cleanup, PPE use, or job description were presented as number (%).  
 For inferential statistics, log-linear regression models were used to compare the levels of 
1-OHPG among days of cleanup (days 2-4, days 5-7, days 8-14, days 15-21 and days 22-28), 
adjusting for urinary cotinine and/or creatinine.  To adjust for workers’ dehydration status, 
creatinine concentration was added as a covariate in the log-linear regression models.  Finally, the 
log-linear regression models were used to compare levels of 1-OHPG among job description 
categories, adjusting for days of cleanup and cotinine concentration.  P-values for trends of the 
geometric difference ratios were calculated using Rao’s score test.21  Generalized estimating 
equations (GEE), as described in Liang and Zeger (1986)22 were used to account for multiple 
samples from the same workers.   
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 Detailed t,t-MA data was not reported in the previous two published papers from the 
Rayong oil spill.12, 23  Therefore, we re-analyzed the complete urinary t,t-MA data set, previously 
measured by the Rayong Hospital, and adjusted these results with our cotinine measurements. 
Because of the large proportion of non-detectable samples (67.5%), the urinary t,t-MA data was 
analyzed as a binary variable (detectable vs non-detectable).  In addition, due to the relatively 
smaller sample size, t,t-MA data from the 3rd and 4th weeks of cleanup were combined before the 
statistical analysis.  To further adjust for smoking, stratification by nonsmokers and smokers 
(urinary cotinine ≤ 50 ng/ml and >50 ng/ml) and logistic regression was used to assess the 
association between odds of having detectable t,t-MA in urine and days of cleanup, job descriptions 
and PPE use, adjusting for cotinine and creatinine.  All statistical analysis was completed using R 







 In the 1,343 urine samples analyzed, the median level of urinary 1-OHPG was 0.79 
pmol/ml (Q1-Q3: 0.31-1.81).  The number of urine samples with the non-detectable levels was 94 
(7.0%).  Using the suggested categorical values from Kang et al (1995), 57.6% of the urine samples 
had “low” levels of 1-OHPG (<1.0 pmol/ml), 36.5% had “moderate” levels (1.0-5.0 pmol/ml) and 
5.9% had “high” levels (>5.0 pmol/ml) as shown Figure 3.4.  
Figure 3.4: Laboratory Results of Urinary 1-OHPG (n=1,343) 
 
  1-OHPG exhibited a decreasing trend by days of cleanup as shown in Figure 3.5.  We 
assigned the starting date of on-land cleanup (29th July) as “day 1 of cleanup” in our study.  Urine 
samples from day 1 of cleanup were not available because the health surveillance protocol was not 
implemented until day 2 of the study.  The median of urinary 1-OHPG on days 2-4 of the Rayong 
oil spill cleanup was 0.97 pmol/ml, and the levels decreased by 66.7% to 0.32 pmol/ml by day 21-
28 of cleanup.  This was consistent with our hypothesis that the exposure levels of PAHs would be 
the highest in the first week of cleanup and decline thereafter. 
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Figure 3.5: Urinary 1-OHPG (Logscale) by Days of Cleanup 
 
 Presenting the urinary 1-OHPG data as dose strata by days of cleanup (Figure 3.6), the 
proportion of workers with “low” levels of 1-OHPG increased over time from 51.0% on days 2-4 
to 82.7% on days 22-28; whereas, the proportion of workers with “high” levels of 1-OHPG 




Figure 3.6: Strata of Urinary 1-OHPG by Days of Cleanup 
 
Urinary Cotinine 
 Since smoking status of cleanup workers recorded on questionnaires was limited (only 387 
workers had available smoking status) we measured urinary cotinine as a biomarker of tobacco 
smoke exposure.  Overall, the median level of urinary cotinine was 37.3 pmol/ml (Q1-Q3: 3.0-
1229.5) and urinary 1-OHPG was 2.8 times higher in the 4th cotinine quartile than in the 1st quartile 
(1.65 vs 0.58 pmol/ml). 
























Using a urine cotinine cutoff concentration of 50 ng/ml to distinguish between smokers 
and non-snokers18, 19, we observed that the median urinary 1-OHPG concentration of smokers was 
2 to 3 fold higher than that of nonsmokers, by days of cleanup.  In nonsmokers, urinary 1-OHPG 
exhibited a clearly decreasing trend by days of cleanup, as shown in Figure 3.8.  The median 
concentration of urinary 1-OHPG on days 2-4 in nonsmokers was 0.81 pmol/ml, decreasing by 
79% to 0.18 pmol/ml by day 21-28 of cleanup.  Whereas in smokers, the median of urinary 1-
OHPG on days 2-4 was 1.40 pmol/ml, decreasing by 59% to 0.57 pmol/ml by day 21-28 of cleanup 
(Figure 3.8). 
 






Regression Analysis of 1-OHPG by Days of Cleanup. 
 We performed 3 different log-linear regression models for 1-OHPG and days of cleanup. 
For Model 1, the association between 1-OHPG and days of cleanup was adjusted solely by urinary 
creatinine.  For model 2, only urinary cotinine was used as an adjusting variable.  For model 3, both 
urinary creatinine and cotinine were used as adjusting variables. All the models showed 
significantly decreasing trends in 1-OHPG geometric mean (GM) ratio over time (P-Trend <0.001) 
(Table 3.5).  After adjusting for cotinine (Model 2), the GM ratio declines were larger compared to 
the univariable (unadjusted) model, suggesting that smoking might be a confounder in the 
association between urinary 1-OHPG and days of cleanup.  In Model 3, the declining trend in 1-
OHPG GM ratio with days of cleanup remained significant after adjusting for both creatinine and 
cotinine.   
Table 3.5: Log-Linear Regression with GEE* of Urinary 1-OHPG by Days of Cleanup (n = 
1,343)   
 
Weeks of Study Days of Cleanup 
Geometric Mean Ratio of 1-OHPG (95% CI) 
Univariable Model Model 1 Model 2 Model 3 
Week 1.1 Day 2-4 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 




































P-Trend <0.001 <0.001 <0.001 <0.001 
 
Model 1: Adjusted by Urinary Creatinine 
Model 2: Adjusted by Urinary Cotinine 
Model 3: Adjusted by Urinary Creatinine and cotinine 
* Generalized Estimating Equation with Exchangeable Correlation Structure 
Bold numbers indicate statistically significant results. (P<0.05) 
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Log-linear regression also showed that urinary cotinine (smoking) and urinary creatinine 
were independently associated with concentration of urinary 1-OHPG.  The GM of urinary 1-
OHPG increased by 7% (GM ratio: 1.07, 95% CI: 1.06-1.07) per 100 μg/ml increase in urinary 
creatinine; and the GM of urinary 1-OHPG increased by 71% (GM ratio: 1.71, 95% CI: 1.57-1.86) 
per 1 μg/ml increase in urinary cotinine (data not shown).      
 
Urinary 1-OHPG and Job Descriptions 
 The urinary 1-OHPG levels were stratified by job description of cleanup workers (Table 
3.5).  Contaminated sand and trash removal (57.9%) was the most common job description. The 
highest GM level of urinary 1-OHPG was found in urine samples from oil dispersant applicators 
who sprayed oil dispersants (GM: 1.79, IQR: 0.31-1.81 pmol/ml).  The second highest level was 
found in urine samples from workers who removed contaminated sand and trash (GM:  0.75, IQR: 
0.32-1.87 pmol/ml).  The lowest 1-OHPG level was found in support personnel (coordinators, 
PTTGC corporate representatives, visitors, photographers, and journalists) (GM: 0.44, IQR: 0.25-




Table 3.6: Urinary 1-OHPG by Job Descriptions of Cleanup Workers (n = 1,343) 
(Descending Order by Geometric Mean of 1-OHPG) 
 
Job Descriptions 








Total 1,343 (100.0%) 0.72 0.79 0.31 1.81 
Oil Dispersant Applicator 17 (1.3%) 1.79 3.02 0.97 6.98 
Contaminated Sand/ 
Trash Removal 
778 (57.9%) 0.75 0.81 0.32 1.87 
Environmental Sampling 
Personnel 
9 (0.7%) 0.72 1.42 0.54 1.91 
Oil Vacuum/ 
Oil Slick Removal 
315 (23.5%) 0.70 0.70 0.32 1.72 
Supervisor/ 
Health Care Professional 
38 (2.8%) 0.68 0.69 0.35 1.80 
Transport Driver/ 
Ship Pilot 
23 (1.7%) 0.61 0.88 0.26 2.31 
Support Personnel* 61 (4.5%) 0.44 0.45 0.25 1.04 
Others 44 (3.3%) 0.64 0.55 0.34 1.67 
Missing 58 (4.3%) 0.72 0.90 0.32 1.66 
 





Figure 3.9: Urinary 1-OHPG (Logscale) by Job (Descending Order by Median of 1-OHPG) 
  
 In the GEE and log-linear regression analysis of 1-OHPG by job descriptions, support 
personnel, with the lowest GM of urinary 1-OHPG, was used as the reference group (Table 3.7).  
In the univarible model, compared to support personnel, oil dispersant applicators had the highest 
1-OHPG GM ratio (4.1; 95% CI: 1.57-10.69).  Contaminated sand/trash removal and oil vacuum/oil 
slick removal were two other job groups with significantly elevated GM ratios (95% CI) of 1-
OHPG, compared to the support personnel (1.71 (1.24-2.36) and 1.61 (1.15-2.67), respectively).  
The other job groups exhibited non-significantly elevated GM ratios compared to the support 
(reference) group -- perhaps due to small sample sizes.  After adjusting for cotinine (Model 3), the 
GM ratios (95% CI) of the transport driver/ship pilot group decreased from 1.40 (0.65-3.00) to 1.06 
(0.55-2.07), suggesting that this group of workers might include a high proportion of smokers.   
After adjusting for days of cleanup, urinary creatinine and urinary cotinine (Model 4), only oil 
dispersant applicators and contaminated sand/trash removal workers demonstrated significantly 
elevated 1-OHPG, compared to support personnel ((GM ratio: 2.33, 95% CI: 1.29-4.21) and (GM 
ratio: 1.33, 95% CI: 1.02-1.75), respectively).
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Table 3.7: Log-Linear Regression with GEE* of Urinary 1-OHPG by Job Descriptions (n = 1,285)** 
 
Job Descriptions 
Geometric Mean Ratio of 1-OHPG (95% CI) 
Univariable Model Model 1 Model 2 Model 3 Model 4 
Support Personnel*** 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Oil Dispersant Applicator 4.10 (1.57-10.69) 4.39 (1.68-11.48) 3.06 (1.39-6.70) 3.20 (1.34-7.64) 2.33 (1.13-4.83) 
Contaminated Sand/ 
Trash Removal 
1.71 (1.24-2.36) 1.85 (1.33-2.58) 1.56 (1.16-2.10) 1.55 (1.14-2.09) 1.33 (1.02-1.75) 
Environmental Sampling 
Personnel 
1.65 (0.62-4.36) 1.71 (0.64-4.56) 1.58 (0.70-3.58) 2.08 (0.80-5.46) 1.90 (0.84-4.31) 
Oil Vacuum/ 
Oil Slick Removal 
1.61 (1.15-2.67) 1.56 (1.10-2.21) 1.37 (1.00-1.86) 1.36 (0.99-1.87) 1.21 (0.91-1.61) 
Supervisor/ 
Health Care Professional 
1.54 (0.94-2.51) 1.58 (0.99-2.54) 1.26 (0.84-1.88) 1.63 (0.99-2.57) 1.31 (0.89-1.92) 
Transport Driver/Ship 
Pilot 
1.40 (0.65-3.00) 1.48 (0.68-3.21) 1.55 (0.79-3.03) 1.06 (0.55-2.07) 1.14 (0.66-2.00) 
Others 1.46 (0.88-2.43) 1.28 (0.76-2.15) 0.91 (0.58-1.43) 1.14 (0.71-1.84) 0.84 (0.55-1.28) 
Model 1: Adjusted by days of cleanup (day 2-4, day 5-7, day 8-14, day 15-21 and day 22-28) 
Model 2: Adjusted by days of cleanup and urinary creatinine 
Model 3: Adjusted by days of cleanup and urinary cotinine 
Model 4: Adjusted by days of cleanup, urinary cotinine and creatinine 
* Generalized Estimating Equation with Exchangeable Correlation Structure 
** 58 Unknown Job Description 
*** Coordinators, PTTGC Corporate Representatives, Visitors, Photographers, and Journalists were grouped as the support personnel. 




Urinary 1-OHPG and Protective Equipment (PPE) Use 
 Personal protective equipment (PPE) use by oil-spill cleanup workers did not show 
evidence of protection against PAH exposure as measured by urinary 1-OHPG concentration.  This 
was true for overall PPE use, as well as for use of individual equipment, including N95 and R95 
masks, gloves, boots and coveralls.  The urinary 1-OHPG levels in cleanup workers who wore 
PPEs, was not significantly lower than in those who did not wear PPEs (Table 3.8 and Appendix 
Table 3.3).  In the univariable model, the GM of 1-OHPG in workers who wore mask or coveralls 
were higher than the workers who did not wear mask or coveralls ((GM ratio: 1.27, 95% CI: 1.09-
1.47) and (GM ratio: 1.40, 95% CI: 1.20-1.63), respectively).  This may be because mask and 
coveralls were used by workers mostly in the early days of cleanup when the 1-OHPG levels were 
high (data not shown).  After adjusting by days of cleanup (Model 1), the GM ratios move toward 
one (null) (Models 1-3).  Although not significant, workers who “sometimes” or “often” used PPE, 
had lower levels of 1-OHPG, compared to those who never used PPE. 
Table 3.8:  Log-Linear Regression with GEE* of Urinary 1-OHPG by PPE Use (n=1,294)**  
Type of PPE 
Geometric Mean Ratio of 1-OHPG (95% CI) 
Univariable Model Model 1 Model 2 Model 3 
Any PPE Use 
(vs No PPE use) 
0.99 (0.79-1.25) 0.97 (0.77-1.22) 0.97 (0.78-1.20) 0.97 (0.80-1.16) 
Mask 
(vs No Mask use) 
1.27 (1.09-1.47) 1.12 (0.95-1.31) 1.14 (0.98-1.32) 1.17 (1.02-1.33) 
Coveralls 
(vs No Coverall use) 
1.40  (1.20-1.63) 1.22 (1.04-1.44) 1.16 (0.99-1.35) 1.15 (1.01-1.31) 
Gloves 
(vs No Glove use) 
0.95  (0.82-1.11) 1.05 (0.89-1.23) 1.03 (0.89-1.20) 0.98 (0.86-1.11) 
Boots 
(vs No Boots use) 





















Model 1: Adjusted by days of cleanup (day 2-4, day 5-7, day 8-14, day 15-21 and day 22-28) 
Model 2: Adjusted by days of cleanup and urinary cotinine 
Model 3: Adjusted by days of cleanup, urinary cotinine and creatinine 
*Generalized Estimating Equation with Exchangeable Correlation Structure 
**49 workers had at least one piece of missing data 




 The distribution of urinary t,t-MA among cleanup workers is shown in Figure 3.10.  There 
was a large number of samples with non-detectable levels of t,t-MA (907 out of 1,343)( 67.5%).  
The minimum quantifiable concentration, observed from the recorded data was 0.10 μg/ml.  Since 
a large percentage of urine sample had non-detectable levels of t,t-MA, we elected to statistically 
analyze the t,t-MA data as a binary variable (detectable vs non-detectable).  Non-detectable samples 
were assigned the value LOQ/21/2 or 0.07 ug/ml 
Figure 3.10: Urinary t,t-MA Results from Rayong Hospital  
   
 In order to increase statistical power when analyzing t,t-MA as a binary variable, we 
grouped data from week 3 (day 15-21) and week 4 (day 22-28) together.  Before adjusting for 
covariates, the proportion of urine samples with detectable levels of t,t-MA were not different by 







Figure 3.11: Urinary t,t-MA Detectable Percentages by Days of Cleanup (n = 1,343) 
 
However, this result was confounded by tobacco smoke exposure, which is known to 
contain benzene.  Detectable t,t-MA was more frequent in the urine of smokers (urinary cotinine > 
50 ng/ml) than non-smokers (44.2% vs 21.2%, respectively, P<0.001) (Appendix Table 3.2).  In 
addition, by quartiles of urinary cotinine, the percentage of urine samples with detectable t,t-MA 
was much higher in subjects with cotinine levels in the 4th quartile than in subjects with lower 
quartiles (64.9% vs 21.3%, 21.1% and 22.6%, P<0.001) (Figure 3.12).  Therefore, we controlled 
for smoking by stratifying urinary cotinine concentrations in subsequent analyses of the association 


































Figure 3.12: Urinary t,t-MA Detectable Percentages by Cotinine Quartiles (n = 1,343) 
 
 We distinguished presumed smokers from non-smokers using a urinary cotinine cut-off of 
50 ng/ml.  The nonsmoker group (cotinine ≤ 50 ng/ml) exhibited a clearly decreasing trend in t,t-
MA detectable percentage by days of cleanup (P-trend =0.001) (Figure 3.13).  The percentages of 
non-smoking workers with detectable urinary t,t-MA were 26.3%, 20.9%, 14.8% and 6.3% on days 
2-4, days 5-7, days 8-14 and days 15-28 of cleanup, respectively.  While in the smoker group 
(urinary cotinine > 50 ng/ml), a decreasing trend in detectable t,t-MA with days of cleanup was not 
observed, consistent with our finding that smoking increases the probability of having detectable 





























Quartiles of Urinary Cotinine (ng/ml)
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Figure 3.13: Urinary t,t-MA Detectable Percentages by Days of Cleanup in Smokers and 
Nonsmokers (n = 1,343) 
 
*Smokers were workers whose urinary cotinine was more than 50 ng/ml. 
 
By logistic regression, the odds ratio of having detectable urinary t,t-MA among 
nonsmokers (urinary cotinine ≤ 50 ng/ml) also showed a decreasing trend by days of cleanup work 
(Table 3.9).  In the univariable model, the odds ratio (95% CI) of detectable t,t-MA declined to 
0.19 (0.07-0.54) on day 15-28 compared to the reference group (day 2-4) with a highly significant 
trend (P<0.001).  The decreasing trends remained significant after adjustment for creatinine and/or 
cotinine.  Among smokers there was no evidence of a decreasing trend in odds ratio of detectable 




































Non-Smokers (Cot < 50 ng/ml) Smokers (Cot >50 ng/ml)
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Table 3.9: Logistic Regression with GEE* of Detectable t,t-MA by Days of Cleanup (Non-
Smokers: Cotinine ≤50 ng/ml) (N=679) 
Weeks of 
Study 
Days of  
Cleanup 
Odds Ratio of Detectable t,t-MA (95%CI) 
Univariable 
Model Model 1 Model 2 Model 3 
Week 1.1 Day 2-4 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
























P-Trend <0.001 0.077 <0.001 0.028 
 
Model 1: Adjusted by Urinary Creatinine 
Model 2: Adjusted by Urinary Cotinine 
Model 3: Adjusted by Urinary Creatinine and cotinine 
* Generalized Estimating Equation with Exchangeable Correlation Structure 
Bold numbers indicate statistically significant results. (P<0.05) 
 Urinary t,t-MA detectable percentages did not differ substantially among workers by job 
description (P=0.335 by Fisher’s exact test), ranging from 29.4 to 47.8% among job groups with 
15 or more workers (Table 3.10).  Similarly, by logistic regression, odds of detectable t,t-MA did 
not differ among non-smoking workers by job description (Table 3.11).  Also, there was no 
evidence for a protective effect of PPE use for benzene exposure, assessed by urinary t,t-MA 
concentration.  The proportion of urine samples with detectable t,t-MA were not different between 




Table 3.10: Urinary t,t-MA Detectable Percentages by Job Description 
 





N Percent N Percent 
Total 1,343 436 32.5 907 67.5 
Oil Dispersant Applicator 17 5 29.4 12 70.6 
Contaminated Sand/Trash Removal 778 265 34.1 513 65.9 
Environmental Sampling Personnel 9 1 11.1 8 88.9 
Oil Vacuum/Oil Slick Removal 315 91 28.9 224 71.1 
Supervisor/Health Care Professional 38 10 26.3 28 73.7 
Transport Driver/Ship Pilot 23 11 47.8 12 52.2 
Support Personnel 61 21 34.4 38 62.3 
Others 44 16 36.4 28 63.6 
Missing 58 16 27.6 42 72.4 
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Table 3.11: Logistic Regression with GEE* of Detectable t,t-MA by Job Description (Subgroup Nonsmokers) (N=655)** 
 
Job Descriptions 
Odds Ratio of t,t-MA Detectable (95% CI) 
Univariable Model Model 1 Model 2 Model 3 Model 4 
Support Personnel*** 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 1.00 (Ref) 
Oil Dispersant Applicator NA NA NA NA NA 
Contaminated Sand/ 
Trash Removal 
1.05 (0.48-2.29) 1.23 (0.55-2.71) 0.64 (0.28-1.44) 1.13 (0.51-2.51) 0.56 (0.24-1.29) 
Environmental Sampling 
Personnel 
NA NA NA NA NA 
Oil Vacuum/ 
Oil Slick Removal 
0.96 (0.42-2.28) 1.03 (0.44-2.39) 0.55 (0.23-1.34) 0.94 (0.40-2.20) 0.49 (0.20-1.19) 
Supervisor/ 
Health Care Professional 
0.77 (0.23-2.58) 0.87 (0.26-3.00) 0.49 (0.13-1.82) 0.86 (0.25-2.96) 0.47 (0.12-1.76) 
Transport Driver/Ship 
Pilot 
1.38 (0.30-6.27) 1.58 (0.29-8.79) 1.73 (0.31-8.12) 1.33 (0.24-7.23) 1.33 (0.31-5.74) 
Others 1.59 (0.56-4.54) 1.40 (0.48-4.05) 0.72 (0.21-2.51) 1.29 (0.45-3.71) 0.65 (0.18-2.29) 
 
Model 1: Adjusted by days of cleanup (day 2-4, day 5-7, day 8-14, day 15-28) 
Model 2: Adjusted by days of cleanup and urinary creatinine 
Model 3: Adjusted by days of cleanup and urinary cotinine 
Model 4: Adjusted by days of cleanup, urinary cotinine and creatinine 
 
NA because 0/6 of the oil dispersant applicator and 0/8 of environmental sampling personnel had detectable t,t-MA levels 
 
* Generalized Estimating Equation with Exchangeable Correlation Structure 
** 24 Unknown Job Description 
*** Coordinators, PTTGC Corporate Representatives, Visitors, Photographers, and Journalists were grouped as the support personnel. 
 




In our study of Rayong oil spill cleanup workers, we examined internal dose of PAHs and 
benzene to examine factors related to their exposure.  The internal dose of PAHs, as measured by 
urinary 1-OHPG, was highest in individuals who worked during the first 3 days of cleanup work 
and was significantly lower among individuals who worked in the final week of the study three 
weeks later.  This was consistent with our hypothesis that the exposure levels of PAHs would be 
the highest in the first week of cleanup and decline thereafter.  After adjusting for cotinine and 
creatinine by regression analysis, the decline in urinary 1-OHPG concentration with days of 
cleanup remained highly significant.  Job descriptions with the highest level of urinary 1-OHPG 
after adjustment were oil dispersant applicators and contaminated sand/trash handlers. We also 
observed a decreasing trend by days of cleanup of detectable urinary t,t-MA, a biomarker of 
benzene exposure.  These results demonstrate that oil spill cleanup workers can be exposed to PAH 
and benzene at concentrations sufficient to be measured internally as metabolites.  Furthermore, 
these exposures occurred after a relatively small spill of only about 50-300 barrels of oil, much less 
than that of the Deepwater Horizon (5 million barrels)24 or Hebei (80,000 barrels)3 oil spills.   
 Previous studies from the Hebei oil spill measured biomarkers of PAHs in urine, as well 
as biomarkers of benzene, toluene, ethyl benzene, and xylene (BTEX) (Cheong et al, 2011 and Ha 
et al, 2012).9, 10  They reported elevated levels of t,t-MA, mandelic acid (a metabolite of 
ethylbenzene), and 1-hydroxypyrene in urine samples collected after cleanup, compared to samples 
collected before participation (p<0.05) (Ha et al).9  Comparing another group of Hebei cleanup 
workers with an unexposed reference group, they found no difference between the groups in 
concentrations of biomarkers of PAHs or the four BTEX compounds (Cheong et al).10  However, 
they did report a decline in the levels of two PAH biomarkers (1-OHP and 2-naphthol) over the 
course of several weeks among the cleanup workers.  In general, the levels of PAH biomarkers 
reported in these studies were high overall (1-OHP geometric mean: 0.5 μg/gCr; range: 0.1 - 2.4 
μg/gCr, approximately equivalent to ~ 0.69 - 16.5 pmol/ml), even in the unexposed reference group 
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(GM: 0.6 μg/gCr; range: 0.2 - 1.7 μg/gCr approximately equivalent to 1.38 - 11.70 pmol/ml) 
compared to other studies.  
A number of factors could contribute to differences in exposure between spills and between 
studies.  The half-life of PAHs in crude oil in the environment can range from a few hours up to  
weeks or months depending on the chemical composition of the oil, the molecular weights of the 
PAHs, bacterial biodegradation and photolysis.25, 26  After a spill and during cleanup, low molecular 
weight (LMW) PAHs would be expected to evaporate within a few days, resulting in the rapid 
decline in biomarkers, while the higher molecular weight (HMW) PAHs might take a few weeks 
to evaporate or degrade.  Pyrene, the parent compound of 1-OHPG, is of intermediate MW (m=202) 
having both rapid and slow evaporation characteristics.  The Hebei oil spill workers were recruited 
for study 2 or more weeks after the oil spill occurred9, 10 thereby reducing expected PAH exposure.   
 In our study, the median of urinary 1-OHPG among all oil spill workers was 0.79 pmol/ml, 
with median levels declining from 0.97 pmol/ml when the cleanup began (days 2-4) to 0.32 
pmol/ml 4 weeks later (days 22-28).  These levels of 1-OHPG are similar to those reported by Kang 
et al (1995)27 for steel plant workers (1.82 pmol/ml) and controls (0.38 pmol/ml), in a study that 
used the same laboratory and method for 1-OHPG analysis as our study.  For comparison, the GM 
of urinary 1-OHPG in non-smokers in the US is 0.16-0.25 pmol/ml28, and 0.025 μmol/molCr 
(approximately equivalent to ~0.38 pmol/ml) in rural non-smokers in Thailand.29  Thus, the 1-
OHPG levels we observed were comparable to occupational exposures during the early days of 
cleanup, and declined to near background (general population) levels by the end of the cleanup 
operations (0.18 pmol/ml in non-smokers). 
We also examined the levels of urinary 1-OHPG among cleanup workers with different job 
descriptions.  We found that certain types of jobs including, oil dispersant applicators, contaminated 
sand/trash removal workers and oil vacuum/oil slick removal workers, had higher levels of urinary 
1-OHPG than other workers and support personnel.  Oil dispersant applicators might be at increased 
risk of PAH exposure because spraying dispersants on oil-water interfaces generates aerosols that 
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are respirable (Ehrenhauser et al, 2013).  Water wave action on the sea while applying dispersants 
can also facilitate aerosolization and evaporation of PAHs (Ehrenhauser et al, 2013).  Workers 
dealing with contaminated sand/trash removal and oil vacuum/oil slick removal were often in close 
(or direct) contact with crude oil, thereby enhancing the possibility of dermal contamination.  Thus, 
these workers might be expected to have higher levels of exposure than other workers or support 
personnel who did not directly contact crude oil.  The study of Ha et al. (2012) among the Hebei 
oil spill cleanup workers explored the association between PAH metabolites and job types, but did 
not find any differences in PAH metabolite levels between “direct cleanup jobs” and “logistics-
related jobs”9, the only categories reported.   
We also examined the potential effect of PPE use on PAH exposure among cleanup 
workers.  Unexpectedly, levels of 1-OHPG were not associated with overall PPE use, consistent 
with the finding of Lee et al. (2009) from Hebei oil spill.30  Furthermore, individual equipment use 
(masks, gloves, boots, or coveralls) was not associated with a protective effect.  This suggests that 
PPE was not effective, or was not used properly, or that the questionnaire data was not reliable.  
Paradoxically, mask and coverall use were associated with elevated levels of 1-OHPG.  This might 
have resulted from exposure selection bias because of higher hazard recognition (resulting in 
enhanced PPE use) in the early days of cleanup when the beach was covered in oil, compared to 
later weeks of cleanup.  About 60% of workers who worked in the first 3 days of cleanup (when 
exposure was high) wore masks or coveralls, whereas only 1-10% of workers during the last 2 
weeks of cleanup wore them.  In addition to exposure recognition, masks can be contaminated 
accidentally by direct contact with oil soaked gloves.  Another complicating factor is the possible 
limitation of supply of PPE which would be expected to restrict PPE use.  For example, boot and 
glove use increased over the course of cleanup from 37% (boots) and 47% (gloves) during the first 
3 days of cleanup, to 62% and 78%, respectively, during the last 2 weeks of cleanup. 
 We found that the percentage of  oil spill workers with detectable urinary t,t-MA  decreased 
from day 2-4 to week 3-4 of cleanup in nonsmokers, but not in smokers.  The method used to 
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measure t,t-MA in these workers20 had limited sensitivity, with an estimated limit of quantification 
of 0.10 μg/ml.  This compares unfavorably with the background t,t-MA level in the general 
population of 0.07 μg/ml  (range: 0.02-0.30 μg/ml).31, 32  Because of the high percentage (67.5%) 
of samples that were not detectable in our study, we analyzed the t,t-MA data as a binary variable.  
This limited our statistical power to detect associations33 and might partially explain why we did 
not observe a decreasing trend with time of cleanup in smokers.  In addition, tobacco smoke 
contains benzene and significantly increases concentration of urinary t,t-MA in smokers compared 
to nonsmokers.34  Although we did adjust for smoking by including urinary cotinine concentration 
in regression models, this adjustment may not have been sufficient to completely control for the 
confounding effects of benzene from smoking.  In addition, sorbic acid-containing foods can 
artificially increase levels of urinary t,t-MA, apart from exposure to benzene, and this was not 
controlled for in our analysis. Compared to 1-OHPG, the percentage of detectable t,t-MA samples 
among nonsmokers decreased more rapidly with days of cleanup than the levels of 1-OHPG.  The 
rapid decline in detectable t,t-MA, is not unexpected as benzene is relatively more volatile than 
PAHs, and would be expected to evaporate within a few days of the oil spill.  Detectable urinary 
t,t-MA was not found to be related to job descriptions as was urinary 1-OHPG.  This lack of 
association could be due to the rapid evaporation of benzene or the lack of statistical power.  In 
addition, urinary t,t-MA was not associated with PPE use, similar to our findings on PPE use and 
urinary 1-OHPG.  
 Urinary t,t-MA measured in other studies of oil spill workers is somewhat limited. Ha et al 
(2012) found that levels of urinary t,t-MA of workers at the Hebei spill were higher after cleanup 
participation compared to levels before participation among both smokers (2.5-fold higher) and 
nonsmokers (3.2-fold higher).9  In contrast, among another group of Hebei spill cleanup workers, 
Cheong et al (2011) found no difference in t,t-MA levels between workers and unexposed controls, 
and no change in t,t-MA levels between weeks 2-3 and weeks 5-6 of cleanup.   
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 Our study is the first investigation of PAH and benzene biomarkers in cleanup workers’ 
urine samples that were collected within two days of a fresh oil spill.  In contrast to the studies of 
cleanup workers at the most intensively investigated spill, the Hebei oil spill, where urine sample 
collection started 2 weeks after cleanup started, our study assessed internal dose of PAHs and 
benzene beginning on the 2nd day of cleanup, at which time exposure  was expected to be close to 
maximum. To our knowledge, none of the studies of oil spill incidents that incorporated exposure 
biomarkers had access to urine samples collected on the first few days of cleanup.  In addition, our 
study had a relatively large sample size (n=1343) compared to the three studies from the Hebei oil 
spill (n=121, n=154, n=724)9,10,32 and the study of D’Andrea and Reddy (2014)35 from the 
Deepwater Horizon oil spill (n=117).  In the current study, we also used urinary cotinine to adjust 
for expected confounding effects of smoking on PAH biomarkers.  
 The current analysis has several limitations.  It employs a cross-sectional exposure 
analysis, thus limiting our ability to assess causal inference.  Secondly, the questionnaire data was 
initially designed as part of a health surveillance program initiated by the Rayong Provincial Health 
office, rather than a formal scientific study.  As a result, some of the data, such as hours of cleanup 
participation, smoking status, dietary patterns, and pre-exposure assessment was not complete or 
unavailable for statistical analysis.  Third, we were unable to assess possible confounding effects 
due to diet, including sorbic acid-containing foods affecting t,t-MA36 and PAH-containing foods, 
such as broiled and smoked meats, affecting 1-OHPG,37, 38 that may have resulted in either 
underestimating or overestimating our results. Urinary S-phenyl mercapturic acid, which is more 
specific for benzene than t,t-MA, might be a better biomarker to use in future studies.  Fourth, our 
study did not have an ideal negative control population that was absolutely unexposed to crude oil, 
such as pre-cleanup baseline measurements of workers, or non-participants who were not involved 
in the cleanup.  For these reasons, it is difficult to assess the magnitude of the increase in levels of 
PAH and benzene biomarkers among the oil spill cleanup workers on the first days of the spill.  In 
addition, genetic polymorphisms in Phase I enzymes, such as CYP1A1 and CYP1B139, and Phase 
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II enzymes, such as glutathione S-transferases (GSTs), N-acetyltransferase-1 (NAT1) and epoxide 
hydrolase (EPHX1), might explain some of the variation in the levels of urinary 1-OHPG and t,t-
MA that we observed. 
 This study will serve as the baseline exposure assessment and characteristics of workers 
for future research from the Rayong oil spill cohort.  The health followup of these workers at 
Rayong Hospital is ongoing and planned to last 5 years.  Since our study found evidence of 
moderate to high exposure to carcinogenic substances, PAHs and benzene, we believe that long 
term surveillance of these workers is prudent.  
 In conclusion, Rayong oil spill cleanup workers exhibited evidence of elevated levels of 
PAH and benzene exposure during the early days of cleanup, compared to near background levels 
4 weeks after cleanup began. Certain types of jobs including, oil dispersant applicators, 
contaminated sand/trash removal workers, and oil vacuum/oil slick removal workers, were at 
highest risk of PAH exposure.  Long-term health monitoring of oil spill cleanup workers should be 
implemented.   
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CHAPTER 4: POST-SHIFT SYMPTOMS AMONG RAYONG OIL SPILL CLEANUP 
WORKERS 
ABSTRACT 
Background: In July of 2013, a pipeline connecting an offshore oil platform to a tanker caused 
crude oil to spill into the Sea of Rayong off the coast of Thailand.  The estimated amount of oil 
spilled was between 50 and 190 cubic meters or 336-1,200 barrels.  The resulting oil slick washed 
ashore one day later on the island of Samet. On-land cleanup lasted about a month and was 
performed by a combination of territorial defense volunteers, citizen volunteers, Thai military 
personnel and company employees.  We examined prevalence of post-shift acute symptoms among 
Rayong oil spill cleanup workers, and assessed their association with predictive factors, including 
internal dose biomarkers of PAH and benzene exposure, day of cleanup worked, job description, 
PPE use, and age of workers.  
Methods: Post-shift acute symptoms and other variables recorded by questionnaire were linked to 
internal dose estimates based on urinary concentrations of 1-hydroxypyrene-glucuronide (1-
OHPG), trans,trans-muconic acid (t,t-MA), and cotinine.  Logistic regression models were used to 
assess the association between each of 23 physical symptoms and urinary 1-OHPG concentration 
or t,t-MA detectable levels, adjusting for day/week of cleanup worked, and urinary cotinine.  
Cleanup job descriptions, personal protective equipment use, and age of workers, were also 
examined as potential modifying factors.  Symptom groups were also determined by exploratory 
factor analysis.  The association between 7 symptom groups and potential exposure variables was 
then assessed by ordinal logistic regression models.  
Results:  Prevalence of several post-shift symptoms, including irritation of throat and nose, 
increased with concentration of urinary 1-OHPG, an internal dose biomarker of PAHs, with an 
odds ratio (95% CI) of 1.04 (1.00 - 1.08) per 1 pmol/ml increase in 1-OHPG.  Similarly, one group 
of symptoms determined by factor analysis, designated as “irritative symptoms”, including 
irritation of the eye, throat and/or nose, eye injection (redness) and excessive tearing (epiphora) 
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was associated with increased concentration of urinary 1-OHPG (OR = 1.03; 95% CI = 1.00-1.06, 
per 1 pmol/ml increase in 1-OHPG).  After adjusting for cotinine and day of cleanup worked, this 
association remained significant.  Unexpectedly, the prevalence of reported symptoms was higher 
in support personnel than in workers performing cleanup jobs with more direct potential exposure 
to oil.  None of the symptoms were related to urinary t,t-MA concentration, a biomarker of benzene 
exposure,  or PPE use.  
Conclusion:  Rayong oil spill cleanup workers exhibited evidence of an association between 
prevalence of acute irritative symptoms and PAH exposure measured by urinary 1-OHPG.  Long-
term health monitoring of oil spill cleanup workers should be implemented, particularly among 





On 27 July, 2013, a pipeline connecting an offshore oil platform to a tanker, operated by 
PTT Global Chemical (PTTGC), a corporation owned by the government of Thailand, leaked and 
caused crude oil to spill into the Sea of Rayong off the coast of Thailand.1  The crude oil covered 
an area of approximately 20 square kilometers and washed ashore on the island of Samet in an area 
called “Ao Prao” on 28 July, 2013.2  The estimated amount of oil spilled was between 50 and 190 
cubic meters or 336-1,200 barrels.1  On-land cleanup lasted about a month and was performed by 
a combination of territorial defense volunteers, citizen volunteers, Thai military personnel and 
PTTGC employees.  Cleanup procedures included oil containment, skimming, and dispersal, using 
absorbent pads, high-pressure water spraying and removal and disposal of contaminated soil, sand 
and rocks.2   
 A recent study quantified internal dose of polycyclic aromatic hydrocarbons (PAHs) and 
benzene in these workers to examine their potential exposure.  The internal dose of PAHs as 
measured by urinary 1-hydroxypyrene-glucuronide (1-OHPG) was highest in individuals who 
worked during the first 3 days of cleanup work (median: 0.97 pmol/ml) and was 66.7% lower 
(median: 0.32 pmol/ml) among individuals who worked in the final week of the study (days 21-
28).  This suggests that the exposure levels of PAHs were highest in the first week of cleanup and 
declined thereafter (Chapter 3).  The percentage of cleanup worker’s urine samples with detectable 
levels of t,t-muconic acid (t,t-MA), a metabolite of benzene, also declined over the four-week 
cleanup period (limit of quantitation of t,t-MA ~0.10 ug/ml). 
The International Agency for Research on Cancer (IARC) has classified benzene and some 
PAHS, including benzo[a]pyrene, as group 1 carcinogens, known to cause cancer in humans3.  
PAHs from occupational exposure are associated with respiratory and urinary tract cancers.4 
Workers exposed to PAHs report various symptoms, including breathing problems, chest pains, 
chest irritation, throat irritation and cough.5  PAHs are also associated with asthma and allergy in 
children.6  Sub-chronic to chronic exposure to benzene can result in pancytopenia, aplastic anemia 
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and eventually leukemia -- especially acute myelogenous leukemia (AML).7-14  Whereas acute 
inhalation of high doses of benzene (> 60 ppm) can result in neurotoxic symptoms, including 
dizziness, headache and drowsiness.15    
In the current study, we examined prevalence of post-shift acute symptoms among Rayong 
oil spill cleanup workers, and assessed their association with predictive factors, including internal 
dose biomarkers of PAH and benzene exposure, day of cleanup worked, job description, PPE use, 





MATERIALS AND METHODS 
 The symptom and related data were first collected as part of the health surveillance for oil 
spill cleanup workers. The consent for use of this data for scientific study was obtained by the 
Rayong Hospital and the Thai Naval Medical Department.  Approval for the further analysis of de-
identified data in our study was approved by the institutional review board of the Johns Hopkins 
Bloomberg School of Public Health, and the ethical committees of the Prince of Songkla 
University, Rayong Hospital, and the Thai Naval Medical Department. 
Study Population and Questionnaire 
 The study population consisted of workers who participated in the Rayong oil spill cleanup 
of July-August, 2013.  It included workers from a variety of backgrounds (territorial defense 
volunteers, citizen volunteers, Thai military personnel and PTTGC employees) who were recruited 
into a health surveillance program by Rayong Hospital and the Thai Naval Medical Department.   
Our study used data from the Rayong Hospital symptoms questionnaire and our internal dose 
measurements of urinary PAH and benzene metabolites from our exposure study of these workers 
(Chapter 3).  The questionnaire was designed by a team composed of committees from Rayong 
Provincial Public Health Office, Rayong Hospital, Thai Naval Medical Department and Thai 
Department of Disease Control.  Workers who provided urine were asked to answer self-reported 
questions regarding their post-shift acute physical symptoms at the time their urine was collected.  
The data from the questionnaire was linked to the 1,343 usable urine samples that we had analyzed 
previously for 1-OHPG and t,t-MA.  
Details of the Rayong Oil Spill Cleanup Study 
The date that the on-land cleanup began (29 July 2013) was counted as Day 1 of cleanup 
in our study.  The health surveillance protocol, including questionnaire and urine sample collection, 
began the next day (Day 2).  A calendar depicting the cleanup sequence and our study time periods 




Figure 4.1: Rayong Oil Spill Cleanup Study (27 July 2013 – 26 August 2013) 
 
  
Demographic factors and their distribution are shown previously in Table 3.1 in Chapter 
3.  Of 1,343 oil spill study cleanup workers, 93.2% were males. The median age was 27 years old 
(Interquartile Range (IQR) = 18.0) and the majority (55.3%) of the workers’ background 
occupations were military personnel.  Forty percent of the workers participated in the oil spill 
cleanup on Day 2 to Day 4 of the cleanup, and 24.4% of the workers participated on Day 5 to Day 
7 of cleanup.  Working hours per day was not available in the questionnaires.  The workers 
performed various oil spill cleanup jobs.  Of 1,343 workers, 57.9% were assigned the job to 
manually remove oil-contaminated sand, rocks, and trash (Table 3.2), and 23.5% were assigned the 
job to vacuum or manually remove the oil slick from water.   
 
 Workers were also asked about their personal protective equipment (PPE) use.  They were 
asked if they wore any PPE, an N95 mask, an R95 mask, any mask with filter, coveralls, gloves or 
boots.  The mask questions were grouped as “any mask use” if the workers answered “yes” to at 
least one of the questions, regarding the use of N95, R95 or mask with filter.  Most of the workers 
(84%) self-reported using at least one piece of PPE (either mask, coveralls, gloves or boots) during 
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their shifts (Table 3.3).  However, only 16.8% of the workers wore the complete set of PPE, and 
31.7% reported that they “often” wore at least one piece of PPE. 
Laboratory Methods 
Urinary 1-hydroxypyrene-glucuronide (1-OHPG), a measurable metabolite of pyrene in 
urine, was measured to assess the internal dose of PAH of each worker.  Urinary 1-OHPG was 
measured by immunoaffinity chromatography and synchronous fluorescence spectroscopy (SFS), 
modified from protocols of Strickland et al. (1994)16 as described in our exposure assessment study 
(Chapter 3).  The limit of detection (LOD) was 0.04 pmol/ml, the recovery of the assay was 82% 
and the coefficient of variation was 5.6%.     
Urinary t,t-MA levels, measured by HPLC with fluorescence detection, were retrieved 
from Rayong Hospital data.17  The coefficient of variation was 71-85% and the recovery rate was 
91-95%.17  The limit of quantitation (LOQ) was estimated to be 0.01 mg/dl or 0.10 µg/ml. 
Creatinine and cotinine were measured as previously described (Chapter 3).  The 
coefficient of variation of creatinine was 5% and the limit of detection was 0.1 mg/dl.  The 
coefficient of variation of cotinine was 8% and the limit of detection was 2 ng/ml.  We used the 
generally recommended cut-off of 50 ng/ml of urinary cotinine to differentiate between non-
smokers and passive smokers.18, 19 
Statistical Methods 
All available questionnaire data was linked to the 1-OHPG, t,t-MA, and cotinine 
measurements.  Non-detectable measurements of urinary 1-OHPG and cotinine were replaced with 
the value of the LOD/√2.  The prevalence of symptoms by categorical variables, such as day of 
cleanup, PPE use, smoking status (cotinine concentration), age of workers, or job description was 
explored.  Because of the large proportion of non-detectable samples (67.5%), the urinary t,t-MA 
data was analyzed as a binary variable (detectable vs non-detectable).  In addition, due to the 
relatively smaller sample size, t,t-MA data from the 3rd and 4th weeks of cleanup were combined 
before the statistical analysis.  
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For inferential statistics, logistic regression models were used to assess the association 
between each physical symptom and urinary 1-OHPG concentration or t,t-MA detectable levels, 
adjusting for days of cleanup (day 2-4, day 5-7, week 2, week 3-4 of cleanup) and urinary cotinine.  
 A latent variable approach, exploratory factor analysis (EFA), was used to assess the 
underlying correlation between the post-shift symptoms.  This method uses the correlation patterns 
among variables to group them into underlying latent factors, without a priori hypothesis of the 
measured factors and patterns.  Based on Bayesian information criterion and the VSS (very simple 
structure) model selection method described by Revelle and Rocklin (1979)20, the optimal number 
of symptom factors selected was 7.  The root mean square error of approximation (RMSEA) index 
of the EFA 7 factor model was 0.05, indicating good model fit.21  To explore the factor (group) 
structures of the post-shift symptoms, the weighted least squares factor analysis described by 
Harman et al (1966)22 was used.  The direct oblimin rotation procedure was used to allow 
correlations between factors using a correlation cut-off of 0.3.  Each symptom in the 7 groups was 
assigned a score of 1, with each symptom group having a cumulative score ranging up to 5 
depending on the number of symptoms in the group (see factor analysis results).  Ordinal logistic 
regression models were used to assess the association between the 7 symptom groups and potential 
exposure variables.   
 Sensitivity analysis by adding age of workers as an adjusted variable in the logistic 
regression models of symptoms and 1-OHPG and t,t-MA was performed.  The results were not 
different from the models without age.  Therefore, we report results from the models without age 
of workers (See Appendix Table 4.4 and 4.7). 
 All statistical analysis was completed using R version 3.2.4. (R Development Core Team, 





Prevalence of Post-Shift Symptoms  
 Acute physical symptoms were assessed by questionnaire completed by workers 
immediately after their work shift.  The questionnaire consisted of 23 items regarding post-shift 
symptoms, including dizziness, irritated throat, irritated eye, muscle pain, irritated nose, sore throat, 
cough, heavy breathing, running nose, skin itching, nausea, blurred vision, feeling faint, abdominal 
pain, excessive tearing of eyes (epiphora), diarrhea, eye injection (redness), eczema, chest 
tightness, palpitation, injuries, taste change and vomiting.  Overall, 36.3% of workers reported 
having at least one of the symptoms.  The 5 symptoms with the greatest prevalence were dizziness 
(10.6%), irritated throat (9.2%), irritated eye (8.9%), muscle pain (7.8%) and irritated nose (7.4%) 
(Table 4.1). 
Self-reported dizziness was the only symptom that showed a decreasing trend in prevalence 
as cleanup progressed through the full 4 weeks (P-trend=0.005) (Table 4.2). Other symptoms 
including irritated throat, irritated eyes, muscle pain, sore throat, cough, running nose, skin itching, 
abdominal pain, diarrhea and injuries showed increasing trends over the 4 weeks of cleanup (P-
value <0.05).  Some of these symptoms (cough, runny nose and abdominal pain) may have been 




Table 4.1: Prevalence of 23 self-reported symptoms 
Post-shift Symptoms Prevalence (n) % 
Total Number 1343 100.0 
Missing Symptoms Data 25 1.9 
Any Symptoms 487 36.3 
Dizziness 142 10.6 
Irritated Throat 124 9.2 
Irritated Eyes 120 8.9 
Muscle Pain 105 7.8 
Irritated Nose 99 7.4 
Sore Throat 80 6.0 
Cough 75 5.6 
Heavy Breathing 70 5.2 
Running Nose 68 5.1 
Skin Itching 39 2.9 
Nausea 38 2.8 
Blurred Vision 31 2.3 
Feeling Faint 27 2.0 
Abdominal Pain 25 1.9 
Excessive Tearing of Eyes (Epiphora) 24 1.8 
Diarrhea 21 1.6 
Eye Injection (Redness) 20 1.5 
Eczema 19 1.4 
Chest Tightness 16 1.2 
Palpitation 16 1.2 
Injuries 13 1.0 
Taste Change 8 0.6 







Table 4.2: Prevalence of Symptoms by Days of Cleanup  
Post-Shift Symptoms 









Total Number 537 328 282 196 
 
Dizziness 12.1 13.7 6.4 7.1 0.005 
Irritated Throat 6.1 13.1 8.5 12.2 0.027 
Irritated Eyes 8.9 13.7 5.3 6.1 0.053 
Muscle Pain 3.7 8.2 10.3 14.8 <0.001 
Irritated Nose 8.8 6.7 6.0 6.6 0.157 
Sore Throat 2.0 6.4 7.4 13.8 <0.001 
Cough 1.1 3.7 4.3 23.0 <0.001 
Heavy Breathing 5.4 6.1 2.8 6.6 0.770 
Running Nose 3.0 1.8 3.9 17.9 <0.001 
Skin Itching 1.3 2.7 5.7 3.6 0.005 
Nausea 2.6 4.0 2.8 1.5 0.533 
Blurred Vision 1.5 3.7 2.8 1.5 0.660 
Feeling Faint 1.7 2.1 0.4 5.1 0.106 
Abdominal Pain 0.4 1.5 2.5 5.6 <0.001 
Eye Tearing (Epiphora) 0.9 2.7 1.4 3.1 0.113 
Diarrhea 0.2 0.9 2.5 5.1 <0.001 
Eye Injection (Redness) 0.7 2.7 1.4 1.5 0.428 
Eczema 0.6 0.9 3.9 1.0 0.035 
Chest Tightness 0.6 2.1 1.8 0.5 0.601 
Palpitation 0.7 2.7 1.1 0.0 0.528 
Injuries 0.4 0.6 1.8 2.0 0.014 
Taste Change 0.4 1.2 0.4 0.5 0.966 
Vomiting 0.2 0.0 0.4 0.5 0.375 
 
*P-trend was calculated by Mantel-Haenstzel chi-squared test for trend.      Decreasing trend;     Increasing trend. 





Post-Shift Symptoms and Urinary Cotinine 
Certain symptoms, including, irritated nose, cough and sore throat were associated with 
smoking, classified as urinary cotinine more than 50 ng/ml (Appendix Table 4.1 and Figure 4.2).  
Prevalence of sore throat and cough (7.4% and 7.5%, respectively) in the smokers (cotinine > 50 
ng/ml) was greater than the prevalence in nonsmokers (cotinine < 50 ng/ml) (4.6% and 3.7%, 
respectively).  The prevalence of irritated nose was lower in smokers (5.7%) than in nonsmokers 
(9.0%).  These findings suggested that smoking might confound the association between exposure 
variables (e.g., 1-OHPG, t,t-MA) and physical symptoms.  Therefore, cotinine was used as an 




Figure 4.2: Prevalence of Post-Shift Symptoms by Cotinine Levels (Less than or greater 
than 50 ng/ml)  
 



















































































Post-Shift Symptoms and Age of Workers 
 Age of workers was also related to prevalence of symptoms.  Workers aged 40 years or 
older reported higher prevalence of several post-shift symptoms, including irritated throat, eyes and 
nose, blurred vision and eye injection (redness), compared to worker younger than 40 years of age. 
Whereas, cough, runny nose and abdominal pain were reported less frequently in workers 40 years 
or older, compared to younger workers (Table 4.3).  These latter three symptoms (cough, runny 
nose and abdominal pain) may have been due to stomach flu and were concentrated in the military 




Table 4.3: Prevalence of Post-Shift Symptoms Stratified by Age (N=1,311)* 
Post-Shift 
Symptoms 
Total Age < 40 yrs Age >= 40 yrs 
P-value** 
N N % N % 
Total Number 1,311 982 100.0 329 100.0  
Dizziness 141 105 10.7 36 10.9 0.899 
Irritated Throat 123 80 8.1 43 13.1 0.011 
Irritated Eyes 120 80 8.1 40 12.2 0.029 
Muscle Pain 105 77 7.8 28 8.5 0.699 
Irritated Nose 99 57 5.8 42 12.8 <0.001 
Sore Throat 80 62 6.3 18 5.5 0.581 
Cough 75 69 7.0 6 1.8 <0.001 
Heavy Breathing 70 50 5.1 20 6.1 0.491 
Running Nose 68 58 5.9 10 3.0 0.042 
Skin Itching 39 26 2.6 13 4.0 0.228 
Nausea 37 24 2.4 13 4.0 0.153 
Blurred Vision 31 18 1.8 13 4.0 0.029 
Feeling Faint 27 25 2.5 2 0.6 0.032 
Abdominal Pain 25 23 2.3 2 0.6 0.046 
Eye Tearing (Epiphora) 24 15 1.5 9 2.7 0.157 
Diarrhea 21 17 1.7 4 1.2 0.519 
Eye Injection (Redness) 20 10 1.0 10 3.0 0.010 
Eczema 19 15 1.5 4 1.2 0.682 
Chest Tightness 16 11 1.1 5 1.5 0.568 
Palpitation 16 12 1.2 4 1.2 0.993 
Injuries 13 12 1.2 1 0.3 0.204 
Taste Change 8 6 0.6 2 0.6 1.000 
Vomiting 3 2 0.2 1 0.3 1.000 
 
*32 missing data (either symptoms or age) 




Logistic Regression of Post-shift Symptoms and Internal Dose (1-OHPG and t,t-MA) 
Post-shift symptoms that were significantly associated with urinary 1-OHPG levels 
included irritated throat, irritated nose, muscle pain, irritated nose, cough, diarrhea and chest-
tightness (Figure 4.3).  The risk (95% CI) of having irritated throat or irritated nose increased 1.05 
(1.01-1.10) and 1.05 (1.01-1.10) fold respectively, per 1 pmol/ml increase in 1-OHPG.  Whereas, 
the risk (95% CI) of having cough, diarrhea or chest tightness was 0.80 (0.64-0.94), 0.47 (0.18-
0.91) and 0.64 (0.33-0.99) fold respectively, per 1 pmol/ml increase in 1-OHPG (Appendix Table 
4.3).  Although urinary 1-OHPG appeared to be protective for these latter 3 symptoms, they may 
have been considered serious enough to cause these workers to stop working early, thereby 
reducing their exposure levels. Although not significant, other irritation symptoms, including 
irritated eye, eye injection (redness) and tearing (epiphora) were also positively associated with 
urinary 1-OHPG (Figure 4.3, Appendix Table 4.3 - 4.4).  None of the post-shift symptoms were 
associated with detectable levels of urinary t,t-MA except irritated throat (Figure 4.4, Appendix 




Figure 4.3: Adjusted Odds Ratio* of Post-Shift Symptoms (per 1 pmol/ml change in 1-OHPG) 
 




Figure 4.4: Adjusted Odds Ratio* of Post-Shift Symptoms by Detectable t,t-MA 
 






Post-Shift Symptoms and Job Description 
 Due to the small number of workers in most job categories with physical symptoms, we 
were only able to examine the distribution of post-shift symptoms in two high PAH exposure job 
descriptions (contaminated sand/trash removal and oil vacuum/oil slick removal) and one relatively 
low PAH exposure job description (support personnel).  For this reason, the total number of workers 
in this section of the analysis was 1,150 (rather than 1,343) (Table 4.4).  Prevalences of irritated 
throat, irritated eyes, irritated nose, and heavy breathing, were higher in support personnel than in 
workers involved in removing contaminated sand/trash or vacuuming/removing oil slicks (P<0.05 
from chi-squared or fisher’s exact test).  Whereas, prevalence of cough was highest in the workers 
whose job was to vacuum/remove oil slicks (P=0.025).  Because the support personnel group 
tended to be older than the other two groups, they may have had more frequent background 
symptoms (prior to involvement with the cleanup), or be more sensitive to heat-related symptoms 
or toxicants present during the cleanup work (Appendix Table 4.8).  None of the support personnel 
reported having cough, feeling faint, chest tightness or palpitation symptoms.  In our regression 
analysis, we chose the support personnel as the reference group because they had the lowest median 
levels of urinary 1-OHPG from our exposure assessment study (Chapter 3).  Adjusting for days of 
cleanup and urinary cotinine, the odds of having irritation of throat and nose, sore throat, heavy 
breathing and nauseate in contaminated sand/trash removal workers was significantly lower than 
in support personnel (Table 4.5).  Whereas, in oil vacuum/oil slick removal workers, only the odds 
of having irritation of throat and nose, and heavy breathing was significantly lower than in support 
personnel (Table 4.5).  Results from the univariable model and the model further adjusted for age 



















N N % N % N % 
Total Number 1,150 60 100.0 775 100.0 315 100.0  
Dizziness 123 8 13.3 83 10.7 32 10.2 0.713 
Irritated Throat 99 15 25.0 64 8.3 20 6.3 <0.001 
Irritated Eyes 97 7 11.7 54 7.0 36 11.4 0.039 
Muscle Pain 93 3 5.0 64 8.3 26 8.3 0.754 
Irritated Nose 85 11 18.3 51 6.6 23 7.3 0.009 
Sore Throat 74 7 11.7 46 5.9 21 6.7 0.205 
Cough 73 0 0.0 58 7.5 15 4.8 0.019 
Heavy Breathing 60 8 13.3 39 5.0 13 4.1 0.025 
Running Nose 65 2 3.3 51 6.6 12 3.8 0.172 
Skin Itching 32 3 5.0 17 2.2 12 3.8 0.135 
Nausea 34 6 10.0 18 2.3 10 3.2 0.010 
Blurred Vision 23 2 3.3 12 1.5 9 2.9 0.182 
Feeling Faint 27 0 0.0 16 2.1 11 3.5 0.192 
Abdominal Pain 23 1 1.7 16 2.1 6 1.9 1.000 
Eye Tearing 19 1 1.7 13 1.7 5 1.6 1.000 
Diarrhea 20 1 1.7 14 1.8 5 1.6 1.000 
Eye Injection  11 2 3.3 7 0.9 2 0.6 0.155 
Eczema 16 1 1.7 6 0.8 9 2.9 0.028 
Chest Tightness 14 0 0.0 11 1.4 3 1.0 0.891 
Palpitation 14 0 0.0 11 1.4 3 1.0 0.891 
Injuries 12 1 1.7 5 0.6 6 1.9 0.108 
Taste Change 7 1 1.7 4 0.5 2 0.6 0.453 
Vomiting 2 0 0.0 2 0.3 0 0.0 1.000 
*Coordinators, PTTGC Corporate Representatives, Visitors, Photographers, and Journalists were grouped as support 
personnel. 
 
**P-value from Chi-squared or Fisher’s exact test 
Bold numbers indicate statistically significant results. (P<0.05) 
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Table 4.5: Adjusted Odds Ratio of Post-Shift Symptoms by Job descriptions (n=1,150) 






Oil Slick Removal 
OR OR** (95% CI) OR** (95% CI) 
Dizziness 1.00 (Ref) 1.02 (0.48-2.41) 0.94 (0.42-2.33) 
Irritated Throat 1.00 (Ref) 0.25 (0.13-0.50) 0.21 (0.10-0.45) 
Irritated Eyes 1.00 (Ref) 0.74 (0.33-1.88) 1.28 (0.56-3.37) 
Muscle Pain 1.00 (Ref) 1.60 (0.55-6.81) 1.91 (0.62-8.38) 
Irritated Nose 1.00 (Ref) 0.32 (0.16-0.70) 0.34 (0.15-0.78) 
Sore Throat 1.00 (Ref) 0.34 (0.14-0.91) 0.51 (0.20-1.42) 
Cough 1.00 (Ref) NA    
Heavy Breathing 1.00 (Ref) 0.37 (0.16-0.91) 0.32 (0.12-0.90) 
Running Nose 1.00 (Ref) 1.05 (0.29-6.74) 0.84 (0.21-5.65) 
Skin Itching 1.00 (Ref) 0.34 (0.10-1.54) 0.59 (0.17-2.76) 
Nausea 1.00 (Ref) 0.31 (0.12-0.91) 0.39 (0.13-1.23) 
Blurred Vision 1.00 (Ref) 0.59 (0.15-3.94) 1.11 (0.26-7.66) 
Feeling Faint 1.00 (Ref) NA    
 
*Coordinators, PTTGC Corporate Representatives, Visitors, Photographers, and Journalists were grouped as support 
personnel. 
 
**Odds ratio adjusted by urinary cotinine and days of cleanup (Multivariable Model) 
Bold numbers indicate statistically significant results. (P<0.05) 
NA because the prevalence of symptoms in the reference group is too small to calculate the odds ratio: 0/60 in cough, 
0/60 feeling faint 
 
For abdominal pain, epiphora, diarrhea, eye injection, eczema, chest tightness, palpitation, injuries, taste change and 






Post-shift Symptoms and Personal Protective Equipment (PPE) Use 
 Using at least one piece of PPE was associated with decreased prevalence of cough, 
diarrhea, and chest tightness, but increased prevalence of irritated throat and nose (Table 4.6).  
Using a mask was associated with increased prevalence of dizziness, muscle pain, irritated nose, 
cough, nausea and blurred vision.  We attempted to control for (exposure) selection bias by 
adjusting for day of cleanup that the workers worked.  In contrast to mask use, boot or coverall use 
showed no consistent trends in sympton protection or exacerbation.  To summarize, the overall 
evidence was not adequate to support the hypothesis that PPE use by Rayong oil spill workers was 




Table 4.6: Adjusted Odds Ratio* of Post-Shift Symptoms by PPE use (n=1,294)** 
 
* Odds ratio adjusted by urinary cotinine and day of cleanup.      
**49 workers had at least one piece of missing data     Bold numbers indicate statistically significant results (P<0.05). 
Post-shift  
Symptoms  












OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
Dizziness 1.30 (0.85 - 1.02) 1.50 (1.03 - 2.21) 1.02 (0.71 - 1.47) 1.05 (0.73 - 1.50) 1.06 (0.73 - 1.56) 1.18 (0.73 - 1.99) 
Irritated Throat 1.04 (1.01 - 1.10) 1.25 (0.83 - 1.88) 0.70 (0.48 - 1.04) 0.95 (0.65 - 1.38) 0.82 (0.53 - 1.26) 0.63 (0.40 - 1.02) 
Irritated Eyes 1.02 (0.97 - 1.07) 1.31 (0.87 - 1.99) 0.86 (0.58 - 1.28) 1.09 (0.74 - 1.61) 1.02 (0.67 - 1.54) 0.78 (0.49 - 1.29) 
Muscle Pain 1.01 (0.94 - 1.05) 1.69 (1.07 - 2.66) 1.03 (0.66 - 1.61) 1.31 (0.87 - 1.98) 1.36 (0.83 - 2.22) 1.32 (0.74 - 2.54) 
Irritated Nose 1.05 (1.01 - 1.10) 1.86 (1.16 - 3.00) 0.91 (0.59 - 1.42) 1.19 (0.78 - 1.83) 0.70 (0.44 - 1.12) 0.99 (0.57 - 1.83) 
Sore Throat 1.00 (0.90 - 1.05) 0.96 (0.56 - 1.62) 1.04 (0.63 - 1.75) 1.44 (0.90 - 2.32) 1.42 (0.80 - 2.53) 0.62 (0.35 - 1.13) 
Cough 0.80 (0.64 - 0.94) 1.86 (1.03 - 3.37) 0.75 (0.44 - 1.31) 1.66 (1.00 - 2.81) 1.85 (0.88 - 3.93) 0.70 (0.36 - 1.45) 
Heavy Breathing 1.00 (0.88 - 1.06) 1.30 (0.76 - 2.23) 0.73 (0.44 - 1.22) 0.80 (0.48 - 1.31) 0.63 (0.36 - 1.10) 0.67 (0.38 - 1.26) 
Running Nose 1.03 (0.96 - 1.08) 1.42 (0.78 - 2.60) 0.90 (0.52 - 1.59) 1.59 (0.94 - 2.70) 0.84 (0.40 - 1.71) 0.93 (0.46 - 2.09) 
Skin Itching 1.02 (0.94 - 1.07) 1.52 (0.75 - 3.07) 1.04 (0.52 - 2.16) 0.94 (0.49 - 1.81) 1.08 (0.50 - 2.28) 1.03 (0.45 - 2.78) 
Nausea 0.95 (0.75 - 1.06) 2.57 (1.24 - 5.61) 0.63 (0.32 - 1.24) 0.54 (0.26 - 1.07) 0.86 (0.42 - 1.73) 0.92 (0.42 - 2.32) 
Blurred Vision 1.00 (0.85 - 1.06) 2.88 (1.28 - 6.86) 0.84 (0.39 - 1.82) 1.01 (0.48 - 2.12) 1.39 (0.62 - 3.11) 1.36 (0.52 - 4.69) 
Feeling Faint 1.03 (0.88 - 1.10) 1.19 (0.49 - 2.90) 0.90 (0.40 - 2.08) 1.08 (0.49 - 2.38) 0.75 (0.28 – 2.00) 0.96 (0.36 - 3.35) 
Abdominal Pain 0.97 (0.73 - 1.06) 0.96 (0.34 - 2.43) 1.07 (0.44 - 2.86) 1.39 (0.61 - 3.27) 0.86 (0.25 - 2.63) 0.81 (0.29 - 2.86) 
Eye Tearing 1.04 (0.94 - 1.09) 1.58 (0.64 - 3.92) 0.57 (0.24 - 1.34) 0.85 (0.67 - 1.95) 3.22 (1.18 - 9.80) 0.83 (0.28 - 2.25) 
Diarrhea 0.47 (0.18 - 0.91) 0.61 (0.16 - 1.81) 0.98 (0.38 - 2.85) 1.48 (0.60 - 3.82) 0.17 (0.01 - 0.92) 0.93 (0.30 - 4.05) 
Eye Injection  1.05 (0.98 - 1.11) 0.55 (0.18 - 1.50) 0.34 (0.12 - 0.88) 0.37 (0.12 - 0.98) 0.38 (0.10 - 1.14) 0.17 (0.07 - 0.44) 
Eczema 0.99 (0.77 - 1.06) 1.37 (0.49 - 3.66) 1.00 (0.37 - 2.96) 1.69 (0.67 - 4.45) 1.03 (0.33 - 2.88) 0.98 (0.32 - 4.27) 
Chest Tightness 0.64 (0.33 - 0.99) 1.77 (0.62 - 5.34) 0.59 (0.21 - 1.68) 0.68 (0.23 - 1.87) 0.87 (0.28 - 2.56) 0.95 (0.30 - 4.19) 
Palpitation 1.02 (0.82 - 1.09) 1.26 (0.45 - 3.69) 0.76 (0.27 - 2.12) 0.52 (0.16 - 1.45) 0.90 (0.31 - 2.51) 0.71 (0.24 - 2.60) 
Injuries 0.79 (0.39 - 1.06) 0.56 (0.12 - 2.05) 1.02 (0.31 - 3.95) 2.40 (0.76 - 9.02) 0.18 (0.01 - 1.06) 0.54 (0.16 - 2.47) 
Taste Change 0.98 (0.57 - 1.12) 4.00 (0.81 - 30.45) 1.24 (0.29 - 6.24) 1.85 (0.44 - 9.16) 0.84 (0.16 - 3.94) 1.58 (0.27 - 29.95) 
Vomiting Sample size is too small to calculate odds ratio 
100 
 
Exploratory Factor Analysis  
 
 An exploratory factor analysis was performed in order to examine the hypothesis that 
some of these symptoms might share underlying common pathologies and be highly correlated in 
groups.  As described earlier, the optimal number of factors (groups) was 7, and post-shift 
symptoms were grouped by factor analysis as shown in Table 4.7 and Figure 4.5. 
Table 4.7: Groups of Symptoms Determined by Factor Analysis 
 
Group  Symptoms Symptom Group Name 
MR1  Chest tightness, Palpitation Chest Symptoms 
MR2 Urticaria, Skin Itching Allergic Skin Reaction 
MR3 Irritation of Eye, Throat, Nose, 
Eye injection (Redness), Eye Tearing (Epiphora) 
Irritative Symptoms 
MR4 Diarrhea, Abdominal Pain, Vomiting Gastrointestinal 
Symptoms 
MR5 Sore Throat, Running Nose, Cough Respiratory Tract 
Symptoms 
MR6 Feeling Faint, Taste Changes Sensation Errors 
MR7 Heavy Breathing Heavy Breathing 
 
*MR = Minimun Residual; In our exploratory factor analysis, we used the Ordinary Least Squares (OLS) method to 




Figure 4.5: Factor Analysis Diagram showing the EFA results (Correlation coefficients) of 
23 Post-Shift Symptoms   
 






















Factor Analysis on Post-Shift Symptoms and Urinary Metabolites (1-OHPG and t,t-MA) 
 The results from ordinal logistic regression on group symptoms indicated that the 
irritative symptoms were associated with the level of urinary 1-OHPG in workers.  The adjusted 
odds ratio of irritative symptoms, a symptom group consisting of irritated eye, throat and nose, 
eye injection (redness) and excessive tearing (epiphora), was 1.04 (95%CI: 1.01 - 1.07) per 1 
pmol/ml increase in urinary 1-OHPG concentration (Table 4.8).  On the other hand, detectable 
urinary t,t-MA was not statistically associated with any symptom group (Table 4.9). 
Table 4.8: Adjusted Odds Ratio of Symptom Groups (per 1 pmol/ml increase in 1-OHPG) 
from Ordinal Logistic Regression and Factor Analysis (n=1,318) 
 
Symptom Group MR 
Crude OR Adjusted OR* 
OR 95% CI OR 95% CI 
Chest Symptoms  1 0.98 (0.79 - 1.06) 0.98 (0.77 - 1.06) 
Allergic Skin Reaction 2 1.02 (0.93 - 1.07) 1.02 (0.94 - 1.06) 
Irritative Symptoms 3 1.03 (1.00 - 1.06) 1.04 (1.01 - 1.07) 
Gastrointestinal Symptoms 4 0.84 (0.62 - 1.02) 0.89 (0.64 - 1.04) 
Respiratory Tract Symptoms 5 0.96 (0.88 - 1.02) 1.00 (0.93 - 1.05) 
Sensation Errors 6 1.01 (0.88 - 1.07) 1.03 (0.89 - 1.09) 
Heavy Breathing 7 0.99 (0.88 - 1.05) 1.00 (0.88 - 1.06) 
 
*Odds ratio adjusted by urinary cotinine and days of cleanup  





Table 4.9: Adjusted Odds Ratio of Symptom Groups (by detectable vs non-detectable t,t-
MA) from Ordinal Logistic Regression and Factor Analysis (n=1,318) 
 
Symptom Group 
Crude OR Adjusted OR* 
OR 95% CI OR 95% CI 
Chest Symptoms  0.65 (0.23 - 1.54) 0.54 (0.18 - 1.43) 
Allergic Skin Reaction 1.06 (0.55 - 1.97) 1.10 (0.53 - 2.23) 
Irritative Symptoms 0.93 (0.70 - 1.24) 1.01 (0.73 - 1.37) 
Gastrointestinal Symptoms 1.48 (0.74 - 2.89) 1.51 (0.67 - 3.33) 
Respiratory Tract Symptoms 0.84 (0.58 - 1.20) 0.81 (0.53 - 1.23) 
Sensation Errors 1.14 (0.52 - 2.35) 1.02 (0.43 - 2.29) 
Heavy Breating 1.23 (0.74 - 2.02) 1.31 (0.75 - 2.24) 
 
*Odds ratio adjusted by urinary cotinine and days of cleanup  
Bold numbers indicate statistically significant results. (P<0.05) 
 
Factor Analysis on Post-Shift Symptoms and Job Descriptions 
 Due to the relatively small sample size, ordinal logistic regression could not be performed 
for the analysis of symptoms by job description.  Therefore, we assessed the association between 
symptom groups (having at least one symptom in the group) and job descriptions using simple 
logistic regression.  The results from the simple logistic regression on symptom groups indicated 
(unexpectedly) that the prevalence of heavy breathing was lower in contaminated sand/trash 
removal workers and oil vacuum/oil slick removal workers than in support personnel (Table 
4.10).  The odds (95%CI) of heavy breathing were 0.34 (0.15 - 0.87) in contaminated sand/trash 
removal workers and 0.30 (0.11 - 0.84) in oil vacuum/oil slick removal workers, compared to 




Table 4.10: Adjusted Odds Ratio of Symptom Groups by Job Descriptions from Simple 







Oil Slick Removal 
OR* OR* (95% CI) OR* (95% CI) 
Chest Symptoms  1.00 (Ref) NA  NA  
Allergic Skin Reaction 1.00 (Ref) 0.37 (0.11 - 1.74) 0.82 (0.23  -  3.92) 
Irritative Symptoms 1.00 (Ref) 0.56 (0.31 - 1.05) 0.73 (0.38  -  1.40) 
Gastrointestinal 
Symptoms 
1.00 (Ref) 1.05 (0.18 - 20.34) 1.70 (0.26  -  33.7) 
Respiratory Tract 
Symptoms 
1.00 (Ref) 0.64 (0.29 - 1.57) 0.77 (0.33  -  1.97) 
Sensation Errors 1.00 (Ref) 1.00 (0.18 - 18.94) 2.38 (0.41  -  45.67) 
Heavy Breathing 1.00 (Ref) 0.34 (0.15 - 0.87) 0.30 (0.11  -  0.84) 
 
*Odds ratio adjusted by urinary cotinine and days of cleanup 
NA due to too small sample size to calculate Odds Ratio. 0/60 support personnel had Chest tightness and palpitation 
symptoms. 
Bold numbers indicate statistically significant results. (P<0.05) 
 
Factor Analysis on Post-Shift Symptoms and PPE Use 
 Personel protective equipment use did not appear to be related to group symptoms, with 




Table 4.11: Adjusted Odds Ratio of Symptom Groups by PPE Use from Ordinal Logistic Regression and Factor Analysis  (n=1,294) 










Complete set  
 of PPE 
OR  95%CI OR  95%CI OR  95%CI OR  95%CI OR  95%CI OR  95%CI 
Chest Symptoms  1.00 (0.37 - 3.49) 2.17 (0.93 - 5.40) 0.73 (0.32 - 1.68) 0.74 (0.32 - 1.66) 1.05 (0.44 - 2.44) 1.18 (0.42 - 2.88) 
Allergic Skin Reaction 1.27 (0.53 - 3.76) 1.36 (0.69 - 2.63) 1.21 (0.62 - 2.48) 1.13 (0.61 - 2.09) 1.01 (0.49 - 2.03) 1.03 (0.41 - 2.28) 
Irritative Symptoms 0.92 (0.62 - 1.41) 1.36 (1.01 - 1.84) 0.77 (0.58 - 1.03) 1.13 (0.86 - 1.50) 0.88 (0.65 - 1.20) 1.08 (0.74 - 1.54) 
Gastrointestinal 
Symptoms 
0.72 (0.31 - 1.99) 0.68 (0.27 - 1.55) 1.23 (0.58 - 2.87) 1.48 (0.74 - 3.03) 0.52 (0.16 - 1.38) 1.02 (0.29 - 2.86) 
Respiratory Tract 
Symptoms 
0.78 (0.48 - 1.30) 1.19 (0.79 - 1.78) 0.97 (0.66 - 1.42) 1.54 (1.08 - 2.19) 1.28 (0.83 - 1.99) 1.23 (0.73 - 2.02) 
Sensation Errors 2.09 (0.61 - 13.14) 1.65 (0.73 - 3.80) 0.87 (0.41 - 1.89) 1.10 (0.53 - 2.30) 0.83 (0.34 - 2.00) 1.39 (0.49 - 3.49) 
Heavy Breathing 0.84 (0.44 - 1.80) 1.30 (0.76 - 2.23) 0.73 (0.44 - 1.22) 0.80 (0.48 - 1.31) 0.63 (0.36 - 1.10) 1.07 (0.54 - 1.99) 
 
*Odds ratio adjusted by urinary cotinine and days of cleanup   




 In this study of Rayong oil spill cleanup workers, we examined prevalence of post-shift 
acute symptoms among the workers, and assessed their association with potential causative factors, 
including internal dose biomarkers of PAH and benzene exposure, day of cleanup worked, job 
description, PPE use, and age of workers.  We further examined causative factors associated with 
groups of correlated symptoms determined by factor analysis.  Prevalence of some post-shift 
symptoms, including irritation of throat and nose, increased with concentration of urinary 1-OHPG, 
an internal dose biomarker of PAHs.  Similarly, one group of symptoms designated as “irritative 
symptoms”, including irritation of the eye, throat and/or nose, eye injection (redness) and excessive 
tearing (epiphora), was also associated with increased concentration of urinary 1-OHPG.  After 
adjusting for cotinine and day of cleanup worked, this association remained significant. In 
occupational settings, PAHs have been reported to be related to irritation of the chest and throat.23 
Our study suggests that the levels of PAHs (or other compounds) present at oil spill sites are 
sufficient to cause irritative symptoms in cleanup workers.  The association between 1-OHPG and 
irritative symptoms might be due to related effects from the bioaerosols and particulate matter to 
which the PAHs are bound.24   
In the current study, none of the physical symptoms reported by workers were associated 
with urinary t,t-MA, an internal dose biomarker of benzene.  However, this may be due to the 
relatively low proportion of workers with detectable urinary t,t-MA in our study, and is consistent 
with the knowledge that benzene causes acute symptoms only at relatively high concentrations in 
air (> 50 ppm).15, 16  Previous studies from the Hebei oil spill examined the association between 
post-shift symptoms and biomarkers of PAHs in urine, as well as biomarkers of benzene, toluene, 
ethyl benzene, and xylene (BTEX) (Cheong et al, 2011 and Ha et al, 2012).23, 25  They reported that 
only musculoskeletal symptoms were associated with concentration of urinary 1-hydroxypyrene 
(1-OHP) (Cheong et al.)25, and only dermal irritation was associated with concentration of urinary 
t,t-MA (Ha et al).23  In contrast to our study, none of the reported irritative symptoms were found 
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to be associated with urinary 1-OHP.23, 25  However, they found that nasal irritation, nausea 
sensation, vomiting, fatigue and fever were associated with other BTEX biomarkers, including 
urinary hippuric and methyl-hippuric acid.25  The study of Peres et al (2016) from the Deepwater 
Horizon oil spill found that a burning sensation in the nose, throat or lungs, sore throat, dizziness 
and wheezing, were strongly associated with an exposure category by factor analysis of “high 
physical-environmental exposure” (including cleanup participation and property lost due to the oil 
spill) in adult women (overall n=2126, high n = 453).26 
 Several factors may have contributed to the variation in self-reported symptoms and their 
association with internal dose biomarkers.  Post-shift symptoms were self-reported and subjective.  
People in different cultures and settings may perceive and interpret symptoms caused by the same 
pathophysiology, in a different manner, such as hypoglycemia27 and menopause28, even in the same 
country.  Another complicating factor is the lack of standardization of symptom questionnaires for 
oil spill cleanup workers, adding to variability in question phrasing and symptoms emphasized. 
  Physical symptoms and their determining factors were reported differently among various 
studies that assessed symptoms among oil spill cleanup workers.  In our study, 36.3% of workers 
reported having at least one of 23 different symptoms, with the most prevalent symptom being 
dizziness (10.7%).  Another study of workers at the Rayong oil spill reported by Sithisarankul et 
al, (2015), 29 found that the five organ systems with the highest prevalence of symptoms were 
pulmonary (38.6%), integumentary and mucous membranes (17.0%), neurological (16.9%), 
musculoskeletal (7.7%) and gastrointestinal (6.1%) (n = 2,096).29  The study of Meo et al (2009) 
from the Tasman Spirit oil spill reported prevalence of symptoms among cleanup workers ranging 
from 18% for general illnesses to 38% for cough, and these prevalences were much higher than 
among matched controls.  The two studies from the Hebei oil spill reported the prevalence of post-
shift symptoms as 36-47% (Ha et al)23 and 37-90% (Cheong et al)25 in the participants.  The Hebei 
studies combined 41 symptom questions into 14 categories, reporting prevalence of categories 
rather than individual symptoms.  The study of D’ Andrea and Reddy (2013) found that the top 3 
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symptoms reported by Deepwater Horizon oil spill workers were headaches (75%), shortness of 
breath (71%) and skin rash (61%) (n=117).  The size of the Rayong oil spill was relatively small 
with only about 50-300 barrels of oil released, much less than that of the Deepwater Horizon (5 
million barrels)30 or Hebei (80,000 barrels)31 oil spills.  This may explain the lower prevalence of 
symptoms reported among the Rayong workers.  In addition, there may be differences in perception 
of symptoms in large versus small oil spills, artificially elevating symptom prevalence in large 
spills with expectation of high toxicant levels.  
 We also examined the prevalence of post-shift symptoms by days of cleanup.  We found 
that prevalence of dizziness decreased in subsequent days/weeks of cleanup, compared to the first 
three days (day 2-4) of cleanup.  This was consistent with our measure of internal dose of PAHs, 
urinary 1-OHPG, which decreased significantly over the 4 week course of the cleanup.  Conversely, 
other symptoms did not decrease (or even increased) in subsequent days of cleanup, compared to 
day 2-4 of cleanup.  Some of these symptoms (cough, runny nose and abdominal pain) may have 
been due to a possible outbreak of stomach flu among the military personnel in the latter weeks of 
cleanup.  The study of Cheong et al. (2012) also explored the prevalence of symptoms by days of 
cleanup but did not find a decreasing trend as the cleanup progressed.25 
 Many factors, including those stated above, may have influenced the prevalence of 
symptoms, in addition to PAH exposure.  For example, we also examined the prevalence of post-
shift symptoms by age of workers, and found that workers aged 40 years and older reported higher 
prevalence of symptoms, including irritated throat, irritated eyes, irritated nose, blurred vision and 
red eye (eye injection), than younger workers.  The older workers may have been more sensitive to 
physical labor or toxic chemicals, as has been suggested by studies of symptoms in construction 
workers32 and white-collar workers.33   
 In our study, prevalence of symptoms also varied by job description in an unexpected 
pattern.  For example, prevalence of irritated throat and nose, sore throat, and heavy breathing was 
highest in the support personnel (a group with lowest median levels of urinary 1-OHPG in our 
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exposure study), compared to oil contaminated sand/trash removal workers and oil vacuum/oil slick 
removal workers.  Even after adjustment by age of workers, days of cleanup, and urinary cotinine 
levels, the prevalence of these symptoms was still significantly higher in the support personnel than 
in workers with job descriptions associated with higher potential oil exposure.  These findings are 
complicated by the fact that most of the higher exposure jobs were performed by military personnel 
and PTTGC employees, whereas the support personnel consisted mostly of citizen volunteers.  In 
addition to being younger, the military personnel and PTTGC employees may have been better 
informed and more thoroughly instructed regarding the potential hazards and safety procedures of 
oil spill cleanup work.   This training may, in turn, have influenced their perception of the risks 
involved and related symptoms.  Similar to our study, Ha et al24 also found that the prevalence of 
eye and nose irritation, and headache was higher in logistics-related jobs, compared to direct 
cleanup jobs.  
 We also examined the association between post-shift symptoms and personal protective 
equipment (PPE) use.  Wearing at least one piece of PPE appeared to be protective against three 
symptoms: cough, diarrhea, and chest tightness.  Wearing coveralls appeared to be protective 
against diarrhea.  However, the overall findings on the effectiveness of PPE use were not consistent.  
Other symptoms did not decrease in prevalence (or in some cases increased in prevalence) with use 
of PPEs, including mask, gloves, boots, or the complete set of PPEs.  This suggests that not all 
PPEs were effective, or they were not used properly, or that the questionnaire data of PPE use 
and/or symptoms was not valid.  Similar to our finding, Lee et al. (2009) found no evidence of 
protection by PPE use against post-shift symptoms, among workers at the Hebei oil spill. 
 Our study investigated PAH and benzene internal dose biomarkers in cleanup workers and 
their post-shift symptoms, ascertained within the first two days of a fresh oil spill.  In contrast to 
studies of cleanup workers at the most intensively investigated spill, the Hebei oil spill, where urine 
sample collection started 2 weeks after cleanup started, our study assessed internal dose of PAHs 
and benzene beginning on the 2nd day of cleanup, at which time exposure was expected to be close 
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to maximum.  In addition, we used factor analysis to categorize correlated groups of symptoms, 
rather than grouping symptoms by pre-defined categories or organ systems which may have 
resulted in misclassification and reduced statistical power.  Furthermore, our study had a relatively 
large sample size (n=1343) compared to the three studies from the Hebei oil spill (n=121, n=154, 
n=724)9,10,32   
 The current study has several limitations.  First, the statistical analysis was performed as a 
cross-sectional symptom analysis because most cleanup workers (88%) only worked one day, thus 
limiting our ability to assess causal inference.  Second, post-shift symptoms were self-reported and 
somewhat subjective.  The perceptions of workers (not captured by the questionnaire) toward the 
dangers of oil spill cleanup work, may have influenced their answers to the symptom questionnaire. 
Third, the study questionnaire and sampling strategy was initially designed as part of a health 
surveillance program initiated by the Rayong Provincial Health office, rather than a formal 
scientific study.  As a result, some of the data, such as hours of cleanup participation, smoking 
status, dietary patterns, and pre-exposure assessment was not complete or unavailable for statistical 
analysis.  Fourth, our study did not have an ideal negative control population that was unexposed 
to crude oil, such as pre-cleanup baseline measurements of workers, or non-participants who were 
not involved in the cleanup.  For these reasons, it is difficult to assess the magnitude of the increase 
in prevalence of post-shift symptoms.   
 This study will form the foundation for the health followup and survelliance of these 
workers at Rayong Hospital, which is ongoing and planned to last 5 years.  In future studies, 
biomarkers of oxidative damage, such as urinary malondialdehyde (MDA), that has been associated 
with PAH exposure in several studies34, 35 might be useful in understanding the association between 
acute symptoms and PAHs.  Additional studies are needed to explore the occurrence and 
persistence of symptoms among oil spill cleanup workers with complementary exposure data.  
There is a need for standardized symptom questionnaires designed for oil spill cleanup workers, as 
well as standardized sample collection strategies. 
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 In conclusion, Rayong oil spill cleanup workers exhibited evidence of an association 
between prevalence of acute irritative symptoms and PAH exposure measured by urinary 1-OHPG.  
Long-term health monitoring of oil spill cleanup workers should be implemented, particularly 
among those workers suspected of sustaining high exposure to crude oil.  Standard health guidelines 
and symptom questionnaires for oil spill cleanup worker should be established internationally. 
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CHAPTER 5: CONCLUSIONS 
 The goal of this dissertation was to determine if Rayong oil spill cleanup workers were 
exposed to elevated levels of PAHs and benzene, and determine if these exposures were associated 
with recorded acute symptoms.  To address this goal, the urinary concentrations of 1-OHPG were 
measured in the 1,343 available frozen stored urine samples from the workers, and the previously 
measured urinary concentrations of t,t-MA were re-examined.  To assess possible factors related to 
PAH and benzene exposure, the health, work, and demographic questionnaire data was linked to 
the measured concentrations of 1-OHPG and t,t-MA.  Finally, the post-shift acute symptom data 
was linked to the aforementioned dataset to assess the association between acute symptoms and the 
internal dose biomarkers.  The results and conclusions are described in the context of our specific 
aims. 
 
Specific Aim 1: To determine the internal dose of PAHs and benzene among 1,343 Rayong oil 
spill cleanup workers by measuring the PAH biomarker 1-OHPG in previously collected urine 
samples and re-examining the t,t-MA concentrations previously measured. 
 In the first manuscript, Chapter 3, we reported elevated levels of urinary 1-OHPG among 
oil spill workers who worked during the first few days of the cleanup, when potential exposures to 
crude oil were high.  These levels of 1-OHPG are similar to those reported in occupational settings 
with high PAH exposures, such as in steel plant workers (Kang et al 1995)1.  For comparison, the 
observed levels of 1-OHPG in our workers were much higher than those observed among non-
smokers in the U.S. or in Thailand.2  We reported a high percentage (67.5%) of samples with 
nondetectable concentrations of urinary t,t-MA in our study.  However, the method previously used 
to measure t,t-MA in these workers3 had limited sensitivity, with an estimated limit of 
quantification of about 0.10 ug/ml.  This is comparable to background t,t-MA levels in the general 
population of 0.07 μg/ml  (range: 0.02-0.30 μg/ml).4, 5 Therefore, we can only conclude that about 
30% of the workers, whose urinary t,t-MA levels were detectable, had benzene exposures 
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comparable to the top quartile of that experienced by the general U.S. population.  In conclusion, 
the Rayong oil spill cleanup workers were exposed to PAHs at elevated levels, comparable to 
occupational exposures in high PAH exposure settings, whereas benzene exposures among the oil 
spill workers fell within the general population range. 
 
Specific Aim 2: To compare the internal dose of workers who worked on different days of cleanup: 
early week 1 (day 2-4), late week 1 (day 5-7), week 2, week 3 and week 4, adjusting for smoking 
status (cotinine) and to examine factors related to their dose, including personal protective 
equipment (PPE) use and job descriptions. 
 We reported that the elevated levels of urinary 1-OHPG among oil spill workers who 
worked during the first few days of cleanup (0.97 pmol/ml) declined to 0.32 pmol/ml in workers 
who worked 4 weeks later (days 22-28).  Thus, the 1-OHPG levels we observed were comparable 
to occupational exposures during the early days of cleanup, and declined to near background 
(general population) levels by the end of the cleanup operations.     
We also examined the levels of urinary 1-OHPG among cleanup workers with different job 
descriptions.  We found that certain types of jobs including, oil dispersant applicators, contaminated 
sand/trash removal workers and oil vacuum/oil slick removal workers, had higher levels of urinary 
1-OHPG than other workers and support personnel.  Oil dispersant applicators might be at increased 
risk of PAH exposure because spraying dispersants on oil-water interfaces generates aerosols that 
are respirable (Ehrenhauser et al, 2013).  Water wave action on the sea while applying dispersants 
can also facilitate aerosolization and evaporation of PAHs (Ehrenhauser et al, 2013).  Workers 
dealing with contaminated sand/trash removal and oil vacuum/oil slick removal were often in close 
(or direct) contact with crude oil, thereby enhancing the possibility of dermal contamination.  These 
findings expand our knowledge of the exposure profiles of oil spill cleanup workers with respect 
to specific job descriptions.   
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The effect of PPE use on PAH exposure among cleanup workers was investigated, but 
levels of urinary 1-OHPG were not associated with overall PPE use, consistent with the finding of 
Lee et al. (2009) from Hebei oil spill.6  Furthermore, individual equipment use (masks, gloves, 
boots, or coveralls) was not associated with a protective effect.  This suggests that PPE was not 
effective, or was not used properly, or that the questionnaire data was not reliable.  Alternatively, 
this might have resulted from exposure selection bias because of higher hazard recognition 
(resulting in enhanced PPE use) in the early days of cleanup when the beach was covered in oil, 
compared to later weeks of cleanup. 
This is the first investigation of PAH biomarkers in cleanup workers’ urine samples that 
were collected within two days of a fresh oil spill.  Furthermore, the sample size of our study 
(n=1343) is relatively large, compared to other studies from the Hebei oil spill9,10,32 and the 
Deepwater Horizon oil spill7.  In the current study, we also used urinary cotinine to adjust for 
expected confounding effects of smoking on PAH biomarkers, which were not used in previous 
studies.  These new findings confirm the assumption that oil spill cleanup workers are exposed to 
significantly elevated levels of PAHs, especially during the first days of a spill, and that PAH 
exposure declines within a few weeks of cleanup following a relatively small spill. 
In addition to the cleanup process, a number of other factors could contribute to differences 
in PAH exposure patterns between spills and between studies.  The half-life of PAHs in crude oil 
in the environment can range from a few hours up to weeks or months depending on the chemical 
composition of the oil, the molecular weights of the PAHs, bacterial biodegradation and 
photolysis.8, 9  After a spill and during cleanup, low molecular weight PAHs would be expected to 
evaporate within a few days, resulting in the rapid decline in biomarkers, while the higher molecular 
weight PAHs might take a few weeks to evaporate or degrade.  Pyrene, the parent compound of 1-
OHPG, is of intermediate MW (m=202) having both rapid and slow evaporation characteristics.   
We also found that the percentage of oil spill workers with detectable urinary t,t-MA  
decreased from day 2-4 to week 3-4 of cleanup in nonsmokers, but not in smokers.  Because a high 
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percentage (67.5%) of samples had nondetectable levels of t,t-MA in our study, we analyzed the 
t,t-MA data as a binary variable – detectable vs nondetectable..  This limited our statistical power 
to detect associations10 and might partially explain why we did not observe a decreasing trend of 
urinary t,t-MA detectable percentage with time of cleanup in smokers.  In addition, tobacco smoke 
contains benzene and significantly increases the concentration of urinary t,t-MA in smokers 
compared to nonsmokers.11  Compared to 1-OHPG, the percentage of detectable t,t-MA samples 
among nonsmokers decreased more rapidly with days of cleanup than the decline in levels of 1-
OHPG.  The rapid decline in detectable t,t-MA, is not unexpected as benzene is relatively more 
volatile than pyrene, and would be expected to evaporate within a few days of the oil spill.   
 These findings contribute to our knowledge of possible benzene exposure among oil spill 
cleanup workers.  The observation that urinary t,t-MA declined over the course of the cleanup 
among non-smokers strongly suggests that the workers did experience elevated benzene exposure 
in the early days of the cleanup.  Urinary t,t-MA measured in other studies of oil spill workers is 
somewhat conflicting.  Ha et al (2012) found that levels of urinary t,t-MA of workers at the Hebei 
spill were higher after cleanup participation compared to levels before participation among both 
smokers and nonsmokers,12 whereas, in another group of Hebei spill cleanup workers, Cheong et 
al (2011) reported no difference in t,t-MA levels between workers and unexposed controls.   
  
Specific Aim 3: To examine the association between levels of internal dose biomarkers and acute 
symptoms previously recorded. 
In the second manuscript, Chapter 4, the prevalence of post-shift acute symptoms among 
the oil spill workers and their associations with potential causative factors, including internal dose 
biomarkers of PAH and benzene exposure, were explored and assessed.  We further examined 
causative factors associated with groups of correlated symptoms determined by factor analysis.   
 Prevalence of some post-shift symptoms, including irritation of throat and nose, increased 
with concentration of urinary 1-OHPG.  Similarly, one group of symptoms designated as “irritative 
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symptoms” in factor analysis, including irritation of the eye, throat and/or nose, eye injection 
(redness) and excessive tearing (epiphora), was also associated with increased concentration of 
urinary 1-OHPG.  Our study suggests that the levels of PAHs (or other compounds) present at oil 
spill sites are sufficient to cause irritative symptoms in cleanup workers.  On the other hand, none 
of the physical symptoms reported by workers were associated with urinary t,t-MA.  This may be 
due to the relatively low proportion of workers with detectable urinary t,t-MA in our study, and is 
consistent with the knowledge that benzene causes acute symptoms only at relatively high 
concentrations in air (> 50 ppm).15, 16  While previous studies from the Hebei oil spill reported that 
musculoskeletal symptoms were associated with urinary 1-hydroxypyrene (Cheong et al.)13, and 
dermal irritation was associated with concentration of urinary t,t-MA (Ha et al),12 our study is the 
first to show an association between a group of correlated irritative symptoms and internal dose of 
PAHs.12, 13   
 We also examined the prevalence of post-shift symptoms by days of cleanup.  We found 
that prevalence of dizziness decreased in subsequent days/weeks of cleanup, compared to the first 
three days (day 2-4) of cleanup.  This was consistent with our measure of internal dose of PAHs, 
urinary 1-OHPG, which decreased significantly over the 4 week course of the cleanup.  Conversely, 
other symptoms did not decrease (or even increased) in subsequent days of cleanup, compared to 
day 2-4 of cleanup.  Many factors, including those stated above, may have influenced the 
prevalence of symptoms, in addition to PAH exposure.  For example, we examined the prevalence 
of post-shift symptoms by age of workers, and found that workers aged 40 years and older reported 
higher prevalence of symptoms, including irritated throat, irritated eyes, irritated nose, blurred 
vision and red eye (eye injection), than younger workers.  
 In our study, prevalence of symptoms also varied by job description in an unexpected 
pattern.  For example, prevalence of irritated throat and nose, sore throat, and heavy breathing was 
highest in the support personnel (a group with the lowest median level of urinary 1-OHPG in our 
exposure study), compared to oil contaminated sand/trash removal workers and oil vacuum/oil slick 
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removal workers.  These findings are complicated by the fact that most of the higher exposure jobs 
were performed by military personnel and PTTGC employees, whereas the support personnel 
consisted mostly of citizen volunteers.  In addition to being younger, the military personnel and 
PTTGC employees may have been better informed and more thoroughly instructed regarding the 
potential hazards and safety procedures of oil spill cleanup work.   This training may, in turn, have 
influenced their perception of the risks involved and related symptoms.   
 We also examined the association between post-shift symptoms and personal protective 
equipment (PPE) use. The overall findings on the effectiveness of PPE use were not consistent. 
Although wearing at least one piece of PPE appeared to be protective against cough, diarrhea, and 
chest tightness, other symptoms did not decrease in prevalence (or in some cases increased in 
prevalence) with use of PPEs, including mask, gloves, boots, or the complete set of PPEs. This 
finding is analogous to our earlier observation that PPE use did not appear to influence internal 
PAH dose among the workers, but we cannot rule out the possibility that the PPEs were not used 






PUBLIC HEALTH IMPLICATION AND FUTURE RESEARCH 
 Since fossil fuels remain a major source of energy, the probability of oil spills and their 
consequences to human health and the environment, persists.  A prudent strategy to deal with these 
unwanted events may be to have an emergency response plan in place prior to spills occurring.  In 
addition to efforts to contain and remove oil-contaminated debris from the environment, such a 
plan should consider the health of people residing near the spill site and workers participating in 
the cleanup.  
Many health and exposure studies of oil spill cleanup workers have severe limitations due 
to the fact that oil spills are unpredictable, thereby resulting in studies designed and implemented 
on very short notice.  Exposure and health assessment instruments are rarely in place during the 
critical early days of an oil spill response.  Most studies are cross-sectional in design and seldom 
have pre-exposure baseline data, thus limiting their ability to assess causal inference.  Investigations 
of health effects following an oil spill often use self-reported symptoms that are subjective and can 
be unreliable.  For these reasons, it is difficult to assess the magnitude of an increase in exposure 
or prevalence of post-shift symptoms and causal inference. 
 Our study emphasizes the risk of exposure to PAHs in oil spill cleanup workers, especially 
during the first days and weeks of cleanup.  The evidence for exposure to benzene among the 
workers is less compelling, but suggests that some of the workers may have experienced benzene 
exposures during the early days of cleanup.  Based on our results, the current health surveillance 
plan of the Rayong hospital will focus on the oil spill cleanup workers who experienced the highest 
PAH exposures, based on internal dose measurements during the first week of cleanup, that is, oil 
vacuuming/oil slick removal workers and sand/trash removal workers.  This plan is currently 
supported by the Thai government for a period of up to 5 years.  Because benzene and some PAHs 
are carcinogens, it may be prudent to continue to follow these workers, and others similarly 
exposed, for periods longer than 5 years.  Long term surveillance could be passive, using the Thai 
national cancer registry.   
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Since our worker symptom results showed that only irritative symptoms were associated 
with PAH exposure, it may be necessary to include more objective measurements of early effects, 
such as biomarkers of oxidative stress, e.g., urinary malondialdehyde (MDA).  These biomarkers 
have been associated with PAH exposure in several studies,14, 15 and could prove useful in 
understanding the association between acute symptoms and PAHs.   There is also a need for 
standardized symptom questionnaires designed for oil spill cleanup workers, as well as 
standardized sample collection strategies.  Standard health guidelines and symptom questionnaires 
for oil spill cleanup workers should be established internationally.   
There are also significant ethical issues associated with conducting epidemiological 
research following public health emergencies, such as oil spills.  For example, Resnick et al16    have 
examined a variety of ethical issues encountered in the GuLF Study following the Deepwater 
Horizon spill, including obtaining valid informed consent on short notice, expediting IRB review, 
and preparing for future events.  They suggest “developing protocols, consent forms, survey 
instruments, and other documents prior to the advent of a public health emergency to allow for 
adequate and timely review.”  This would allow for more rapid implementation of health related 
studies.   
 Regarding future studies, the optimal study design would be a longitudinal study assessing 
worker exposure and health consequences over the course of their participation in an oil spill 
cleanup.  Although difficult to implement on short notice, this approach would allow the 
exploration of temporal exposure and outcome patterns.  In addition, biomarkers of internal dose 
and early biological effects should be used to monitor exposure and health outcomes over time.  
Improved biomarkers for benzene exposure, such as, urinary S-phenyl mercapturic acid, which is 
more specific for benzene than t,t-MA, could be used in future studies.  Also, genetic 
polymorphisms in phase I enzymes, such as CYP1A1 and CYP1B117, and phase II enzymes, such 
as glutathione S-transferases, N-acetyltransferase-1, and epoxide hydrolase, might explain some of 
the variation in levels of internal dose and symptoms that we observed.  
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Additional studies are needed to explore the occurrence and persistence of symptoms 
among oil spill cleanup workers with complementary exposure data.  Although several studies, 
including ours, reported that PPE use did not appear to reduce internal PAH or benzene dose among 
the workers, we cannot rule out the possibility that workers were subject to exposure recognition 
bias, or that the PPEs were not used properly.  Therefore rigorous PPE training and cleanup 
preparedness for workers, as well as other volunteers, should be implemented before participation 





Rayong oil spill cleanup workers exhibited evidence of elevated levels of PAH and benzene 
exposure during the early days of cleanup, compared to near background levels among workers 
during the fourth week of cleanup.  Certain types of jobs including, oil dispersant applicators, 
contaminated sand/trash removal workers, and oil vacuum/oil slick removal workers, were at 
highest risk for PAH exposure.  Prevalence of acute irritative symptoms were positively 
associated with PAH exposure measured by urinary 1-OHPG.  Therefore, the Rayong oil spill 
cleanup workers may be at risk of developing adverse health consequences.  Long-term health 
monitoring of oil spill cleanup workers should be implemented, particularly among those workers 
suspected of sustaining high exposure to crude oil. Although recommended guidelines for oil spill 
response procedures are well-established, guidelines for recruiting and health monitoring of oil 
spill cleanup workers is less developed.  Standardized health guidelines, sample collection 
methods, and post-shift questionnaires for oil spill cleanup workers should be established 
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APPENDICES, CHAPTER 2 
Appendix 2.1 Laboratory Analysis of Urinary 1-OHPG using Immunoaffinity Chromatography 
and Synchronous Fluorescence Spectroscopy (SFS) 
 
Lab Protocol 
1. Acid Hydrolysis 
- 2 mls of urine + 0.2 ml of 1N HCL 
- Incubate for 1 hr at 90 C using heating blocks 
 
2. Solid Phase (Extraction) 
- Apply C18 Sep-Pak catride with vacuum systems 
- Prime with 4 ml of water, 4 ml of 30% methanol (in water), 4ml of 80% methanol (in 
water),  4 ml of water 
- Load acid hydrolyzed sample by less than 1ml/min of flow rate 
- Wash with 4 ml of water, 4 ml of 30% methanol (in water) 
- Elute with 4 ml of 80% methanol (in water) 
 
3. Evaporating down eluted sample 
- Using Speed Vaccuum with heater on 
- Watching the samples every 20 minutes twice, then every 15 minute 
- Stop evaporating when 0.5 ml of volume left in the tube 
- Add 1.5 mls of 0.5X PBS to each test tube and gently vortex 
- Put reconstituted sample in heating block  at 37 C for 20 minutes 
- Add 2 mls of 0.5X PBS to each tube and vortex 
 
4. Imunoaffinity Chromatography 
- Immunoaffinity columns were prepared using poly-prep columns (0.8x4 cm) filled with 
CNBr-activated Sepharose4B (0.8 ml) coupled with monoclonal antibody 8E11, which 
recognizes PAH metabolites 
- Prewash columns with 4 mls 0.5X PBS 
- Load prepared samples 
- Wash column with 4 mls 0.5X PBS 
- Wash column with 4mls 35% MEOH/0.5X PBS Collect Fraction 
- Wash column with 4mls 60% MEOH/0.5X PBS Collect Fraction 
- Wash column with 4 mls 0.5X PBS 
- Store column with 0.5X PBS 
- Measure 1-OHPG in the final fraction (4mls) with SFS using large curvette 
 
5. SFS Reading 
Using Perkin Elmer LS-50B, Luminescence/Fluorescence Spectrophotometer, the 
wavelength difference was set at 34 nm, samples containing 1-OHPG possess a characteristic 




APPENDICES, CHAPTER 3 
 
Appendix Table 3.1: Urinary 1-OHPG in Oil Spill Workers by Day of Work, Cotinine 













Total  1,343 0.72 0.79 0.31 1.81 
Days of Cleanup 
Week 1.1 Day 2-4 537 0.88 0.97 0.42 2.14 
Week 1.2 Day 5-7 328 0.68 0.75 0.29 1.79 
Week 2 Day 8-14 282 0.72 0.76 0.29 1.92 
Week 3 Day 15-21 115 0.59 0.60 0.29 1.33 
Week 4 Day 22-28 81 0.28 0.32 0.16 0.74 
Cotinine Categories (ng/ml) 
1st Quartile ND-3.0 334 0.54 0.58 0.27 1.37 
2nd Quartile 3.0-37.3 337 0.57 0.58 0.28 1.37 
3rd Quartile 37.3-1,230 336 0.55 0.58 0.26 1.39 
4th Quartile 1,230-3,177 336 1.53 1.65 0.87 3.02 
Nonsmoker <=50.0  679 0.55 0.58 0.27 1.37 
Smokers > 50.0  664 0.93 1.07 0.45 2.28 
Demographic Factors 
Sex Male 1252 0.71 0.78 0.31 1.82 
 Female 90 0.77 0.88 0.36 1.60 
Age 20-30 772 0.65 0.70 0.30 1.61 
 >30 557 0.82 0.91 0.34 2.04 
Background Occupation 
- Military Personnel 
- PTTGC Employee 





















Appendix Table 3.2: Urinary 1-OHPG in Oil Spill Workers by Days of Cleanup Stratified 
by Smoking Status (Based on Cotinine Concentration of 50 ng/ml) 
Variables Description 




















   
Week 1.1 Day 2-4 346 0.73 0.81 0.36 1.71 
Week 1.2 Day 5-7 150 0.50 0.58 0.24 1.36 
Week 2 Day 8-14 122 0.44 0.47 0.23 0.89 
Week 3 Day 15-21 32 0.33 0.31 0.25 0.62 
Week 4 Day 22-28 31 0.14 0.18 0.03 0.32 
Smokers > 50.0 
ng/ml of 
cotinine 







   
Week 1.1 Day 2-4 191 1.24 1.40 0.54 2.89 
Week 1.2 Day 5-7 180 0.86 0.95 0.37 2.33 
Week 2 Day 8-14 160 1.05 1.37 0.57 2.64 
Week 3 Day 15-21 83 0.73 0.78 0.44 1.47 





Appendix Table 3.3:  Urinary 1-OHPG by Personal Protective Equipment (PPE) Use 
(n=1294)* 
PPE USE Details 






Median 1st Quartile 
3rd  
Quartile 
Total  1,343 0.72 0.79 0.31 1.81 
Missing  49 0.90 0.98 0.48 1.99 
Any PPE USE Yes 1,132 0.72 0.78 0.32 1.78 
 No 162 0.71 0.80 0.28 2.03 
Mask  Yes 603 0.80 0.87 0.37 1.97 
(N95, R95) No 691 0.64 0.71 0.28 1.65 
Coverall Yes 523 0.87 0.91 0.40 2.13 
 
No 771 0.62 0.70 0.28 158 
Gloves Yes 770 0.70 0.76 0.31 1.74 
 No 524 0.74 0.80 0.32 1.89 
Boots Yes 589 0.67 0.72 0.31 1.89 
 No 705 0.75 0.82 0.32 1.73 
Frequency Never 46 0.99 0.95 0.41 2.50 
 Sometimes 426 0.70 0.80 0.31 1.75 
 Often 737 0.71 0.76 0.31 1.81 
 Missing 134 077 0.93 0.30 1.90 
 





Appendix Table 3.4: Urinary t,t-MA Detectable in Oil Spill Workers by Day of Work, 
Cotinine Concentration, and Demographic Factors 






N Percent N Percent 
Total  1,343 436 32.5 907 67.5 
 
Days of Cleanup 
Week 1.1 Day 2-4 537 161 30.0 376 70.0 0.460 
Week 1.2 Day 5-7 328 112 34.1 216 65.9 
 
Week 2 Day 8-14 282 97 34.4 185 65.6 
 
Week 3-4 Day 15-28 196 66 33.7 130 66.3 
 
Cotinine Categories (ng/ml) 
1st Quartile ND-3.0 334 71 21.3 263 78.7 <0.001 
2nd Quartile 3.0-37.3 337 71 21.1 266 78.9 
 
3rd Quartile 37.3-1,230 336 76 22.6 260 77.4 
 
4th Quartile 1,230-3,177 336 218 64.9 118 35.1 
 
Non-Smoker <=50.0  679 144 21.2 535 78.8 <0.001 
Smokers > 50.0  664 292 44.0 372 56.0 
 
Demographic Factors 
Sex Male 1252 407 32.5 845 67.5 1.000 
 Female 90 29 32.2 61 67.8  
Age 20-30 772 252 32.6 520 67.4 0.919 
 >30 557 179 32.1 378 67.9  
Background Occupation 
- Military Personnel 
- PTTGC Employee 




















*P-value by chi-squared test 





Appendix Table 3.5: Urinary t,t-MA Detectable in Oil Spill Workers by Day of Work 
Stratified by Smoking Status (Based on Cotinine Concentration of 50 ng/ml)  






(Cotinine <=50 ng/ml) 
Smokers 














Total  679 144 21.2 664 292 44.0 
Week 1.1 Day 2-4 346 91 26.3 191 70 36.6 
Week 1.2 Day 5-7 148 31 20.9 180 81 45.0 
Week 2 Day 8-14 122 18 14.8 160 79 49.4 
Week 3-4 Day 15-28 63 4 6.3 133 62 46.6 
 P-Trend* 0.001 0.090 
 
*P-Trend by Kruskal-Wallis 





Appendix Table 3.6:  Urinary t,t-MA Detectable in Oil Spill Workers by Job Description 
Stratified by Smoking Status (Based on Cotinine Concentration of 50 ng/ml) 
   Urinary t,t-MA Detectable (>LOQ) 
Job Descriptions Nonsmokers 
(Cotinine <=50 ng/ml) 
Smokers  
(Cotinine >50 ng/ml) 
Total Number 
>LOQ 
% >LOQ Total Number 
>LOQ 
% >LOQ 
Total 679 144 21.2 664 292 44.0 
Oil Dispersant 
Applicator 
6 0 0.0 11 5 45.5 
Contaminated Sand/ 
Trash Removal 
356 79 22.2 422 186 44.1 
Environmental 
Sampling Personnel 
8 0 0.0 1 1 100.0 
Oil Vacuum/ 
Oil Slick Removal 
170 35 20.6 145 56 38.6 
Supervisor/Health 
Care Professional 
29 5 17.2 9 5 55.6 
Transport Driver/ 
Ship Pilot 
11 3 27.3 12 8 66.7 
Support Personnel* 42 9 21.4 19 12 63.2 
Others 33 10 30.3 11 6 54.5 





Appendix Table 3.7: Urinary t,t-MA Detectable in Oil Spill Workers by Personal Protective 
Equipment (PPE) Use   
 
  Urinary t,t-MA  




N Percent N Percent 
Total  1,343 436 32.5 907 67.5  
Missing  49 15 3.4 34 3.7  
Any PPE USE Yes 1,132 364 32.2 768 67.8 0.441 
 No 162 57 35.2 105 64.8  
Mask  Yes 603 186 30.8 417 69.2 0.226 
(N95, R95) No 691 235 34.0 456 66.0  
Coverall Yes 523 174 33.3 349 66.7 0.642 
 
No 771 247 32.0 524 68.0  
Gloves Yes 770 257 33.4 513 66.6 0.433 
 No 524 164 31.3 360 68.7  
Boots Yes 589 195 33.1 394 66.9 0.688 
 No 705 226 32.1 479 67.9  
Frequency Never 46 15 32.6 31 67.4 0.744 
 Sometimes 426 147 34.5 279 37.9  
 Often 731 231 31.3 506 118.8  
 





Appendix Table 3.8: Logistic Regression with GEE* of Detectable t,t-MA by Personal 
Protective Equipment (PPE) Use (n=1,294)** 
Type of PPE 
Odds Ratio of t,t-MA Detectable (95% CI) 
Univariable Model Model 1 Model 2 Model 3 
Any PPE Use 
(vs No PPE use) 
0.87 (0.62-1.24) 0.89 (0.63-1.28) 0.88 (0.60-1.29) 0.86 (0.56-1.34) 
Mask 
(vs No Mask use) 
0.87 (0.68-1.09) 0.92 (0.71-1.19) 0.95 (0.72-1.26) 0.99 (0.72-1.36) 
Coverall 
(vs No Coverall use) 
1.06 (0.83-1.34) 1.15 (0.88-1.50) 1.07 (0.80-1.43) 1.07 (0.77-1.48) 
Gloves 
(vs No Gloves use) 
1.10  (0.87-1.40) 1.06 (0.82-1.35) 1.03 (0.79-1.35) 0.95 (0.70-1.29) 
Boots 
(vs No Boots use) 




















Model 1: Adjusted by days of cleanup (day 2-4, day 5-7, day 8-14, day 15-21 and day 22-28) 
Model 2: Adjusted by days of cleanup and urinary cotinine 
Model 3: Adjusted by days of cleanup, urinary cotinine and creatinine 
 
* Generalized Estimating Equation (GEE, Exchangeable Correlation Structure) 
**49 workers had at least one piece of missing data 
 
Bold numbers indicate statistically significant results. (P<0.05)
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Appendix Table 4.1: Prevalence of Post-Shift Symptoms by Cotinine Levels (Less than or 





(Cotinine <50 ng/ml) 
Smokers 
(Cotinine > 50 ng/ml) P-value* 
 N % N % N % 
Total Workers 1343 100.0 679 100.0 664 100.0 
 
Any Symptoms 487 36.3 242 35.6 245 36.9 0.553 
Dizziness 142 10.6 75 11.0 67 10.1 0.604 
Irritated Throat 124 9.2 63 9.3 61 9.2 0.991 
Irritated Eyes 120 8.9 63 9.3 57 8.6 0.689 
Muscle Pain 105 7.8 55 8.1 50 7.5 0.729 
Irritated Nose 99 7.4 61 9.0 38 5.7 0.025 
Sore Throat 80 6.0 31 4.6 49 7.4 0.027 
Cough 75 5.6 25 3.7 50 7.5 0.002 
Heavy Breathing 70 5.2 34 5.0 36 5.4 0.707 
Running Nose 68 5.1 31 4.6 37 5.6 0.381 
Itching of Skin 39 2.9 21 3.1 18 2.7 0.695 
Nausea 38 2.8 22 3.2 16 2.4 0.372 
Blurred Vision 31 2.3 13 1.9 18 2.7 0.320 
Feeling Faint 27 2.0 12 1.8 15 2.3 0.507 
Abdominal Pain 25 1.9 8 1.2 17 2.6 0.058 
Ephiphora 24 1.8 10 1.5 14 2.1 0.369 
Diarrhea 21 1.6 9 1.3 12 1.8 0.465 
Eye Injection  20 1.5 9 1.3 11 1.7 0.604 
Eczema 19 1.4 7 1.0 12 1.8 0.222 
Chest Tightness 16 1.2 6 0.9 10 1.5 0.286 
Palpitation 16 1.2 5 0.7 11 1.7 0.116 
Injuries 13 1.0 4 0.6 9 1.4 0.147 
Taste Change 8 0.6 4 0.6 4 0.6 0.966 
Vomiting 3 0.2 1 0.1 2 0.3 0.546 
 
*P-value from chi-squared test or Fisher’s exact test. 
Bold numbers indicate statistically significant results. (P<0.05) 
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N % N % N % 
Number of Workers 189 100.0 402 100.0 743 100.0  










Male 151 79.9 351 87.3 742 99.9 <0.001 
Female 38 20.1 51 12.7 1 0.1  
 
*9 workers with missing background occupation data 
**P-Value from Kruskal-Wallis test for age and Fisher’s exact test for sex. 




Appendix Table 4.3: Adjusted Odds Ratio of Post-Shift Symptoms (per 1 pmol/ml increase 
in 1-OHPG) (n=1,318)*  
Post-Shift Symptoms 
Crude Odds Ratio** Adjusted Odd Ratio*** 
OR (95%CI) OR (95%CI) 
Dizziness 0.94 (0.85 - 1.01) 0.93 (0.83 - 1.01) 
Irritated Throat  1.04 (1.00 - 1.08) 1.05 (1.01 - 1.10) 
Irritated Eyes 1.02 (0.97 - 1.06) 1.03 (0.98 - 1.07) 
Muscle Pain 1.00 (0.92 - 1.04) 1.01 (0.95 - 1.06) 
Irritated Nose          1.04 (1.00 - 1.08) 1.05 (1.01 - 1.10) 
Sore Throat 0.96 (0.85 - 1.04) 1.00 (0.90 - 1.05) 
Cough 0.86 (0.71 - 0.99) 0.80 (0.64 - 0.94) 
Heavy Breathing 0.99 (0.88 - 1.05) 1.00 (0.88 - 1.06) 
Running Nose 1.00 (0.91 - 1.05) 1.03 (0.96 - 1.08) 
Itching of the Skin 1.02 (0.93 - 1.07) 1.02 (0.94 - 1.07) 
Nausea 0.91 (0.72 - 1.04) 0.95 (0.75 - 1.06) 
Blurred Vision 1.00 (0.86 - 1.07) 1.00 (0.85 - 1.06)  
Feeling Faint 1.01 (0.87 - 1.07) 1.03 (0.88 - 1.10) 
Abdominal Pain 0.96 (0.74 - 1.06) 0.97 (0.73 - 1.06)  
Excessive Eye Tearing (Epiphora) 1.03 (0.93 - 1.08) 1.04 (0.94 - 1.09) 
Diarrhea 0.40 (0.16 - 0.76) 0.47 (0.18 - 0.91)  
Eye Injection (Redness) 1.05 (0.98 - 1.10) 1.05 (0.98 - 1.11) 
Eczema 1.00 (0.80 - 1.07) 0.99 (0.77 - 1.06) 
Chest Tightness 0.77 (0.43 - 1.03) 0.64 (0.33 - 0.99) 
Palpitation 1.01 (0.83 - 1.08) 1.02 (0.82 - 1.09) 
Injuries 0.76 (0.39 - 1.04) 0.79 (0.39 - 1.06) 
Taste Change 0.95 (0.55 - 1.09) 0.98 (0.57 - 1.12) 
Vomiting Prevalence is too small to perform regression 
 
* 25 workers with missing symptom data 
** Unadjusted odds ratio (Univariable model) 
*** Odds ratio adjusted by urinary cotinine and days of cleanup (Multivariable Model) 




Appendix Table 4.4: Adjusted Odds Ratio of Post-Shift Symptoms, Further Adjusting for 
Age of Workers (per 1 pmol/ml increase in 1-OHPG) (n=1,318)*  
Post-Shift Symptoms 
Crude Odds Ratio** Adjusted Odd Ratio*** 
OR (95%CI) OR (95%CI) 
Dizziness 0.94 (0.85 - 1.01) 0.93 (0.83 - 1.01) 
Irritated Throat  1.04 (1.00 - 1.08) 1.04 (1.00 - 1.09) 
Irritated Eyes 1.02 (0.97 - 1.06) 1.02 (0.97 - 1.06) 
Muscle Pain 1.00 (0.92 - 1.04) 1.01 (0.94 - 1.05) 
Irritated Nose          1.04 (1.00 - 1.08) 1.04 (1.00 - 1.09) 
Sore Throat 0.96 (0.85 - 1.04) 1.00 (0.90 - 1.05) 
Cough 0.86 (0.71 - 0.99) 0.96 (0.79 - 1.05) 
Heavy Breathing 0.99 (0.88 - 1.05) 0.99 (0.88 - 1.05) 
Running Nose 1.00 (0.91 - 1.05) 1.03 (0.96 - 1.08) 
Itching of the Skin 1.02 (0.93 - 1.07) 1.02 (0.93 - 1.07) 
Nausea 0.91 (0.72 - 1.04) 0.94 (0.74 - 1.05) 
Blurred Vision 1.00 (0.86 - 1.07) 0.98 (0.83 - 1.05) 
Feeling Faint 1.01 (0.87 - 1.07) 1.05 (0.89 - 1.12) 
Abdominal Pain 0.96 (0.74 - 1.06) 0.98 (0.74 - 1.07) 
Excessive Eye Tearing (Epiphora) 1.03 (0.93 - 1.08) 1.03 (0.93 - 1.08) 
Diarrhea 0.40 (0.16 - 0.76) 0.46 (0.18 - 0.90) 
Eye Injection (Redness) 1.05 (0.98 - 1.10) 1.04 (0.96 - 1.09) 
Eczema 1.00 (0.80 - 1.07 0.99 (0.78 - 1.06) 
Chest Tightness 0.77 (0.43 - 1.03) 0.63 (0.32 - 0.98) 
Palpitation 1.01 (0.83 - 1.08) 1.02 (0.82 - 1.09) 
Injuries 0.76 (0.39 - 1.04) 0.80 (0.39 - 1.08) 
Taste Change 0.95 (0.55 - 1.09) 0.98 (0.57 - 1.12) 
Vomiting Prevalence is too small to perform regression 
 
* 25 workers with missing symptom data 
** Unadjusted odds ratio (Univariable model) 
*** Odds ratio adjusted by urinary cotinine, days of cleanup and age of workers (Multivariable Model) 





Appendix Table 4.5: Prevalence of Post-Shift Symptoms by Detectable t,t-MA 
Post-Shift 
Symptoms 
Total Non-detectable Detectable 
P-value 
N % N % N % 
Total Workers 1,343 100.0 907 100.0 436 48.1  
Dizziness 142 10.6 95 10.5 47 5.2 0.662 
Irritated Throat  124 9.2 81 8.9 43 4.7 0.432 
Irritated Eyes 120 8.9 86 9.5 34 3.7 0.382 
Muscle Pain 105 7.8 67 7.4 38 4.2 0.157 
Irritated Nose          99 7.4 72 7.9 27 3.0 0.746 
Sore Throat 80 6.0 58 6.4 22 2.4 0.415 
Cough 75 5.6 50 5.5 25 2.8 0.806 
Heavy Breathing 70 5.2 44 4.9 26 2.9 0.328 
Running Nose 68 5.1 52 5.7 16 1.8 0.149 
Itching of the Skin 39 2.9 29 3.2 10 1.1 0.461 
Nausea 38 2.8 28 3.1 10 1.1 0.893 
Blurred Vision 31 2.3 19 2.1 12 1.3 0.528 
Feeling Faint 27 2.0 18 2.0 9 1.0 0.775 
Abdominal Pain 25 1.9 14 1.5 11 1.2 0.592 
Excessive Eye Tearing (Epiphora) 24 1.8 15 1.7 9 1.0 0.676 
Diarrhea 21 1.6 14 1.5 7 0.8 0.508 
Eye Injection (Redness) 20 1.5 13 1.4 7 0.8 0.849 
Eczema 19 1.4 12 1.3 7 0.8 0.920 
Chest Tightness 16 1.2 12 1.3 4 0.4 0.187 
Palpitation 16 1.2 12 1.3 4 0.4 0.499 
Injuries 13 1.0 11 1.2 2 0.2 0.137 
Taste Change 8 0.6 5 0.6 3 0.3 0.560 
Vomiting 3 0.2 3 0.3 0 0.0 0.662 
 




Appendix Table 4.6: Adjusted Odds Ratio of Post-Shift Symptoms by Detectable t,t-MA 
(n=1,318)*  
Post-Shift Symptoms 
Crude Odds Ratio** Adjusted OR*** 
OR (95%CI) OR (95%CI) 
Dizziness 1.02 (0.70 - 1.47) 1.09 (0.73 - 1.62) 
Irritated Throat  1.04 (1.00 - 1.08) 1.19 (0.77 - 1.82) 
Irritated Eyes 0.80 (0.52 - 1.20) 0.82 (0.52 - 1.27) 
Muscle Pain 1.19 (0.78 - 1.79) 1.40 (0.87 - 2.23) 
Irritated Nose          0.76 (0.47 - 1.19) 0.92 (0.56 - 1.49) 
Sore Throat 0.77 (0.46 - 1.26) 0.79 (0.44 - 1.38) 
Cough 1.03 (0.62 - 1.68) 0.93 (0.50 - 1.68) 
Heavy Breathing 1.23 (0.74 - 2.02) 1.31 (0.75 - 2.24) 
Running Nose 0.62 (0.34 - 1.08) 0.62 (0.31 - 1.16) 
Itching of the Skin 0.70 (0.32 - 1.41) 0.74 (0.31 - 1.61) 
Nausea 0.73 (0.33 - 1.47) 0.95 (0.42 - 2.00) 
Blurred Vision 1.31 (0.61 - 2.70) 1.30 (0.56 - 2.88) 
Feeling Faint 1.03 (0.44 - 2.26) 0.88 (0.34 - 2.10) 
Abdominal Pain 1.64 (0.72 - 3.63) 1.30 (0.49 - 3.31) 
Excessive Eye Tearing (Epiphora) 1.24 (0.52 - 2.82) 1.22 (0.46 - 3.04) 
Diarrhea 1.03 (0.39 - 2.50) 1.43 (0.47 - 4.01) 
Eye Injection (Redness) 1.11 (0.42 - 2.74) 1.10 (0.37 - 3.00) 
Eczema 1.21 (0.45 - 3.03) 1.06 (0.34 - 3.04) 
Chest Tightness 0.69 (0.19 - 1.98) 0.42 (0.10 - 1.42) 
Palpitation 0.68 (0.79 - 1.98) 0.65 (0.46 - 2.09) 
Injuries 0.37 (0.06 - 1.39) 0.28 (0.04 - 1.27) 
Taste Change 1.24 (0.25 - 5.08) 1.58 (0.29 - 7.08) 
Vomiting Prevalence is too small to perform regression 
 
* 25 workers with missing symptom data 
** Unadjusted odds ratio (Univariable model) 
*** Odds ratio adjusted by urinary cotinine and days of cleanup (Multivariable Model) 





Appendix Table 4.7: Adjusted Odds Ratio of Post-Shift Symptoms by Detectable t,t-MA, 
Further Adjusting for Age of Workers (n=1,318)*  
Post-Shift Symptoms 
Crude Odds Ratio** Adjusted OR*** 
OR (95%CI) OR (95%CI) 
Dizziness 1.02 (0.70 - 1.47) 1.11 (0.74 - 1.65) 
Irritated Throat  1.04 (1.00 - 1.08) 1.04 (1.00 - 1.09) 
Irritated Eyes 0.80 (0.52 - 1.20) 0.80 (0.50 - 1.24) 
Muscle Pain 1.19 (0.78 - 1.79) 1.37 (0.85 - 2.19) 
Irritated Nose          0.76 (0.47 - 1.19) 0.89 (0.53 - 1.44) 
Sore Throat 0.77 (0.46 - 1.26) 0.77 (0.42 - 1.36) 
Cough 1.03 (0.62 - 1.68) 0.95 (0.51 - 1.72) 
Heavy Breathing 1.23 (0.74 - 2.02) 1.30 (0.74 - 2.22) 
Running Nose 0.62 (0.34 - 1.08) 0.62 (0.31 - 1.17) 
Itching of the Skin 0.70 (0.32 - 1.41) 0.70 (0.29 - 1.55) 
Nausea 0.73 (0.33 - 1.47) 0.96 (0.42 - 2.03) 
Blurred Vision 1.31 (0.61 - 2.70) 1.21 (0.51 - 2.70) 
Feeling Faint 1.03 (0.44 - 2.26) 0.92 (0.36 - 2.19) 
Abdominal Pain 1.64 (0.72 - 3.63) 1.34 (0.51 - 3.42) 
Excessive Eye Tearing (Epiphora) 1.24 (0.52 - 2.82) 1.12 (0.42 - 2.83) 
Diarrhea 1.03 (0.39 - 2.50) 1.41 (0.46 - 3.97) 
Eye Injection (Redness) 1.11 (0.42 - 2.74) 0.95 (0.31 - 2.64) 
Eczema 1.21 (0.45 - 3.03) 1.07 (0.34 - 3.08) 
Chest Tightness 0.69 (0.19 - 1.98) 0.40 (0.10 - 1.36) 
Palpitation 0.68 (0.79 - 1.98) 0.66 (0.16 - 2.11) 
Injuries 0.37 (0.06 - 1.39) 0.30 (0.04 - 1.33) 
Taste Change 1.24 (0.25 - 5.08) 1.59 (0.29 - 7.16) 
Vomiting Prevalence is too small to perform regression 
 
* 25 workers with missing symptom data 
** Unadjusted odds ratio (Univariable model) 
*** Odds ratio adjusted by urinary cotinine, days of cleanup and age of workers (Multivariable Model) 












Oil Slick Removal P-value* 
N % N % N % 
Total Number 60 100.0 775 100.0 315 100.0  










Male 47 78.3 726 93.7 307 97.5 <0.001 
Female 13 21.7 49 6.3 8 2.5  
 
*P-Value from Kruskal-Wallis test for age and Fisher’s exact test for sex. 




Appendix Table 4.9: Unadjusted Odds Ratio of Post-Shift Symptoms by Job Description 
(n=1,150) 






Oil Slick Removal 
OR OR** (95% CI) OR** (95% CI) 
Dizziness 1.00 (Ref) 0.78 (0.38 - 1.82) 0.73 (0.33 - 1.79) 
Irritated Throat 1.00 (Ref) 0.27 (0.14 - 0.52) 0.20 (0.10 - 0.43) 
Irritated Eyes 1.00 (Ref) 0.57 (0.26 - 1.42) 0.98 (0.44 - 2.50) 
Muscle Pain 1.00 (Ref) 1.71 (0.61 - 7.15) 1.71 (0.58 - 7.34) 
Irritated Nose 1.00 (Ref) 0.31 (0.16 - 0.67) 0.35 (0.16 - 0.79) 
Sore Throat 1.00 (Ref) 0.48 (0.22 - 1.20) 0.54 (0.23 - 1.43) 
Cough 1.00 (Ref) NA    
Heavy Breathing 1.00 (Ref) 0.34 (0.16 - 0.83) 0.28 (0.11 - 0.74) 
Running Nose 1.00 (Ref) 2.04 (0.61 - 12.68) 1.14 (0.30 - 7.50) 
Itching of the Skin 1.00 (Ref) 0.43 (0.14 - 1.86) 0.75 (0.23 - 3.38) 
Nausea 1.00 (Ref) 0.21 (0.08 - 0.61) 0.29 (0.10 - 0.90) 
Blurred Vision 1.00 (Ref) 0.46 (0.12 - 2.98) 0.85 (0.21 - 5.69) 
Feeling Faint 1.00 (Ref) NA    
 
*Coordinators, PTTGC Corporate Representatives, Visitors, Photographers, and Journalists were grouped as support 
personnel. 
 
**Odds ratio from univariable model. 
Bold numbers indicate statistically significant results. (P<0.05) 
NA because the prevalence of symptoms in the reference group is too small to calculate the odd ratio: 0/60 in cough, 
0/60 feeling faint 
 
For abdominal pain, epiphora, diarrhea, eye injection, eczema, chest tightness, palpitation, injuries, taste change and 




Appendix Table 4.10: Adjusted Odds Ratio of Post-Shift Symptoms by Job Descriptions, 
Further Adjusting for Age of Workers (n=1,150) 






Oil Slick Removal 
OR OR** (95% CI) OR** (95% CI) 
Dizziness 1.00 (Ref) 0.98 (0.46-2.36) 0.92 (0.40-2.31) 
Irritated Throat 1.00 (Ref) 0.29 (0.14-0.59) 0.24 (0.11-0.55) 
Irritated Eyes 1.00 (Ref) 0.87 (0.38-2.25) 1.55 (0.65-4.15) 
Muscle Pain 1.00 (Ref) 2.03 (0.67-8.82) 2.47 (0.77-11.12) 
Irritated Nose 1.00 (Ref) 0.43 (0.20-0.96) 0.47 (0.20-1.13) 
Sore Throat 1.00 (Ref) 0.35 (0.14-0.97) 0.53 (0.20-1.52) 
Cough 1.00 (Ref) NA    
Heavy Breathing 1.00 (Ref) 0.34 (0.15-0.87) 0.0 (0.11-0.84) 
Running Nose 1.00 (Ref) 1.02 (0.27-6.71) 0.82 (0.20-5.64) 
Itching of the Skin 1.00 (Ref) 0.38 (0.11-1.82) 0.67 (0.18-3.29) 
Nausea 1.00 (Ref) 0.33 (0.12-1.02) 0.46 (0.15-1.53) 
Blurred Vision 1.00 (Ref) 0.73 (0.17-5.08) 1.40 (0.30-10.23) 
Feeling Faint 1.00 (Ref) NA    
 
*Coordinators, PTTGC Corporate Representatives, Visitors, Photographers, and Journalists were grouped as support 
personnel. 
 
**Odds ratio adjusted by urinary cotinine, days of cleanup and age of workers 
Bold numbers indicate statistically significant results. (P<0.05) 
NA because the prevalence of symptoms in the reference group is too small to calculate the odds ratio: 0/60 in cough, 
0/60 feeling faint 
 
For abdominal pain, epiphora, diarrhea, eye injection, eczema, chest tightness, palpitation, injuries, taste change and 





Appendix Table 4.11: Unadjusted Odds Ratio of Symptom Groups by Job Descriptions 
from Simple Logistic Regression and Factor Analysis (n=1,150) 
 






Oil Slick Removal 
OR* OR* (95% CI) OR* (95% CI) 
Chest Symptoms  1.00 (Ref) NA  NA  
Allergic Skin Reaction 1.00 (Ref) 0.45 (0.15 - 1.97) 1.02 (0.32  -  4.47) 
Irritative Symptoms 1.00 (Ref) 0.45 (0.26 - 0.82) 0.54 (0.30  -  1.01) 
Gastrointestinal Symptoms 1.00 (Ref) 1.72 (0.35 - 31.14) 1.93 (0.36  -  35.83) 
Respiratory Symptoms 1.00 (Ref) 1.01 (0.49 - 2.35) 0.86 (0.40  -  2.09) 
Sensation Errors 1.00 (Ref) 1.32 (0.26 - 24.05) 2.34 (0.45  -  42.97) 
Heavy Breathing 1.00 (Ref) 0.34 (0.16 - 0.83) 0.28 (0.11  -  0.74) 
 
*Odds ratio from Univariable Model 
NA, sample size too small to calculate Odds Ratio. 0/60 support personnel had chest symptoms. 















N % N % N % 
Number of Workers 189 100.0 402 100.0 703 100.0   
Dizziness 29 15.3 39 9.7 74 10.5 0.045 
Irritated Throat 35 18.5 30 7.5 59 8.4 <0.001 
Irritated Eyes 32 16.9 23 5.7 65 9.2 <0.001 
Muscle Pain 14 7.4 35 8.7 56 8.0 0.773 
Irritated nose 31 16.4 29 7.2 39 5.5 <0.001 
Sore Throat 14 7.4 16 4.0 50 7.1 0.104 
Cough 3 1.6 6 1.5 66 9.4 <0.001 
Heavy Breathing 19 10.1 10 2.5 41 5.8 <0.001 
Running Nose 6 3.2 14 3.5 48 6.8 0.046 
Skin Itching 9 4.8 13 3.2 17 2.4 0.146 
Nausea 11 5.8 13 3.2 14 2.0 0.009 
Blurred Vision 10 5.3 4 1.0 17 2.4 0.004 
Feeling Faint 2 1.1 5 1.2 20 2.8 0.162 
Abdominal Pain 1 0.5 4 1.0 20 2.8 0.048 
Epiphora (Tearing) 3 1.6 8 2.0 13 1.8 0.944 
Diarrhea 1 0.5 4 1.0 16 2.3 0.160 
Eye Injection (Red) 7 3.7 4 1.0 9 1.3 0.019 
Eczema 4 2.1 5 1.2 10 1.4 0.634 
Chest Tightness 2 1.1 4 1.0 10 1.4 0.868 
Palpitation 2 1.1 1 0.2 13 1.8 0.085 
Injuries 1 0.5 1 0.2 11 1.6 0.107 
Taste Change 3 1.6 0 0.0 5 0.7 0.043 
Vomiting 0 0.0 1 0.2 2 0.3 1.000 
 
*P-value from Chi-squared or Fisher’s exact test 
** 25 workers with missing symptom data 




Appendix Table 4.13: Adjusted Odds Ratio of Post-Shift Symptoms by Background 




Company Employee Military Personnel 
OR OR* 95%CI OR* 95%CI 
Dizziness 1.00 (Ref) 0.60 (0.36-1.03) 0.78 (0.47-1.30) 
Irritated Throat 1.00 (Ref) 0.37 (0.21-0.63) 0.23 (0.14-0.40) 
Irritated Eyes 1.00 (Ref) 0.31 (0.17-0.55) 0.58 (0.35-0.96) 
Muscle Pain 1.00 (Ref) 1.18 (0.61-2.38) 0.45 (0.22-0.92) 
Irritated nose 1.00 (Ref) 0.36 (0.21-0.62) 0.27 (0.15-0.49) 
Sore Throat 1.00 (Ref) 0.50 (0.23-1.09) 0.37 (0.18-0.77) 
Cough 1.00 (Ref) 1.02 (0.26-4.95) 1.92 (0.63-8.35) 
Heavy Breathing 1.00 (Ref) 0.23 (0.10-0.50) 0.56 (0.30-1.07) 
Running Nose 1.00 (Ref) 0.99 (0.38-2.87) 0.72 (0.27-2.15) 
Itching of the Skin 1.00 (Ref) 0.52 (0.21-1.36) 0.20 (0.07-0.53) 
Nausea 1.00 (Ref) 0.54 (0.23-1.26) 0.32 (0.13-0.80) 
Blurred Vision 1.00 (Ref) 0.18 (0.05-0.56) 0.35 (0.14-0.88) 
Feeling Faint 1.00 (Ref) 1.33 (0.28-9.44) 2.10 (0.54-14.0) 
 
*Odds ratio adjusted by urinary cotinine and days of cleanup 
**25 workers with missing symptom data 
Bold numbers indicate statistically significant results. (P<0.05) 
For abdominal pain, epiphora, diarrhea, eye injection, eczema, chest tightness, palpitation, injuries, taste change and 
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